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ABSTRACT 
 
 
PART I 
 
 The chemistry of propargyliumdicobalt cations, known as the Nicholas reaction, 
has witnessed widespread use in organic synthesis mainly owing to the high stabilization 
of the carbocations, accompanied by their compatibility with numerous nucleophiles. 
However, there is a considerable shortage of studies regarding the factors affecting the 
stability and reactivity of the involved cations. 
 In this project, we investigated the chemistry of a novel Nicholas carbocation, 
namely the benzo-homologue of the dehydrotropylium cation, known as a 
benzodehydrotropyliumCo2(CO)6 cation. To obtain the desired cation, preparation of the 
requisite alcohol precursor involved the key ring-closure of the cycloheptyne via an 
intramolecular Sakurai reaction. Additionally, heterocyclic-based 
cycloheptadienynolCo2(CO)6 complexes were also prepared. A Lewis acid mediated 
ionization of the parent alcohol complex led to the in situ generation of the 
benzodehydrotropyliumCo2(CO)6 ion, which was trapped with several nucleophiles, 
where the preferred site of substitution was the site remote to the dicobalt alkyne unit. 
Computational studies using NICS (1) values estimated the ion's aromaticity to be one 
third of that of tropylium ion, which is comparable to that of the 
dehydrotropyliumCo2(CO)6 ion previously studied in our group.  
 
 
 
 
vi 
 
PART II 
 
 
 Allocolchicinoids are a well-recognized family of compounds (including both 
natural and synthetic derivatives) which possess a 6-7-6 tricyclic core. Many of them are 
known to have antitumor activity where they act by the same mode of action as the 
natural alkaloid colchicine, that is to say by inhibiting the cellular tubulin assembly 
process. 
 Particular attention has been devoted by our group to a series of allocolchicinoids 
bearing a modified A-ring substitution pattern, which is different from the one seen in the 
naturally-derived allocolchicine. Biological studies have shown their potency in targeting 
cancer cells. Considering the dibenzocycloheptanone as the core of the allocolchicine, we 
present herein our results on getting to allocolchicinoids based on an approach that 
constructs the B-ring via catalytic conjugate addition reaction chemistry, ultimately 
leading to the synthesis of allocolchicinoids of interest. The viability of this strategy is 
demonstrated by the preparation of differently substituted C-ring substrates. This work 
also reports the formal synthesis of allocolchicine iso-NSC 51046, and the first total 
syntheses of two novel allocolchicines.  
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PART I 
 
CHAPTER 1: INTRODUCTION 
 
 
1.1     Nicholas Reaction 
 
 For many years, the use of propargylic cations as electrophilic synthons has been 
limited owing to the relatively low ability of the alkynyl function to impart stabilization to 
the generated positive charge. This severe limitation has been overcome by the discovery 
of Nicholas and Pettit
1
 in 1971 when they initially reported the use of dicobalt 
hexacarbonyl (Co2(CO)6) unit as a protecting group for the CC triple bond. During their 
development of this chemistry, the authors noted the facile acid-promoted 
hydration/dehydration equilibrium between the dicobalt hexacarbonyl-complexed 
propargyl alcohols (1) and their corresponding 1,3enynes (2) (Scheme 1.1).2,3  
 
 
 
Scheme 1.1  Equilibrium of hydration/dehydration process of Co2(CO)6complexed   
          propargylic alcohols with their enyne complex. 
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 This observation led to the postulation that the dicobalt hexacarbonyl group is 
capable of stabilizing propargyl carbocation. Stemming from this pioneering finding, 
Nicholas et al.
2
 developed the first substitution reaction involving a dicobalt 
hexacarbonyl-complexed propargylic alcohol (3) in the presence of strong protic acid and 
electron-rich benzene compounds. The generation of a cation (3a), propargylic to an 
alkyneCo2(CO)6 group, usually by ionization of an oxygen-based function by a protic or 
Lewis acid, followed by the trapping of that cation by nucleophiles, is commonly known 
as the Nicholas reaction (Scheme 1.2). 
 
 
 
 
Scheme 1.2  The Nicholas Reaction. 
 
 
 
 Generation of the propargyliumdicobalt cation is not restricted to the acid-
promoted ionization of a propargylic alcohol complex. Alternatively, Smit and Caple
4
 
reported that the carbocation could be generated from different precursors, namely 1,3-
enyneCo2(CO)6 complexes (4) and an electrophile (Scheme 1.3). Subsequently, a mild 
3 
 
oxidative demetalation can regenerate the alkyne functionality of the resulting substituted 
products (5). 
 
 
Scheme 1.3  Generation of propargyliumdicobalt cation from enyneCo2(CO)6 complex. 
 
Cation Stability 
 The remarkable thermodynamic and kinetic stability of 
[propargyliumCo2(CO)6]
+
 cations is evidenced by their convenient isolation and long-
term storability as salts. Owing to their exceptional stability, the salts of such cations have 
been isolated by Connor and Nicholas
5
 as stable, dark red solids upon treatment of the 
Co2(CO)6complexed propargylic alcohols with excess HF-SbF5 or tetrafluoroboric acid 
etherate. The authors also studied the thermodynamic stability of a group of cobalt-
coordinated propargylium cations by determining the pK's for ionization of their 
corresponding alcohol complexes. It was reported that the cations' measured pKR+ value 
ranges from 6.8 to 7.4 (5.5 as reported in another reference6), which in fact is 
comparable to that of the well-known stable cation, triphenylmethyl (trityl, Ph3C
+
) cation, 
whose pKR+ is 6.6. It was also noted that the pKR+ values of the studied propargylic 
carbocations were essentially identical, regardless of the substituents at the cation center.
5
 
4 
 
 Furthermore, the stability of the cations have been also confirmed through 
spectroscopic studies. By comparing the IR spectra of the cationic species and the parent 
alcohol complex, a noticeable increase in the IR absorption frequencies of the CO ligands 
of the cationic complex was evident (~ 40-60 cm-1) when compared to those of the 
alcohol complex. This shift denotes a significant charge delocalization onto the cobalt 
carbonyl unit, a feature that can be rationalized by the increased CO bonding resulting 
directly from reduced d (Co)*(CO) donation in the electron-poor cation.5 
 
Reactivity and Regioselectivity of Propargyliumdicobalt Cations 
 The alkyneCo2(CO)6 complexes are readily prepared by stirring 
octacarbonyldicobalt(0), which is commercially available, and the alkyne-containing 
substrates, to form 2-hexacarbonylalkynedicobalt complexes. The reaction normally 
proceeds at room temperature in many different types of organic solvents such as: diethyl 
ether, tetrahydrofuran, and dichloromethane. A wide scope of alkynes can undergo this 
complexation process, including terminal alkynes, symmetrical and unsymmetrical 
disubstituted alkynes, diynes, triynes, and cyclic alkynes.
7
 The resultant complexes are 
purified by chromatography on alumina or silica gel, to afford the products as dark 
brown, or maroon-red colour oils or solids; they have remarkable stability if stored at low 
temperatures. 
 The versatility of the Nicholas reaction largely arises from the compatibility of the 
generated propargylic electrophilic synthon with a wide range of nucleophilic partners, 
including both inter- and intramolecular processes.
8
 Our group and several others have 
expanded the scope of this reaction by exploring a range of nucleophilic partners such as 
5 
 
electron-rich arenes,
9
 alkenes,
10
 ketones,
11
 hydrides,
12
 allylmetaloids,
13
 and enol 
derivatives including carbon and heteroatom-based ones.
14,15
 In addition, heteroatomic 
nucleophiles like ROH, RNH2, RSH, PR3 are also compatible.
16-18
  
 When the generated cation, propargylic to an alkyneCo2(CO)6 group, is in an 
acyclic system, the nucleophilic substitution tends to occur exclusively at the propargylic 
site,
19
 unless the cation is also allylic (6), in which case the substitution has been found to 
occur predominantly at the terminus remote to the alkyne–Co2(CO)6 unit, i.e. -site         
(7, Scheme 1.4). This bias towards (E)-1,3enynes was first addressed by Padmanabhan 
and Nicholas
19a
 in 1982, where it has been attributed to the considerable steric hindrance 
of the Co2(CO)6 moiety and not to any hypothetical stabilizing conjugative interaction 
between the C=C double bond and the alkyne complex. Some exceptions have been 
encountered in literature, such as cases where the nucleophilic attack reactions are 
entropically driven towards the -site.20 Some oxygen-based nucleophiles proceed 
through -site attack pathway to give the corresponding propargylic substitution 
products.
19a, 21
 
 
 
 
 
Scheme 1.4  Reactivity of acyclic propargylic/allylic cations with nucleophiles. 
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 The site selectivity studies were expanded further when our group targeted allylic 
cations derived from cyclic precursor, namely cycloheptynes based ring systems (Scheme 
1.5).
22
 To gain access to the cation of interest, the requisite precursor (i.e. the cyclic 
allylic acetate alkynedicobalt complex (9)) was obtained readily by ring closing 
metathesis. 
 
 
Scheme 1.5  Reactivity of cyclic propargylic/allylic cations with nucleophiles. 
 
 
 
 
 The results of Nicholas reactions on the cation derived from the cyclic precursor 
(9) showed preferential reaction at the terminus remote (i.e. γ-) to the alkynedicobalt 
function (10), with increasing amounts of -product (11) for reaction partners with 
greater nucleophilicity. Heteroatom-based nucleophiles, which react reversibly, gave -
products (10) exclusively. The thermodynamic preference for the -product has been 
ascribed to the conjugative enyne stabilization in -product. Also, kinetically, this product 
is believed to be favoured since it exhibits less steric hindrance at the -position.22  
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1.2     Angle Strained Alkynes 
 
 A recurring theme in organic synthesis is the development of efficient ways to 
synthesize medium-sized cycloalkynes.
23
 Since the triple bond prefers a linear geometry, 
cycloalkynes often have limited stability.
24
 An eight-membered ring alkyne (13), (Figure 
1.1), is the smallest ring size that can tolerate this deformed geometry and still be isolated 
as a stable molecule.
25
 It has been generally accepted that the CC C bond angle in 
cyclooctyne deviates 17 from the idealized 180 angle of a triple carbon-carbon bond.  
 
 
 
Figure 1.1  Categories of various cycloalkynes based on their occurrence.
26 
 
 In contrast to the isolable medium-sized cycloalkynes, their smaller homologues 
(i.e. five-, six-, and seven-membered cycloalkynes, 14-16) are non-isolable; they are 
however capable of existing as transient and highly reactive reaction intermediates that 
oligomerize rapidly.
28
 The occurrence of these unstable cycloalkynes has been confirmed 
experimentally by careful generation in solution and in a matrix. For example, irradiation 
8 
 
of cyclopropenone compound (19) in an argon matrix at 17 K provided (14) readily and 
allowed the measurement of the vibrational spectrum of cycloheptyne (Scheme 1.6).
29 
 
 
Scheme 1.6  Preparation of cycloheptyne by argon-matrix irradiation. 
 
 To gain access to the aforementioned cycloalkynes "in-solution", these highly 
reactive intermediates were generated in situ in a fast reaction at very low temperatures 
and in the absence of any reactive reagents that might interfere with the triple bond of the 
alkyne. Once formed, these transient species could be trapped with specific reagents, 
hence enabling the measurement of the kinetic stability of the cycloalkynes of interest. 
For instance, in dilute dichloromethane solution at 25 C, cycloheptyne possess a half-
life of less than a minute, but it can be increased to one hour at 78 C.30 Under analogous 
conditions, the lifespan of cyclohexyne at 110 C is only a few seconds. Finally, no 
experimental data supports the existence of cyclic alkynes with lower ring sizes (i.e. five-, 
four-, and three-membered ones). 
 In the vast majority of cycloheptynes and smaller cycloalkynes, the strain of 
bending the formally sp-hybridized carbon atoms substantially away from 180° would be 
accompanied with a great energetic cost. This situation may be alleviated by resorting to 
transition metal complexes of these cycloheptynes, particularly the dicobalt hexacarbonyl 
complexes.
31
 Upon complexation of a carbon-carbon triple bond to a Co2(CO)6 unit, there 
9 
 
are two critical features of the newly formed organometallic complex that are worth 
highlighting: 1) a significant added stabilization to the cation generated at the propargylic 
site, and 2) the normally linear digonally hybridized triple bond bends to ca. 140. These 
specific features have made it possible for chemists to derive reactive intermediates and 
cyclic alkynes which would otherwise not accessible in their metal‐free counterparts.  
 
 
1.3    Preparation of Cycloheptynes and Benzocycloheptynes by Nicholas     
         Reaction Chemistry 
 
 Since its discovery just over four decades ago,
2
 the chemistry of 
cycloheptyneCo2(CO)6 complexes (i.e., the Nicholas reaction) has proven to be 
especially intriguing and widely used in organic transformations owing to the reliable site 
of reactivity of the cations, their ready generation and significant stability, coupled with 
their ability to engage in reaction with a broad spectrum of nucleophiles. The 
intermediacy of these complexes has proven to be particularly reliable in the construction 
of cycloheptynedicobalt complexes.
32 
 Additionally, Nicholas reaction chemistry has proven its efficiency in preparation 
of benzo-fused seven-membered ring compounds, in spite of the scarcity of methods 
developed for quick access for those ring systems. Benzocycloheptanes and 
benzocycloheptanones are of remarkable importance since they are commonly 
encountered in a variety of natural and pharmacologically relevant products including 
icetexanes,
33
 ()-colchicine and its analogue ()-allocolchicine,34 and purpurogalline,35 to 
name a few (Figure 1.2).  
10 
 
 
 
 
Figure 1.2  Selected examples of organic compounds with benzocycloheptane-based       
        skeleton. 
 
 
 
1.3.1   Cycloheptynedicobalt Complexes 
 
 
 In 1986, the early efforts by Schreiber et al.
36
 paved the way for the synthesis of 
this class of compounds. Their reported methodology employed a Lewis acid mediated 
reaction of propargyl ether dicobalt hexacarbonyl complexes bearing a remote allylsilane 
(23), to afford a cycloalkyne complex with an exocyclic vinyl group (24). By varying the 
length of the carbon tether in the substrate, eight and even six-membered rings were 
formed analogously. Another related preparation of this class of compounds was 
developed by our group,
37
 where our initial efforts were primarily driven by the 
developed knowledge about the γ-carbonyl cationCo2(CO)6 complexes and their 
potential use as successful precursors for cycloheptyne formation. With that in mind, and 
following experimentation with different substrate designs, a series of allylsilane 
containing propargylic acetates (25) were deemed to be suitable precursors. In the 
presence of BF3-OEt2, they readily underwent facile intramolecular cyclization via 
11 
 
Nicholas reaction to give cycloheptenynes (26), bearing an endocyclic alkene function, in 
respectable yields (84-89 %), (Scheme 1.7). 
 
 
 
      
 
 
Scheme 1.7  Synthesis of cycloheptyneCo2(CO)6 complexes via intramolecular Nicholas   
          reaction.  
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1.3.2   Benzocycloheptynedicobalt Complexes 
 
 
 The use of acyclic alkynedicobalt complexes and Nicholas reaction chemistry 
have been established as powerful means for rapid preparation of cycloheptyneCo2(CO)6 
complexes. Only a limited number of ring fused versions of these cycloheptyne 
complexes are known; of these, our group has a special academic interest in gaining 
access to benzocycloheptyne complexes. Ding and Green
38
 reported an effective 
utilization of Nicholas reaction in the synthesis of a series of benzocycloheptynedicobalt 
complexes in addition to other heterocyclic analogues. In their synthetic approach, the 
design of the precursor was based on exploiting the ability of propargyldicobalt cations to 
react with electron rich arenes via intramolecular Nicholas reaction to afford the benzo-
fused cycloheptyne complexes. By subjecting the precursor (27) to BF3-OEt2, the 
intended benzocycloheptyne-dicobalt complex was successfully formed (28, Scheme 
1.8). Substrates with electron rich benzene rings underwent the cyclization reaction more 
rapidly (compared to the unsubstituted counterparts). In addition, the reaction scope also 
included successful preparation of hetero-fused cycloheptyne complexes, including 
thienyl, furyl and indole systems.  
 
 
 
 
Scheme 1.8  Preparation of benzocycloheptynedicobalt complexes via intramolecular  
 
          Nicholas reaction. 
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1.4   Preparation of Cycloheptynes and Benzocycloheptynes by Other                 
        Methods 
 
1.4.1   Cycloheptynedicobalt Complexes 
 
 
By Ring Closing Metathesis 
 
 
 Nicholas reaction chemistry is not the sole method to access cycloheptynedicobalt 
complexes. Rapid access to cycloheptenyneCo2(CO)6 complexes is available via ring 
closing metathesis (RCM) chemistry. Green
39
 reported the first RCM reactions on alkyne-
cobalt complexes, where hexacarbonyldicobalt complexes of cycloheptenynes (30a) were 
cleanly obtained by the ring closing metathesis of the corresponding acyclic dienes (29a), 
using Grubbs' catalyst, (Cy3P)2Cl2Ru=CHPh in good to excellent yields (Scheme 1.9). 
 
 
 
Scheme 1.9  Synthesis of cycloheptynedicobalt complexes via ring closing metathesis by   
                   Green.
39 
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 Two years later, Young's group
40
 reported the use of analogous chemistry to 
obtain cycloheptyneCo2(CO)6 complexes (among other medium-sized rings). The 
construction of the seven-membered ring of cycloheptyne was achieved by the metathesis 
of dienes (29b) that were linked by a Co2(CO)6complexed alkyne, in the presence of 
Grubbs I pre-catalyst (Cy3P)2Cl2Ru=CHPh (Scheme 1.10). 
 
 
 
 
 
 Scheme 1.10  Synthesis of cycloheptynedicobalt complexes via ring closing metathesis  
                      by Young et al.
40 
 
  
 
 The first attempted reaction was carried out with dienene substrate (29b), where 
R1= H and R2= OH, but it failed to metathesize under the given conditions. This result 
prompted a structural modification by incorporating a protecting group for the alcohol, 
namely OTBDS, which in fact resulted in successful RCM, and the cyclic product was 
obtained in 80 % yield. A variety of cycloheptynedicobalt complexes (30b) were 
synthesized with variable propargylic substituents to furnish the RCM product in yields 
ranging from moderate to excellent. 
15 
 
By Cycloaddition Reactions 
 
 
 Cycloheptynedicobalt complexes have also been prepared by means of 
cycloaddition reactions. Tanino and co-workers
41
 used propargylic cationic species to 
develop a [5+2] cycloaddition protocol to generate cyclic (34) and bicyclic (34a) 
cycloheptyne–Co2(CO)6 adducts (Scheme 1.11). Under the influence of EtAlCl2, 
hexacarbonyldicobalt propargyl cation (32), i.e. the five-carbon entity or pentadienyl 
cation surrogate, reacted with enol triisopropylsilyl ethers (31 and 31a) via Nicholas 
reaction to initially construct silyloxonium ion intermediates (33), which in turn 
underwent intramolecular cyclization to furnish the cycloheptyneCo2(CO)6 complexes in 
good yields (34 and 34a). 
 
 
 
 
 
Scheme 1.11  [5+2] Cycloaddition reactions in the synthesis of cyclic and bicyclic  
 
            cycloheptyneCo2(CO)6 complexes. 
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By Diels-Alder Reaction 
 
 
 Iwasawa group
42
 has demonstrated that cycloheptynedicobalt complexes can also 
be generated by silica gel mediated Diels-Alder reactions (Scheme 1.12). When placed on 
silica gel column under inert atmosphere, furan-enynone complex (35) underwent an 
intramolecular Diels–Alder reaction providing a mixture of the starting alkyneCo2(CO)6 
complex and the desired cyclized alkyneCo2(CO)6 complex (36) in equilibrium. The 
alkene in the furan ring of the Diels-Alder adduct was then rapidly subjected to 
hydrogenation with H2 and Pd/C to furnish reduced (37) as a stable complex in 62 % 
yield (over two steps). 
 
 
Scheme 1.12  Diels-Alder reaction in cycloheptynedicobalt synthesis. 
 
 
 
 
By Michael Reaction 
 
  
 Iwasawa
43
 also reported another strategy that's suited for the stereoselective 
synthesis of medium-sized cyclic compounds, including seven-membered ring ones. 
Through the intermediacy of alkynedicobalt hexacarbonyl complex precursors (38) 
containing silyl enol ether and electron-deficient alkene moieties on opposite ends of the 
molecule, an intramolecular Michael-type reaction was promoted with a Lewis acid in the 
17 
 
presence of 2,6-di-(tert-butyl) pyridine (DTBP) to afford a mixture of cyclized silyl enol 
ether (39) and its hydrolyzed ketone (40)  in a combined yield of 73 % (Scheme 1.13). 
 
 
 
 
 
Scheme 1.13  Synthesis of cycloheptynedicobalt complexes using intramolecular  
 
            Michael-type reaction. 
 
 
 
 
 
1.4.2   Benzocycloheptynedicobalt Complexes 
 
 
By Carbonylative Heck Reaction 
 
 
 A novel approach was reported by Iwasawa and Satoh
44
 which involved the 
unique usage of the carbonylative Heck-type coupling reaction in the synthesis of a 
benzocycloheptynedicobalt complex (43), (Scheme 1.14). In order to carry out the 
palladium catalyzed Heck-type coupling step, hexacarbonylalkynedicobalt complex (41) 
was subjected to ligand exchange with 1,1-bis(diphenylphosphino)methane (dppm) to 
produce the more thermally stable alkyneCo2(CO)4-dppm complex (42). In addition, the 
optimal carbonyl source was found to be diphenylacetyleneCo2(CO)6. 
18 
 
 
 
 
Scheme 1.14  Carbonylative Heck reaction. 
 
 
 
By Rhodium(I)-Catalyzed [3 + 2] Annulation Reaction 
 
 An elegant approach has been reported by Murakami
45
 involving the development 
of rhodium(I) catalyzed [3 + 2] annulation reactions to form benzotropones. In the main 
proposal, reacting 2-cyanophenylboronic acid (45), as a three-carbon component, with an 
internal alkyne or strained alkene afforded the five-membered ring indenone derivative 
(41 to 93 % yield) in the presence of 5 mol % of [Rh(OH)(cod)]2
 
catalyst. However, in 
one case, when ethyl 2-hexynoate (44) was used as the alkyne substrate, its reaction with 
2-cyanophenylboronic acid (45) under similar reaction conditions resulted in the 
unexpected formation of benzotropone (46) as the major product (64 %) instead of the 
five-membered ring indenone derivative (Scheme 1.15).  
19 
 
 
 
Scheme 1.15  Benzotropone skeleton formation via rhodium(I)-catalyzed [3+2]                
           annulation reaction. 
 
 
Cyclization of bis-silyl enol ethers with 1,2-dialdehydes 
 
 
 A series of 4,5-benzotropones have been prepared by Langer and co-workers
46
 
through two related pathways (Scheme 1.16). The first one involved a TiCl4-mediated 
cyclization of 1,3-bis-silyl enol ethers (47) with phthalic dialdehyde (48). Alternatively, 
the same 1,2-dialdehyde compound (48) could react with (2,4-dioxobutylidene) 
triphenylphosphoranes (49) via a Knoevenagel/Wittig reaction to afford similar 
benzotropones (50). 
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Scheme 1.16  Formation of 4,5-benzotropones. 
 
 
1.5    Origin of Current Project and Proposed Research 
 
1.5.1    Dehydrotropylium–Co2(CO)6 Ion 
 
 
 Tropylium ion (also known as cycloheptatrienyl cation), is a well-recognized 
seven-membered ring cyclic cation which depicts a classical example of a Hückel-type 
aromatic compound with 6-electrons (51), (Figure 1.3).47 Given the significance of this 
cationic species, our group has studied and reported the generation and reactivity of the 
dehydrotropyliumCo2(CO)6 cation (52).
48 
 
 
 
Figure 1.3  Tropylium cation (51) and dehydrotropyliumCo2(CO)6 cation (52). 
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 The primary objective of the study was to provide a better understanding of the 
stabilization of propargyldicobalt cations by investigating whether (25) demonstrates 
greater stability than un-functionalized propargyldicobalt cations, and whether its nominal 
6-electron system shows evidence of aromaticity.48 The dehydrotropyliumCo2(CO)6 
cation was accessed from the corresponding cycloheptadienynol–Co2(CO)6 complex 
precursor (54), which was in turn derived from [(diacetoxy)cycloheptenyne] dicobalt 
complex (53), a compound previously prepared in our group via ring-closing metathesis 
chemistry.
39
 The RCM adduct underwent a series of transformations, as shown in 
(Scheme 1.17), including acid-induced alkene isomerization, MnO2 oxidation, and 
DIBAL-H reduction, to give the target alcohol (54) with the desired -conjugated system. 
 
 
 
Scheme 1.17  Synthesis of cycloheptadienynol–Co2(CO)6 complex (cation precursor). 
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 Reaction of alcohol (54) with HBF4 (in CH2Cl2 at -78 C) followed by the 
addition of Et2O (or alternatively subjecting a solution of (54) in Et2O to HBF4 at -78 C) 
afforded the dehydrotropylium ionCo2(CO)6 complex (52) as a dark solid precipitate. 
The resultant precipitate was sufficiently stable to be analyzed by 
1
H NMR spectroscopy. 
In addition to the detection of the desired cation, NMR analysis also revealed the 
presence of two regioisomers of radical dimers (55a and 55b) whose structures are given 
below (Scheme 1.18).
48
  
 
 
 
Scheme 1.18  Generation and precipitation of dehydrotropyliumCo2(CO)6 complex  
                        ion (52): 
1
H NMR resonances assignment and dimerization by-products. 
 
 
 
 Chemical shifts assignments of the cation's protons are depicted in (Scheme 1.18). 
Perhaps the most noteworthy aspect of the spectrum is that all three chemically distinct 
protons have resonances that appear upfield from those of the classical tropylium ion as 
measured by Cox et al.
49
 ( 9.16 ppm in CH2Cl2). In regards to the protons in the two 
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propargylic sites of the complex, they are more downfield (in comparison to the rest of 
the ring), which is indicative of slightly reduced positive charge possession. In view of 
the brief stability of cation (52) as evidenced by its gradual decomposition in solution 
even at temperatures as low as 20 C, this made 13C NMR analysis for the cation 
unattainable.
48
  
 Reactivity studies of cation (52) showed that in the presence of reactive 
nucleophiles (N > 1 on the Mayr
50
 scale), nucleophilic addition reactions took place 
predominantly at the propargylic site (-site) of the cobalt-complexed alkynyl unit in the 
cationic species. In the presence of less reactive nucleophiles (N < 1) however, cation (52) 
underwent a different reaction pathway where dimerization products were formed instead 
(Scheme 1.19).
 
 
Scheme 1.19  Generation and reactivity of dehydrotropyliumCo2(CO)6 complex ion.  
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 To assess the aromaticity (or the lack thereof) of the generated cation, three 
different computational methods were evaluated: the harmonic oscillator model of 
aromaticity (HOMA), by evaluation of homodesmotic reactions involving cation (52), 
and by the nucleus-independent chemical shift, NICS (1) method. Upon examining the 
results gained from each of the three methods, it was concluded that values obtained from 
homodesmotic reactions and NICS(1) calculations presented a more accurate depiction of 
the aromaticity measure, where both suggested that cation (52) possess ca. 25 % the 
aromaticity of tropylium ion (51). On the other hand, the value obtained by HOMA 
method was considered to be less reliable and hence was disregarded in the aromaticity 
assessment.
48 
 
 
1.5.2    Tropylium Ion and Annulation Effect 
 Several decades ago, Pettit and co-workers
51
 disclosed interesting observations 
when they reported that the annulation of benzo- or heterocyclic derived -systems 
significantly affect the properties of the parent ionic species. Tropylium ion (51), which is 
a representative of the nonbenzenoid aromatic 6-electron system, has a good 
thermodynamic stability,
47 
where its pKR+ is 4.7. A significant destabilization of 
tropylium ion is brought about by benzo-annulation as demonstrated by benzotropylium 
ion (56), (Figure 1.4) (pKR+ = 1.7)
52
 and dibenzotropylium ion (57) (pKR+ = 3.7)
53
. This 
suggests that the benzotropylium cation is about 10
3
 times less stable than a tropylium 
cation.
54
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Figure 1.4  Tropylium cation (51) and examples of annulated tropylium ions (56-62). 
 
 Conversely, an appreciable stabilization is evident when a tropylium ion was 
annulated with azulene; cyclohepta[a]-azulenylium ion (58), has been synthesized and its 
enhanced stabilization was measured to be (pKR+ = 7.3)
55
. A similar trend has been 
observed when tropylium ion was annulated to a furan (59) or thiophene ring (60) where 
an increase in stability was obtained (pKR+ = 6.7 and 6.0, respectively).
56
 Two novel 
tropylium ions were studied by Pedaja and Gronowitz
57
, which involved annulating a 
benzo-fused tropylium ion to a thienyl ring in one case, and a selenolo-ring in another. 
Using potentiometric titration methods, the authors measured the corresponding pKR+ 
values of these ions and were found to be 3.8 for benzo[4,5]thieno[2,1-b]tropylium ion 
(61) and 3.4 for benzo[4,5]selenolo[2,1-b]tropylium ion (62).
57
 These values signified 
that the stabilities of these "hybrid" ions were lower than the thienotropylium ion, but 
higher than that of the benzotropylium ion. All these experimental data provide strong 
evidence that combining more than one -system could endow new properties to the 
original -system.54 
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1.5.3   BenzodehydrotropyliumCo2(CO)6 Cation
 
 
 In view of our group's long-standing and sustained interest in developing 
preparation methods of benzocycloheptyneCo2(CO)6 complexes to enable formation of 
various synthetic targets, it seemed to us of primary interest to further expand the utility 
of benzocycloheptyne complexes by investigating the formation and underlying reactivity 
of the benzo-homologue of the dehydrotropylium cation, also known as 
benzodehydrotropyliumCo2(CO)6 cation (Figure 1.5). Encouraged by the fruitful results 
obtained by Amiralaei and Green
48
 in their previous work on preparation of Co2(CO)6 
complex of dehydrotropylium ion, we chose to extend the cation-related studies to 
include the benzo-fused analogue ion as well. It was envisioned that 
benzodehydrotropyliumCo2(CO)6 cation would have a crucial role in acquiring better 
understanding of this novel class of ions, including their preparative methods, generation, 
associated reactivity towards nucleophiles, and finally the aromatic character. 
 
 
 
Figure 1.5 Structure of benzodehydrotropyliumCo2(CO)6 cation. 
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CHAPTER 2: RESULTS AND DISCUSSION 
 
 
2.1 Towards the Synthesis of Target Benzodehydrotropylium
 Co2(CO)6 ion 
 
 
2.1.1 Retrosynthetic Analysis  
 In literature, there are a limited number of methodologies that provide access to 
benzo-annulated cycloheptyne compounds. To prepare the desired benzo-
dehydrotropyliumCo2(CO)6 ion, a synthesis plan was developed which involved two 
main parts. The first one aimed to provide a reasonable synthetic route to the cation 
precursor compound; this in turn would lead to initiating the second part which entailed 
generating the corresponding cationic species and examining the possibility of trapping it 
with nucleophiles of choice. The retrosynthetic strategy followed to prepare the 
benzodehydrotropyliumCo2(CO)6 ion is envisaged in (Scheme 2.1). The central step 
involves forming the cycloheptadienynol complex, which is perceived as the direct 
precursor to the intended cation (63).  
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Scheme 2.1  Proposed retrosynthetic approach to the formation of the benzodehydro-  
          tropyliumCo2(CO)6 ion. 
 
 
 
2.1.2 Preparation of CycloheptadienynolCo2(CO)6 Complex: Cation   
 Precursor 
 
 
 The starting point of the synthetic plan was the assembly of 2-bromobenzaldehyde 
(64) and (trimethylsilyl)acetylene (65) under appropriate Sonogashira-type reaction 
conditions, i.e. palladium(0) as a catalyst and copper(I) as co-catalyst, to give the 
trimethylsilyl-protected alkyne (66) in 85 % yield (Scheme 2.2). Subsequently, the 
obtained alkyne (66) underwent desilylation by potassium carbonate in methanol to give 
the terminal alkyne species (67) quantitatively. 
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Scheme 2.2  Subjecting 2-bromobenzaldehyde to a Sonogashira reaction followed by         
                     desilylation to install the intended terminal alkyne group.  
 
 
 
 The latter compound was in turn submitted to another Sonogashira-type cross 
coupling reaction with 2-bromo-3-(trimethylsilyl)-1-propene (68) to afford the requisite 
enyne substrate (69) in 71 % yield. The next step proceeded smoothly, where the prepared 
alkyne was subjected to complexation with dicobalt octacarbonyl, and the corresponding 
dicobalt hexacarbonyl-alkyne complex (70) was obtained in a very good yield (80 %). 
Having the intended substrate in hand, the stage was set for attempting the cyclization, 
which is the key step to obtain the benzocycloheptyne precursor.   
 
 
 
 
Scheme 2.3  Formation of the enyne followed by complexation to form the dicobalt-    
          alkyne moiety. 
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 To promote the ring-closing process, it was necessary to utilize an appropriate 
Lewis acid to mediate the reaction. Stemming from the fact that most of our previous 
group's work has relied on using boron trifluoride as the preferred Lewis acid, and due to 
its minimized tendency to induce decomposition in related cobalt complexes, it was 
envisioned that it would be a logical starting point for this current work as well. To our 
delight, the cyclization reaction proceeded smoothly in the presence of 1 equiv. of      
BF3-OEt2 and the desired cyclic product (71) was obtained in 75 % yield. 
 
  
 
Scheme 2.4  Proposed mechanism of formation of cycloheptadienynolCo2(CO)6                
         complex via BF3-mediated Sakurai reaction. 
 
 
 
 The ring closing step, which qualifies as a 7-exo-trig process, could be best 
described as an intramolecular Hosomi-Sakurai reaction.
59
 Upon the initial complexation 
of the Lewis acid to the oxygen, the carbonyl's carbon is activated by enhancing its 
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electrophilicity. The allylic silane serves as a nucleophile (through its terminal carbon) 
where it attacks the electron poor carbonyl resulting in the formation of the seven-
membered ring of the cycloheptadienynolCo2(CO)6 complex (71). 
 After successfully achieving the key cyclization reaction, the next objective was to 
further derivatize the cycloheptadienynolCo2(CO)6 complex in hand, with the intent to 
construct the 6-electron system in the cycloheptyne ring of the complex. This was a 
crucial requirement for the benzodehydrotropylium complex ion to be generated from its 
relevant precursor. Having stated this, a series of transformations were designed for this 
purpose (Scheme 2.5).  
 
 
 
Scheme 2.5  A series of transformations to obtain the benzodehydrotropyliumCo2(CO)6            
          ion precursor.          
 
 The first step involved converting the benzylic alcohol to the corresponding 
ketone using a mild oxidant, MnO2, to give the intended oxidized product (72) in sub-
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optimal yields (43% brsm). Although the desired product was obtained, it cannot be 
denied that some drawbacks ascribed to this particular oxidation conditions rendered the 
reaction slow and not highly efficient. The main drawback was the incomplete conversion 
of the reactant even when adding a large excess of MnO2 and increasing the reaction time. 
In addition, some inevitable decomposition was observed (even though it could be 
minimized by keeping the temperature close to 0 C) which again contributed to low 
yields. Due to the presence of cobalt moiety in the substrate, the choices of oxidants were 
rather limited. The use of conventional oxidants such as Swern conditions was avoided 
due to the potential risk of removal of the organometallic unit. Despite the low yields, a 
reasonable amount of the ketone could be generated.  
 The isolated ketone (72) was then subjected to acid-catalyzed alkene 
isomerization which indeed proved to be effective in furnishing the rearranged enone with 
the endocyclic alkene (73) in 88 % yield. Now that the alkene and ketone were 
conjugated in the cycloheptadienynoneCo2(CO)6 complex (73), this constituted the -
system skeleton needed for the cation's precursor.                                 
 The last transformation involved reducing the ketone to the corresponding 
secondary alcohol (74) using hydride-based reducing agent, DIBAL-H. After isolating the 
crude benzo-fused cycloheptadienynolCo2(CO)6 complex, it was purified using silica 
gel-based column chromatography. The proton NMR spectrum of the purified alcohol 
revealed the occurrence of an alkene isomerization, converting (74)  (75), where the 
latter isomer bore a double bond that was in conjugation with the 6-electron system of 
the annulated arene. This acid-induced isomerization indicated that the obtained isomer 
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possessed higher stability than the previous compound, which in fact seems to be a 
logical rationale, given the significant contribution of conjugation in enhancing stability.  
 On a side note, by examining the final structure of the alcohol precursor (75), it 
could be noted that there is a methyl group on the carbon bearing the hydroxyl which 
does not truly contribute to the aromaticity considerations of the cation. The justification 
for the presence of this "extra" methyl group is that the original design of the synthesis 
presented the need for a synthetic handle which was necessary for the cyclization process.  
 
2.2 Hetero-Fused CycloheptadienynolCo2(CO)6 Complexes 
 Considering that the established preparative method worked well for the formation 
of benzene annulated cycloheptyne complex, we sought to prove the viability of this 
method in preparing other bicyclic ring systems, namely heteroaryl-based compounds. To 
demonstrate the flexibility of our methodology, three different -excessive heterocyclic 
ring systems were investigated which were: thiophene, furan, and indole; in addition, the 
electron rich methoxy-aryl substrate was also included in the reaction scope study.  
 To obtain the relevant precursors for hetero-fused and methoxy-aryl 
cycloheptadienynolCo2(CO)6 complexes, a synthetic protocol analogous to the one 
reported earlier (when preparing the precursor for benzo-fused cycloheptyne complex 
ion) was attempted.  
 The synthesis of the intended substrates was initiated by installing an alkyne 
moiety through subjecting the corresponding bromo-arylaldehydes (76a-d) and TMS-
acetylene to Sonogashira reaction (Table 2.1). 
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Table 2.1  Appending the alkyne group for various substrates via Sonogashira               
                  reaction. 
 
 
 
Entry Substrate Product Yield (%) 
1   
79 
2 
  
82 
3 
  
85 
4 
  
98 
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The reactions proceeded with great success and the resultant compounds (77a-d) 
underwent desilylation under the appropriate reaction conditions (K2CO3 in methanol, or 
TBAF) to furnish the terminal alkynes needed for the next coupling reaction. A summary 
of the results is shown in Table 2.2. 
Table 2.2  Products of desilylation reactions using potassium carbonate in methanol. 
 
 
a
 Desilylation was achieved using TBAF (1.0 M in THF). 
Entry Substrate Product Yield (%) 
1 77a 
 
89 
2 77b 
 
65 
3 77c 
 
72 
4
a 
77d 
 
95 
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 In the presence of 2-bromo-3-(trimethylsilyl)-1-propene and (78a-d), the 
Sonogashira reaction was employed again to obtain the acyclic enynes (79a-d), which in 
turn were subjected to complexation with Co2(CO)8 (Table 2.3). Indeed, the desired 
alkyneCo2(CO)6 complexes (80a-d) were readily obtained in excellent yields, and this 
set the stage for running the cyclization reaction, namely, the seven-membered ring 
closure. 
 
Table 2.3  Formation of acyclic enynes of various heterocyclic substrates and their     
       subsequent complexation with Co2(CO)8.        
 
 
Entry Substrate Product/ (Yield) Product/ (Yield) 
1 78a 
  
2 78b 
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 With the prepared precursors complexes in hand, the next transformation involved 
formation of the cycloheptynes via the Sakurai reaction. Once again, BF3 was the first 
Lewis acid to be selected as a suitable mediator for the 7-exo-trig process. The success of 
the cyclization process was variable from one substrate to another. Substrate (80a), 
bearing an electron-donating methoxy group on its benzene ring underwent a rapid 
cyclization and the intended product, (81a), was isolated in 72 % yield. In addition, the 
C3-substituted thienyl-based substrate (80b) was also readily converted to the thiophene-
fused cycloheptyne complex (81b) in 90 % yield. Cyclization was also successfully 
accomplished when C3-substitued furan substrate (80c) was subjected to analogous 
conditions. Despite the fact that the starting material was fully consumed during the 
reaction progress (clearly shown by TLC analysis), some decomposition was apparent 
which led to relatively reduced overall yield of (81c, 60 %). The final heteroaryl substrate 
3 78c 
  
4 78d 
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that we examined was the C3-subsitiuted indole (80d) which also resulted in the 
formation of the intended cyclic product (81d). However, the percentage yield was 
significantly reduced (54 % yield) due to occurrence of some decomposition of the 
isolated product.  
 The ring closing step in all the given substrates was generally rapid, and the 
reaction time ranged from 5 minutes to 1 hour. The cyclized products (81a-d) were 
conveniently isolated following aqueous work-up with saturated sodium bicarbonate 
solution, solvent removal, and silica gel flash chromatography. The results are presented 
in (Table 2.4). 
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Table 2.4  Cyclization reactions of various substrates via BF3mediated Sakurai reaction. 
 
 
 
 
Entry Substrate Product Yield (%) 
1 80a 
 
72 
2 80b 
 
91 
3 80c 
 
60 
4 80d 
 
54 
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 Having established that the proposed ring formation method was indeed widely 
applicable to heteroryl-fused systems as well, it is worth noting that in principle, each of 
the formed bicyclic alcohol compounds (81a-d) could likely be readily converted to the 
corresponding ring-fused dehydrotropyliumCo2(CO)6 complex ion. This could 
potentially generate a reasonable library of novel Nicholas cations that could be further 
evaluated through reactivity studies with nucleophiles of choice.  
 
2.3 Generation of BenzodehydrotropyliumCo2(CO)6 Ion and its 
 Reactivity 
 
 Accessing the benzodehydrotropylium ion now became feasible in light of the 
availability of its requisite alcohol precursor. It was our belief that upon treatment of the 
alcohol (75) with a Lewis acid, the cationic species (63) could be readily generated in 
situ, which could then be trapped with nucleophiles of choice via an intermolecular 
Nicholas reaction. Once again, boron trifluoride was our choice of Lewis acid reagent, 
mainly due to the successful results achieved in generating the dehydrotropylium cation 
in previous work in our lab.
48
 Based on previous reports, it has been shown that the 
reaction of the Nicholas cation with different nucleophiles roughly obeyed Mayr's linear 
free enthalpy equation:
50
 log k (20 °C) = s (E + N); where E is an electrophilicity 
parameter, N is a nucleophilicity parameter, and s is a nucleophile-specific slope 
parameter. On the basis of this model, nucleophile/electrophile combinations with (E + N 
 5) are expected to proceed with a reasonable rate at room temperature. As such, 
[propargyliumCo2(CO)6]
+
 cations which have E values ranging between 1.2 and 2.2 
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are expected to undergo a reaction with nucleophiles with (N > 3).8 Therefore, several 
nucleophiles possessing a range of strengths were studied, particularly as reflected by 
Mayr’s N values of nucleophilicity scale, in an attempt to obtain an experimental measure 
of the cation's electrophilicity and reactivity pattern.  
 Once the ion is generated, two different reactivity pathways were potentially 
possible: substitution and elimination. To start with the substitution pathway, ionization 
of the hydroxyl group leads to formation of a cation in the propargylic site (C-7) i.e. - to 
the alkyne-cobalt unit. By resonance, this positive charge can be delocalized to C-9 i.e. 
site with respect to the cobalt-alkyne unit. This creates two potential cationic sites for 
nucleophiles, which would ultimately lead to two possible substitution products (82a and 
82b) as shown in (Scheme 2.6).   
 
 
Scheme 2.6  Formation of the substitution products upon nucleophilic attack on either    
         - or -sites of the in situ generated cation. 
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 The general synthetic protocol of the intermolecular Nicholas reaction employed 
the addition of BF3-OEt2 (3 equiv.) to a dichloromethane solution of parent alcohol       
(75, 1 equiv.) and nucleophile of interest (5 equiv.) at 0 C. Under these reaction 
conditions, cation (63) readily reacted with allyltrimethylsilane (Mayr N value = 1.79) to 
give primarily the corresponding C-9 (i.e. site) substitution product (84a) in addition to 
a minor amount of C-7 (site) substitution product (84b) (combined yield 83 %; 
84a:84b (: = 6:1). Moreover, the reactivity pattern of the more nucleophilic 2-
methallyltrimethylsilane (N = 4.41) was analogous to that of allyltrimethylsilane 
(combined yield 68 %; 85a:85b (: = 6:1). Among the nucleophiles investigated was 
the trimethylsilyl enol ether of acetophenone (N = 6.22), which underwent a reaction with 
the cation to afford a mixture of C-9 (site) substitution product (86a, major) alongside a 
smaller proportion of C-7 (-site) product (86b) (combined yield 55 %; 86a:86b (: = 
4:1). On the other hand, N-methylpyrrole (N = 5.85) gave exclusively the C-9 (site) 
product (87) in 81 % yield with no observable -site product. 
 Intermolecular trapping of the generated cation with the desired nucleophile was 
not the only anticipated outcome of the reaction. In some cases, the cation underwent 
elimination as shown in (Scheme 2.7), forming the exo-alkene compound (83). With 
nucleophiles such as thiophene (N = 1.01), 1,3,5-trimethoxybenzene (N = 3.40), and 2-
methoxypropene (N = 5.41), the elimination product (83) was the only one obtained.  
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Scheme 2.7  Formation of the elimination by-product. 
 
 
 
 A reversed reactivity pattern was obtained when an oxygen-based nucleophile was 
tested. Methanol was the nucleophile of choice, and it predominantly reacted at the -site 
of the carbocation to give a propargylic substituted product as the major compound (88a), 
while forming only a minor amount of the -substitution product (88b) (combined yield 
54 %; 88a:88b () = 3:1). The results of the Nicholas reaction of cation (63) with 
various nucleophilic species are summarized in (Scheme 2.8). 
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Scheme 2.8  Summary of reactions of carbocation (63) with various nucleophiles. 
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 Theoretically, the stabilization in the -substituted product could be ascribed to 
two main sources: first, the conjugation between the -systems of the alkene function and 
the complexed alkyne unit (in the seven-membered ring), and secondly the lack of steric 
bulk, since the dicobalt hexacarbonyl group and the incoming nucleophile are positioned 
far apart from one another. On the other hand, conjugation is also a major player in 
stabilizing the product. As a matter of fact, it is thought to be of a more pronounced 
effect since the double bond of the substituted product is in conjugation with the 6-
system of the fused benzene ring. This point can be validated by examining the outcome 
of the reaction scheme presented earlier (Scheme 2.5), where the alcohol precursor (74) 
unambiguously underwent an acid-induced isomerization (on silica gel) to the more 
conjugated alkene (75). That is to say that the thermodynamic product is actually the 
substituted product. 
 Having established that product is thermodynamically favoured, results 
deduced from the reactivity studies clearly support that substitution reactions involving 
the Nicholas cation (63) cation and various carbon-based nucleophiles were not under 
thermodynamic control; this was evident by the predominance of the formation of the 
product (either as the major or exclusive product). However, a reversed pattern was 
observed when using an oxygen-based nucleophile, methanol, which delivered a higher 
ratio of -product (Scheme 2.8). This suggests that the nucleophilic substitution by 
MeOH was most likely operating under thermodynamic control, that is to say that the 
attack occurred reversibly under the given reaction conditions. This behaviour can be 
attributed to the presence of an easily protonated oxygen in the product formed initially, 
hence providing a pathway for cation re-formation.  
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 By reviewing the relevant literature,
19,22 
 Nicholas reactions of a cation that is both 
propargylic to an alkyneCo2(CO)6 group and also allylic have been well known to 
favour the -site attack (i.e. the terminus remote to the alkyne–Co2(CO)6 unit) over -site 
for most nucleophiles (especially for lower reactivity nucleophiles) for reasons that are 
not exactly well-understood. This observation has been proven to be consistent in 
acyclic
19
 and cyclic systems
22
 as well. Stemming from these facts, we see that the 
reactivity/selectivity pattern in cation (63) is no exception. Despite the inability of 
drawing a clear-cut trend that relates the nucleophilicity (Mayr's N value) to the resultant 
 substitution ratio, it's evident that the -product is the preferred product. Additionally, 
the reactivity studies of the benzodehydrotropylium cation clearly indicated the relatively 
strong electrophilicity of the cation as proved by its ability to react with nucleophiles 
ranging from moderate (Mayr's N value = 1.79), to ones that are more nucleophilic (N = 
6.22). However, it can be argued that the results of Nicholas reaction with the selected 
nucleophiles was not truly conclusive since it lacked a wider scope of nucleophiles, 
including heteroatomic-based ones which could absolutely provide a better evidence for 
reactions reversibility (as witnessed by the methanol nucleophile). 
 The rationale behind the preference for nucleophiles to attack the remote site of 
the cation (63) could also be backed up by investigating the sterics involved in the cation 
system. Namely, the presence of the methyl group in the propargylic site (i.e. C-7) is 
likely inhibiting addition to the position of the cation. 
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2.4 Computational Assessment of the Cation's Aromaticity 
 
 
 The concept of aromaticity is undoubtedly among the most fundamental tools for 
understanding organic chemistry. Among the available criteria, the nucleus independent 
chemical shift (NICS), which was first introduced by Schleyer et al.
59
 in 1996, has 
recently became the most widely used magnetic index of aromaticity, mainly due to its 
simplicity and efficiency.
60
 This method allows the evaluation of aromaticity, anti-
aromaticity, and non-aromaticity of monocyclic systems and individual rings in 
polycyclic systems (local aromaticities). By definition, NICS is the magnetic shielding 
tensor measured for an arbitrary "ghost atom" which is placed in the middle of the ring of 
interest; this measures NICS (0) value.
59
 Other known key modifications in the 
calculation of NICS include placing the aforementioned "ghost atom" 1 Å above the 
molecular plane of the ring to avoid any potential interaction with the -framework 
electrons; this give NICS (1) values.
61
 Rings with an aromatic character have a significant 
negative NICS values as a result of the diatropic ring current, whereas rings with anti-
aromatic character give rise to positive NICS values due to the existence of paratropic 
ring current; non-aromatic systems have NICS values of zero. 
 In the quest for a better understanding of this concept, we wished to investigate 
whether benzodehydrotropyliumCo2(CO)6 ion possessed any aromaticity, and whether 
this could lead us to draw conclusions about the potential ion's stabilization 
(computational studies were conducted by Dr. Eric Bushnell in Professor James Gauld's 
group). 
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 In this study, the geometries of the benzodehydrotropyliumCo2(CO)6 ion were 
first optimized at the B3LYP/6-311+ G(d,p) level of theory (Figure 2.1).  
 
Figure 2.1  Optimized geometry of cation (63) with basis set B3LYP/6-311+G(d,p), and    
        selected measured bond lengths in Å. 
 
NICS (1) Studies 
 The NICS measurements were obtained by calculating NMR shielding values at 
the gauge independent atomic orbital (GIAO) HF/6-311+G(d,p)//B3LYP/6-311+G(d,p) 
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level. By examining the optimized structure generated for the benzodehydrotropylium 
complex (63), it was noted that the cobalt-cobalt vertex and the cycloheptadienyl unit 
were not perpendicular to one another, hence it was legitimate to place an arbitrary atom 
at two different locations
48
: 1 Å above and 1 Å below the center of the ring, and 
therefore, two different NICS (1) values may be computed. Given that the cation has two 
annulated rings, this would give rise to a total of four NICS (1) values. For the benzene 
ring, the two NICS (1) values were -9.4491 and -8.4815, and those measured for the 
seven-membered ring were -4.8798 and -2.0318. Since the environments at points 1 Å 
above and below the ring centres are not equivalent in the cycloheptyne ring, the 
averaged values were used for NICS (1) values which were calculated to be -3.5 (A-ring) 
and -8.96 (B-ring) as seen in the structure below (Figure 2.2). 
 
Figure 2.2  NICS (1) values of both rings of cation (63). 
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 To put these measurements in perspective, the literature values of NICS (1) 
reported for some known aromatic rings are shown below (Figure 2.3).  
 
 
 
 
Figure 2.3  Literature NICS (1) values of (structures from left to right): tropylium ion,   
       dehydtrotropylium-Co2(CO)6 ion, benzotropylium ion, and benzene (at      
                 B3LYP/6-311+G(d,p) level, except benzene). 
 
 
 The instant conclusion that can be drawn is that the negative sign of NICS (1) 
values of (63) is clearly indicative of the presence of "slight" aromatic character in the 
cation. To be more specific, it can also be noted that the aromaticity of the benzene-ring 
of the cation, i.e. B-ring, whose average NICS (1) is ca. 9.0, is reasonably comparable to 
that of the monocyclic benzene (10.40, computed at the same level of theory62). On the 
other hand, the average NICS (1) values of the A-ring is 3.5, which suggests that 
aromaticity of this annulated seven-membered ring is significantly reduced in comparison 
to the monocyclic tropylium cation (in literature, NICS (1) value of tropylium ion ranges 
from 9.2 to 11.2, depending on the basis set,63 however, it was previously measured in 
our group
48
 using B3LYP/6-311+G(d,p) basis set, and was found to be 10.5). 
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 In summary, by establishing that the aromaticity of the 
benzodehydrotropyliumCo2(CO)6 ion (63) is highly influenced by the local ring current 
of the seven-membered ring, it can be reasonably stated that cation (63) is closely 
comparable to the computed aromaticity of dehydrotropyliumCo2(CO)6 ion complex 
(NICS (1) values of 3.5 and 2.92 respectively). The slight increase in aromaticity of 
(63) may be attributed to the annulation to the benzene ring which itself has a significant 
local aromaticity. Furthermore, its NICS (1) measurements suggests that (63) possess 
roughly 33 % of the aromaticity of tropylium cation. 
 
Bond Length Alternation 
 Bond length equalization is characteristic for aromatic compounds, whereas large 
bond length alternation (∆r) is found in anti-aromatic compounds; the bigger the (∆r) of a 
specific ring is, the less aromatic the system becomes.
65
 Bond lengths in the seven-
membered ring of the bicyclic cation were computed as depicted in (Figure 2.1). With the 
exclusion of the carbon-carbon triple bond (C1-C2) due to its understandable deviation 
from ideal benzenoid bond length of 1.397 Å, bond length calculations show moderate 
bond length alternation, from 1.385 Å (C4-C5) to 1.437 Å (C6-C7), giving ∆r = 0.052 Å 
(at the B3LYP/6-311+G(d,p) level), where ∆r here refers to the difference between the 
longest and shortest bond in the seven-membered ring (A-ring). 
 In the previous work of Amiralaei and Green,
48
 the bond length calculations of 
dehydrotropyliumCo2(CO)6 complex ion were implemented to further assess the 
system's aromaticity using HOMA (the harmonic oscillator model of aromaticity) 
method. In brief, HOMA is one of the most simple and common structure-based indices 
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of aromaticity measurements. It takes into account both deviations from ideal aromatic 
bond lengths (EN) and bond alternation (GEO) according to the following relationship: 
66
  
 
HOMA = 1  EN  GEO 
 
 
HOMA values calculated for dehydrotropyliumCo2(CO)6 complex cation were shown to 
be not useful in quantitative evaluations of the ion's aromaticity. Based on this result, we 
envisioned that the aromaticity assessment of our current system, cation (63), using 
HOMA values will be highly inaccurate; hence, no further bond length-based calculations 
were carried out.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 
CHAPTER 3: CONCLUSIONS  
 
 
 In this study, we investigated the chemistry of a novel Nicholas carbocation, 
namely the benzo-homologue of the dehydrotropylium complex cation, known as 
benzodehydrotropyliumCo2(CO)6 cation. The required alcohol precursor, benzo-
cycloheptadienynolCo2(CO)6 complex, was prepared from commercially available 
starting materials. The desired benzo-fused dehydrotropyliumCo2(CO)6 complex cation 
was generated in situ upon ionization of the parent alcohol precursor with a Lewis acid 
(namely BF3-OEt2). Due to the delocalization of the positive charge in the seven-
membered ring through resonance, this created two possible electrophilic sites in the 
molecule. The cation was trapped with a number of nucleophiles ranging in 
nucleophilicity from moderate to strong (N = 1.79 to 7.54 on the Mayr scale) which 
reacted with the carbocation through intermolecular Nicholas reactions. The main feature 
of reactivity was that nucleophiles predominantly attacked the -site of the cation, that is 
the site remote to the cobalt-alkyne unit, to give the -substituted products as the major 
ones, mixed with a minor ratio of -product (the outcome of the attack on the -site). An 
oxygen-based nucleophile, methanol, was the only exception, where it formed the -
product as the major one, which was ascribed to possible reversibility of the reaction 
hence leading to the formation of the thermodynamic product. On the other hand, a few 
nucleophiles did not react with the cation and instead the elimination product was 
isolated. Finally, the aromaticity of benzodehydrotropyliumCo2(CO)6 cation was 
assessed using computational methods, namely NICS (1) values. The calculated NICS (1) 
value of the seven-membered ring was found to be 3.5 which is indicative of modest 
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aromatic character. It can be said that it is ca. one third the aromaticity of tropylium 
cation and reasonably close to that of the dehydrotropyliumCo2(CO)6 cation.  
 The synthetic methodology for preparing annulated cycloheptyneCo2(CO)6 
complexes was proven to be of a decent applicability. In addition to the facile formation 
of benzene annulated cycloheptyne complex (i.e. the cation's alcohol precursor), the 
chemistry of seven-membered ring formation was further extended to other analogues. 
Heteroaryl-based systems (thiophene, furan, and indole) were also capable of 
participating in the formation of the corresponding fused cycloheptyne complexes. 
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CHAPTER 4: EXPERIMENTAL  
  
 
 General Methods and Materials: All reagents, unless otherwise noted, were 
purchased from Aldrich. Trimethylsilylacetylene was purchased from GFS Chemicals. 
Dicobalt octacarbonyl was purchased from Strem. 3-Bromo-2-formylfuran was purchased 
from Frontier Scientific. All reactions were run under a nitrogen atmosphere using oven-
dried glassware (110 C, > 1h). All reaction solvents were directly obtained from solvent 
purification system (Innovative Technologies). Commercial BF3-OEt2 was distilled and 
stored under nitrogen. The term “conventional workup” refers to extraction of the product 
from the aqueous layer with an organic solvent (such as dichloromethane or diethyl 
ether), drying of the combined organic layers with anhydrous magnesium sulfate and 
filtration of the resultant mixture, followed by evaporation of the volatiles under reduced 
pressure to obtain the crude product(s).  
 Instrumentation: Flash chromatography was performed using silica gel 60 (230-
400 mesh). Analytical thin layer chromatography (TLC) was performed on silica gel 60 
F254 sheets from Silicycle. Preparative TLC was carried out over silica gel GF-254 plates 
from Silicycle. Low-resolution mass spectra were recorded at 20eV on a Varian CP-
3800/1200L GC/MS. High- Resolution Mass Spectrometry (HRMS) results were 
obtained by means of a Direct Insertion Probe-Electron Ionization method (70 eV), on a 
Waters/ Micromass GCT (GC-EI/CI Time of Flight Mass Spectrometer) performed at the 
McMaster Regional Centre for Mass Spectrometry. Proton nuclear magnetic resonance 
(
1
H NMR) data were obtained either on Bruker Avance 300 or 500 MHz spectrometers. 
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Chemical shifts are reported in delta ( units, parts per million (ppm), relative to the 
singlet at 7.26 ppm for chloroform-dl, unless otherwise indicated. Coupling constants are 
reported in Hertz (Hz). Carbon-13 nuclear magnetic resonance (
13
C NMR) data were 
obtained on Bruker Avance 75 or 125 MHz spectrometers. Infrared Spectroscopy (IR) 
data were recorded on a Burker Vector 22 FT-IR spectrophotometer using KBr plates. 
The reported IR data reflects the frequencies of the distinctive functional group stretches 
only. 
 
2-Bromo-3-(trimethylsilyl)-1-propene (68)  
 
 
 Compound (68) was prepared using the method reported by Trost et al.
67
 The 
product showed spectroscopic data identical with the literature (isolated in 71 % yield). 
3-Bromothiophene-2-carbaldehyde (76b) 
 
Compound (76b) was prepared from 3-bromothiophene in a sequence involving 
selective lithiation with LDA at the 2-position and formylation using excess DMF. The 
experimental procedure followed was adapted from literature.
68
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(3-Bromothiophene was distilled under nitrogen prior to use; diisopropylamine was 
freshly distilled with CaH2 under nitrogen before use). 3-Bromothiophene (0.501 g, 3.067 
mmol) was added dropwise to a stirred solution of lithium diisopropylamide (LDA) 
[prepared by addition of n-butyllithium (1.8 M in THF, 1.70 mL, 3.067 mmol) to 
diisopropylamine (0.433 mL, 3.067 mmol)] in anhydrous THF (10 mL) at 0 C and the 
resulting mixture was stirred for a further 30 min at this temperature. Then, DMF (0.47 
mL, 0.448 g, 6.133 mmol) was added dropwise over a period of 20 min. The mixture was 
stirred further until TLC analysis indicated that all the starting material had been 
consumed (ca. 3 h) when an excess of 20% aqueous ammonium chloride was added to it. 
Extraction of the mixture with ether gave 3-bromothiophene-2-carbaldehyde as dark oil. 
The product showed spectroscopic data identical with the literature
68
 (77 % yield). 
 
3-Bromo-1-methyl-1H-indole-2-carbaldehyde (76d) 
  
 
 
 
 To a solution of 1-methylindole-2-carbaldehyde (0.507 g, 3.185 mmol) in 
anhydrous THF was added N-bromosuccinimide (NBS) (0.60 g, 3.371 mmol) portion-
wise. The solution was stirred for 2 h at room temperature. Then, a 2.0 M aqueous NaOH 
solution was added to the reaction mixture, followed by the addition of brine solution. 
Next, the mixture was subjected to a conventional extractive workup using ethyl acetate, 
to afford (76d) as yellow solid. No chromatographic purification was needed; the product 
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obtained was found to be pure enough to be used in subsequent reactions (> 98 % purity). 
The product showed spectroscopic data identical with the literature
69 
(0.743 g, 98 % 
yield), mp 86-88 C (lit. mp 86-89 C).69b 
2-Ethynylbenzaldehyde (67) 
 
Compound (67) was prepared using the method reported by Fujii and Ohno.
70
 The 
product showed spectroscopic data identical with the literature (96 % yield from 2-
bromobenzaldehyde); mp 6061.5 C (lit. mp 60-61 C).70 
2-Ethynyl-5-methoxybenzaldehyde (78a) 
 
Compound (78a) was prepared using the method reported by Fujii and Ohno.
70 
The product showed spectroscopic data identical with the literature (77 % yield from 2-
bromo-5-methoxybenzaldehyde), mp 96-97 C (lit. 98 C).70 
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3-Ethynylthiophene-2-carbaldehyde (78b) 
 
 
 (3-Bromothiophene-2-carbaldehyde (76b) was subjected to Sonogashira coupling 
method following a procedure that was adapted from Eberbach,
71
 to give 3-
((trimethylsilyl) ethynyl)thiophene-2-carbaldehyde (77b) in 82 % yield. To a solution of 
77b (0.1092 g, 0.525 mmol) in methanol (3 mL) was added a catalytic amount 
(unweighed) of anhydrous potassium carbonate at room temperature. The reaction was 
stirred until starting material has been completely consumed, as judged by TLC using 2:1 
petroleum ether/Et2O (30 min). The reaction mixture was concentrated under reduced 
pressure until most of the methanol has evaporated. To the resulting oily crude product 
was added water and Et2O (1:1), and a conventional work-up was performed. The crude 
product was purified by flash chromatography (2:1 petroleum ether/Et2O) to give (78b) as 
yellow oil (0.071 g, 99 % yield). The product showed spectroscopic data identical to 
literature.
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3-Ethynylfuran-2-carbaldehyde (78c) 
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(3-Bromofuran-2-carbaldehyde (76c) was subjected to Sonogashira coupling 
method following a procedure that was adapted from Eberbach,
72
 to give 3-
((trimethylsilyl) ethynyl)furan-2-carbaldehyde (77c) in 85 % yield. To a solution of 77c 
(0.191 g, 0.99 mmol) in methanol (4.6 mL), anhydrous potassium carbonate (0.127 g) 
was added in one portion. The reaction was stirred until starting material has been 
completely consumed; judged by TLC using 5:1 petroleum ether/ether (5–10 min). The 
reaction mixture was concentrated under reduced pressure until most of the methanol has 
evaporated. The resulting oily crude product was washed with water/ether (1:1) solution. 
The organic ether layer was washed with saturated NH4Cl aqueous solution and brine 
solution. The combined organic layer was dried with anhydrous MgSO4. After removing 
the volatiles, compound (78c) was afforded as brown solid (0.103 g, 86 % yield), mp 45-
46 C (lit.72 mp 45 C). The product showed spectroscopic data identical to a previous 
report in literature. 
3-Ethynyl-1-methyl-1H-indole-2-carbaldehyde (78d) 
 
 
 
3-Bromo-1-methyl-1H-indole-2-carboxaldehyde 76d (0.570 g, 2.39 mmol, 1 
equiv.) and trimethylsilylacetylene (0.38 g, 3.87 mmol, 1.6 equiv.) were dissolved in 
degassed triethylamine (30 mL). This solution was stirred at room until a clear 
homogenous solution was obtained. Then, Pd(PPh3)4 (0.138 g, 5 mol %) and CuI (0.045 
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g, 10 mol %) were added quickly to the reaction mixture. The solution was stirred for 1.5 
h at 60 C. After cooling the reaction to room temperature, a saturated solution of 
aqueous ammonium chloride was added and the mixture was subjected to a conventional 
work-up using diethyl ether. The dark oil was purified by flash chromatography (5:1 
petroleum ether/Et2O) to give pure 1-methyl-3-trimethylsilylethynyl-1H-indole-2-
carboxaldehyde (77d) as yellow solid (0.601 g, 98 %). The spectroscopic data were 
identical to a former report by Barluenga et al.
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A solution of 77d (0.741 g, 2.90 mmol) in anhydrous THF (25 mL) was treated 
with a solution of TBAF (1.0 M in THF, 2.9 mL, 1 equiv.) at room temperature. When 
the reaction was judged complete by TLC (5 min), it was quenched with a saturated 
solution of ammonium chloride and subjected to conventional work-up using diethyl 
ether. No further purification was required. Compound (78d) was collected as a yellow 
solid (0.5122 g, 95 % yield), mp 122-123 C. IR (KBr) max 3284, 2102, 1669, 1476 cm
-1
; 
1
H NMR (500 MHz, CDCl3) 10.21 (s, 1H), 7.84 (dt, J= 1.0, 8.0, 1H), 7.47 (apparent td, 
J= 1.0, 8.0, 1H), 7.40 (apparent dt, J= 1.0, 8.5, 1H), 7.26 (td, J= 1.0, 7.5, 1H), 4.09 (s, 
3H), 3.53 (s, 1H); 
1
H NMR (500 MHz, CD2Cl2)  10.20 (s, 1H), 7.82 (d, J= 8.1, 1H), 
7.49-7.43 (m, 2H), 7.26 (td, J= 7.0, 1.0, 1H), 4.07 (s, 3H), 3.61 (s, 1H); 
13
C NMR (75 
MHz, CDCl3)  182.3, 139.3, 136.5, 128.0, 127.8, 122.1, 121.9, 110.6, 110.3, 84.7, 74.8, 
31.8; HRMS m/e for C12H9NO calcd 183.0684, found 183.0684.  
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2-(3-((Trimethylsilyl)methyl)but-3-en-1-yn-1-yl)benzaldehyde (69) 
    
 
General Procedure A: (THF and diisopropylamine were well-degassed with a 
stream of nitrogen for 1 h prior to use in Sonogashira coupling). 2-Ethynylbenzaldehyde 
(67, 0.543 g, 4.18 mmol) and 2-bromo-3-(trimethylsilyl)-1-propene (68, 0.807 g, 4.18 
mmol) were dissolved in a (5:1) solvent mixture of diisopropylamine/THF (40 mL). This 
solution was stirred at room temperature until a clear homogenous solution was obtained. 
Then, Pd(PPh3)4 (0.241 g, 5 mol %) and CuI (0.080 g, 10 mol %) were added quickly to 
the reaction mixture. The solution was stirred for 2 h at room temperature. A saturated 
aqueous solution of ammonium chloride was added and the mixture was subjected to a 
conventional work-up using diethyl ether. The dark oil was purified by flash 
chromatography (25:1 petroleum ether/Et2O) to give pure product 69 (0.719 g, 71 %) as a 
yellow oil. IR (KBr) max 2927, 1700, 1599 cm
-1
; 
1
H NMR (500 MHz, CDCl3)  10.53 
(d, J= 0.5, 1H), 7.91 (m, 1H), 7.53 (m, 2H), 7.41 (m, 1H), 5.37 (d, J= 2.0, 1H), 5.18 (d, 
J= 1.5, 1H), 1.79 (d, J= 0.5, 2H), 0.11 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  192.0, 
135.9, 133.9, 133.2, 128.6, 128.4, 127.3, 127.2, 120.8, 98.7, 83.8, 28.1, -1.5; HRMS m/e 
for C15H18OSi calcd 242.1127, found 242.1130. 
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5-Methoxy-2-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)benzaldehyde (79a) 
 
 
 Procedure A was followed using 2-ethynyl-5-methoxybenzaldehyde (78a, 0.147 
g, 1.1 equiv) and 2-bromo-3-(trimethylsilyl)-1-propene (68, 0.1616 g, 0.836 mmol). Flash 
chromatography (5:1 petroleum ether/Et2O) gave pure product 79a (0.166 g, 73 %) as a 
yellow oil. IR (KBr) max 2955, 2200, 1690, 1601, 1493 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3)  10.49 (s, 1H), 7.45 (d, J= 8.5, 1H), 7.39 (d, J= 3.0, 1H), 7.10 (dd, J= 3.0, 8.5, 
1H), 5.33 (s, 1H), 5.14 (s, 1H), 3.86 (s, 3H), 1.78 (s, 2H), 0.11 (s, 9H); 
13
C NMR (125 
MHz, CD2Cl2)  191.3, 159.8, 137.2, 134.5, 132.0, 128.6, 121.3, 119.6, 109.8, 96.9, 83.6, 
55.7, 27.9, -2.0; HRMS m/e for C16H20O2Si calcd 272.1233, found 272.1239.  
3-(3-((Trimethylsilyl)methyl)but-3-en-1-yn-1-yl)thiophene-2-carbaldehyde (79b) 
 
 
 Procedure A was followed using 3-ethynylthiophene-2-carbaldehyde (78b, 
0.1425 g, 1.05 mmol) and 2-bromo-3-(trimethylsilyl)-1-propene (68, 0.2035 g, 1.05 
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mmol). The reaction mixture was stirred for 2 h at 50 C. Flash chromatography (2:1 
petroleum ether/ether) afforded compound 79b (0.165 g, 63 % yield) as yellow oil.         
IR (KBr) max 2955, 2925, 2195, 1668, 1418, 1248 cm
-1
; 
1
H NMR (500 MHz, CDCl3)  
10.12 (d, J= 1.0, 1H), 7.66 (dd, J= 1.0, 5.0, 1H), 7.15 (d, J= 5.0, 1H), 5.38 (d, J= 1.5, 
1H), 5.20 (d, J= 1.5, 1H), 1.78 (s, 2H), 0.11 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  183.1, 
143.4, 134.0, 131.6, 128.2, 121.3, 110.3, 98.3, 80.5, 28.1, -1.5; HRMS m/e for          
C13H16OSSi calcd 248.0691, found 248.0673. 
3-(3-((Trimethylsilyl)methyl)but-3-en-1-yn-1-yl)furan-2-carbaldehyde (79c) 
 
 
Procedure A was followed using 3-ethynylfuran-2-carbaldehyde (78c, 0.0737 g, 
0.61 mmol) and 2-bromo-3-(trimethylsilyl)-1-propene (68, 0.1185 g, 0.61 mmol). Flash 
chromatography (5:1 petroleum ether/ Et2O) gave compound 79c (0.0939 g, 66 % yield) 
as yellow oil. IR (KBr) max 2956, 1683, 1420, 1250 cm
-1
; 
1
H NMR (500 MHz, CDCl3)  
9.77 (d, J= 1.0, 1H), 7.61 (apparent dd, J= 1.5, 2.8, 1H), 6.58 (d, J= 3.0, 1H), 5.38 (d, J= 
1.5, 1H), 5.21 (d, J= 1.5, 1H), 1.77 (d, J= 0.5, 2H), 0.10 (s, 9H); 
13
C NMR (125 MHz, 
CD2Cl2)  176.2, 153.0, 148.0, 128.6, 121.4, 120.0, 115.5, 99.8, 77.5, 28.1, -1.7; HRMS 
m/e calcd for C13H16O2Si: 232.0920; found: 232.0925. 
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1-Methyl-3-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)-1H-indole-2-carbaldehyde 
(79d) 
 
 
 Procedure A was followed using 3-ethynyl-1-methyl-1H-indole-2-carbaldehyde 
(78d, 0.512 g, 2.79 mmol) and 2-bromo-3-(trimethylsilyl)-1-propene (68, 0.539 g, 2.79 
mmol). The reaction mixture was stirred for 30 min at room temperature. Flash 
chromatography (5:1 petroleum ether/Et2O) gave pure product 79d (0.595 g, 72 %) as a 
yellow oil. IR (KBr) max 2954, 2200, 1668, 1476 cm
-1
; 
1
H NMR (500 MHz, CDCl3)  
10.18 (s, 1H), 7.83 (d, J= 8.0, 1H), 7.46 (td, J= 1.0, 7.5, 1H), 7.37 (d, J= 8.5, 1H), 7.24 
(apparent dd, 1H), 5.39 (d, J= 2.0, 1H), 5.17 (s, 1H), 4.08 (s, 3H), 1.84 (s, 2H), 0.14 (s, 
9H); 
13
C NMR (75 MHz, CDCl3)  182.4, 139.6, 135.4, 128.8, 127.8, 127.7, 122.3, 
121.6, 119.7, 112.2, 110.5, 99.3, 79.2, 31.8, 28.3, -1.5; HRMS m/e for C18H21NOSi calcd 
295.1392, found 295.1384. 
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Hexacarbonyl [μ-η4-(2-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)benzaldehyde)] 
dicobalt (70) 
 
 
 
General Procedure B: Compound 69 (0.132 g, 0.55 mmol) was dissolved in 
anhydrous Et2O and cooled to 0 C in an ice bath. An unweighed amount of dicobalt 
octacarbonyl (excess) was added and the reaction was stirred while maintaining the 
temperature at 0 C. After 1.5 h, the mixture was concentrated under reduced pressure in 
a cold water bath. The crude brown-coloured material was purified on a plug of silica 
(using 100% hexanes to remove the unreacted dicobalt octacarbonyl, and then switching 
to 100% diethyl ether to elute the final product). Compound (70) was obtained as dark 
brown oil (0.230 g, 80 % yield). IR (KBr) max 2925, 2852, 2092, 2055, 2022, 1693, 1593 
cm
-1
; 
1
H NMR (500 MHz, CDCl3)  10.37 (s, 1H), 7.94 (d, J= 7.8, 1H), 7.68 (d, J= 7.5, 
1H), 7.61 (td, J= 1.25, 7.5, 1H), 7.46 (t, J= 7.7, 1H), 5.48 (d, J= 1.0, 1 H), 5.35 (d, J= 1.0, 
1H), 1.72 (d, J= 1.0, 2H), 0.10 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  199.0, 191.1, 
143.7, 141.5, 134.7, 133.5, 132.6, 128.2, 117.3, 101.9, 88.6, 26.5, -0.8; HRMS m/e for 
C21H18Co2O7Si [M
+
 - 2CO] calcd 471.9587, found 471.9604. 
 
67 
 
Hexacarbonyl[μ-η4-(5-methoxy-2-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl) 
benzaldehyde)]dicobalt (80a) 
 
 
A solution of 79a (0.155 g, 0.57 mmol) in anhydrous Et2O (40 mL) was subjected 
to Procedure B to afford product 80a (0.238 g, 75 % yield) as a dark brown oil. IR (KBr) 
max 2959, 2090, 2055, 1689, 1599, 1481 cm
-1
; 
1
H NMR (500 MHz, CDCl3)  10.36 (s, 
1H), 7.60 (d, J= 8.5, 1H), 7.43 (d, J= 2.5, 1H), 7.18 (dd, J= 2.5, 8.5, 1H), 5.48 (s, 1H), 
5.34 (s, 1H), 3.89 (s, 3H), 1.71 (s, 2H), 0.10 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  199.2, 
190.9, 159.7, 143.8, 135.2, 133.8, 133.5, 122.5, 117.3, 110.6, 101.6, 89.1, 55.8, 26.4, -0.8; 
HRMS m/e for C22H20Co2O8Si [M
+
 - 4CO] calcd 445.9795, found 445.9785.  
Hexacarbonyl [μ-η4-(3-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)thiophene-2-
carbaldehyde)]dicobalt (80b) 
 
 
A solution of 79b (0.0165 g, 0.066 mmol) in anhydrous Et2O (15 mL) was 
subjected to Procedure B to afford product 80b (0.0273 g, 77 % yield) as a dark brown 
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oil. IR (KBr) max 2957, 2925, 2855, 2092, 2056, 2026, 1721, 1664, 1461 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3)  10.08 (s, 1H), 7.71 (d, J= 5.0, 1H), 7.23 (d, J= 5.0, 1H), 5.48 (s, 
1H), 5.33 (s, 1H), 1.77 (s, 2H), 0.11 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  198.8, 182.4, 
147.3, 143.5, 137.2, 134.7, 132.9, 117.0, 99.9, 81.4, 26.3, -0.9; HRMS m/e for          
C19H16Co2O7SSi [M
+
 - CO] calcd 505.9101, found 505.9100.  
Hexacarbonyl [μ-η4-(3-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)furan-2-
carbaldehyde)] dicobalt (80c) 
 
 A solution of 79c (0.0305 g, 0.131 mmol) in anhydrous Et2O (35 mL) was 
subjected to Procedure B to afford product 80c (0.058 g, 85 % yield) as a dark brown oil. 
IR (KBr) max 2958, 2094, 2056, 2026, 1679, 1477, 1251 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3)  9.84 (d, J= 0.6, 1H), 7.65 (apparent dd, J= 0.6, 1.8, 1H), 6.64 (d, J= 1.8, 1H), 
5.46 (d, J= 0.9, 1H), 5.29 (d, J= 0.9, 1H), 1.78 (d, J= 0.6, 2H), 0.10 (s, 9H); 
13
C NMR 
(125 MHz, CD2Cl2)  199.0, 176.2, 147.9, 146.6, 143.5, 136.1, 116.5, 115.6, 100.1, 77.9, 
26.0, -1.3; HRMS m/e for C19H16Co2O8Si [M
+
 - CO] calcd 489.9329, found 489.9312. 
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Hexacarbonyl[μ-η4-(1-methyl-3-(3-((trimethylsilyl)methyl)but-3-en-1-yn-1-yl)-1H-
indole-2-carbaldehyde)]dicobalt (80d) 
 
 A solution of 79d (0.0918 g, 0.311 mmol) in CH2Cl2 (30 mL) was subjected to 
Procedure B to afford product 80d (0.146 g, 81 % yield) as a dark green oil. IR (KBr) 
max 2926, 2854, 2088, 2053, 2025, 1728, 1667, 1472 cm
-1
; 
1
H NMR (500 MHz, CDCl3) 
 10.52 (s, 1H), 7.90 (d, J= 8.0, 1H), 7.41-7.48 (m, 2H), 7.23-7.24 (m, 1H), 5.58 (s, 1H), 
5.39 (d, J= 1.0, 1H), 4.12 (s, 3H), 1.73 (s, 2H), 0.11 (s, 9H); 
13
C NMR (75 MHz, CDCl3) 
 199.7, 182.5, 127.9, 122.5, 121.7, 117.2, 110.9, 91.6, 84.8, -0.5; HRMS m/e for 
C24H21Co2NO7Si [M
+ 
- 3CO] calcd 496.9904, found 496.9911. 
Hexacarbonyl [μ-(8,9-dehydro-7-methylene-6,7-dihydro-5H-benzo[7]annulen-5-
ol)]dicobalt (71) 
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 General Procedure C: To a solution of 70 (0.2177 g, 0.410 mmol) in anhydrous 
CH2Cl2 (25 mL) at 0 C was added BF3-OEt2 (0.051 mL, 0.41 mmol, 1.0 equiv). After 
stirring for 20 min at the same temperature, saturated NaHCO3(aq) was added to the 
mixture and a conventional extractive workup using CH2Cl2 followed. After the removal 
of volatiles under reduced pressure, the crude dark oil was purified by flash 
chromatography (2:1 petroleum ether/Et2O) to afford alcohol (71) as dark brown solid 
(0.1415 g, 75 % yield). IR (KBr) max 3438, 2090, 2055, 2022, 1633 cm
-1
; 
1
H NMR (500 
MHz, CDCl3)  7.77 (d, J= 7.5, 1H), 7.31-7.41 (m, 3H), 5.86 (s, 1H), 5.70 (s, 1H), 4.98 
(q, J= 4.0, 1H), 3.11 (d of 0.5 ABq, J= 8.0, 14.5, 1H), 2.88 (0.5 ABq, J= 14.5, 1H), 1.76 
(d, J= 4.0, 1H); 
13
C NMR (75 MHz, CDCl3)  199.2, 143.0, 141.3, 135.8, 134.3, 129.4, 
129.2, 128.5, 123.4, 88.4, 88.0, 73.3, 41.3; HRMS m/e for C18H10Co2O7 [M
+
] calcd 
455.9090, found 455.9085.   
Hexacarbonyl [μ-(8,9-dehydro-3-methoxy-7-methylene-6,7-dihydro-5H-
benzo[7]annulen-5-ol)]dicobalt (81a) 
 
 Following Procedure C, a solution of compound 80a (0.1445 g, 0.259 mmol) in 
anhydrous CH2Cl2 (30 mL) was treated with BF3-OEt2 (32.8 µL, 0.259, 1.0 equiv). The 
reaction was judged to be complete after 5 min where all the starting material was 
consumed (by TLC). The crude compound was purified by flash chromatography (5:1 
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petroleum ether/Et2O) to afford pure compound 81a (0.0901 g, 72 % yield) as dark brown 
solid. IR (KBr) max 3413, 2923, 2088, 2051, 2021 cm
-1
; 
1
H NMR (300 MHz, CDCl3)  
7.69 (d, J= 8.4, 1H), 6.92 (dd, J= 2.7, 8.4, 1H), 6.89 (d, J= 2.7, 1H), 5.84 (s, 1H), 5.67 
(d, J= 0.9, 1H), 4.91 (dd, J= 4.5, 7.5, 1H), 3.85 (s, 3H), 3.09 (d of 0.5 ABq, J= 7.8, 14.5, 
1H), 2.88 (0.5 ABq, J= 14.5, 1H), 1.84 (d, J= 4.5, 1H); 
13
C NMR (75 MHz, CDCl3)  
199.4, 159.9, 143.1, 135.9, 127.4, 123.1, 114.7, 114.5, 88.8, 88.6, 73.3, 55.5, 41.7; 
HRMS m/e for C19H12Co2O8 [M
+
] calcd 485.9196, found 485.9202.  
Hexacarbonyl [μ-(7,8-dehydro-6-methylene-6H-cyclohepta[b]thiophen-8-ol)]dicobalt 
(81b) 
 
A solution of compound 80b (0.0165 g, 0.031 mmol) in anhydrous CH2Cl2 (8 mL) 
was treated with BF3-OEt2 (3.48 µL, 0.031 mmol, 1.0 equiv) as described in Procedure C. 
The crude compound was purified by flash chromatography (2:1 petroleum ether/Et2O) to 
afford pure compound 81b (0.0131 g, 91 % yield) as brown oil. IR (KBr) max 3398, 
2926, 2855, 2090, 2055, 2022, 1715, 1625 cm
-1
; 
1
H NMR (500 MHz, CDCl3)  7.29 (d, 
J= 5.5, 1H), 7.25 (d, J= 5.0, 1H), 5.85 (s, 1H), 5.70 (s, 1H), 5.05 (m, 1H), 3.00 (d of 0.5 
ABq, J= 14.0, 1H), 2.87 (0.5 ABq, J= 14.0, 1H), 2.04 (d, J= 6.5, 1H); 
13
C NMR (125 
MHz, CDCl3)  199.2, 143.5, 142.3, 133.4, 130.9, 125.7, 124.2, 89.3, 82.3, 68.2, 41.7; 
HRMS m/e for C16H8Co2O7S [M
+
] calcd 461.8655, found 461.8652.  
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Hexacarbonyl [μ-(7,8-dehydro-6-methylene-6H-cyclohepta[b]furan-8-ol)]dicobalt 
(81c) 
 
 
A solution of compound 80c (0.041 g, 0.079 mmol) in anhydrous CH2Cl2 (15 mL) was 
treated with BF3-OEt2 (9.8 µL, 0.079 mmol, 1.0 equiv) as described in Procedure C. The 
crude compound was purified by flash chromatography (2:1 petroleum ether/Et2O) to 
afford pure compound 81c (0.0208 g, 60 % yield) as brown oil. IR (KBr) max 3390, 
2094, 2056, 2026 cm
-1
; 
1
H NMR (500 MHz, CDCl3) 7.43 (s, 1H), 6.62 (s, 1H), 5.85 (s, 
1H), 5.70 (s, 1H), 5.02 (m, 1H), 2.99 (dd, J= 6.0, 14.0, 1H), 2.77 (d, J= 14.5, 1H), 1.85 
(d, J= 7.0, 1H); HRMS m/e for C16H8Co2O8 [M
+
 - 2CO] calcd 389.8985, found 389.8989.  
Hexacarbonyl [μ-(9,10-dehydro-5-methyl-8-methylene-5,6,7,8-tetrahydrocyclo-
hepta[b]indol-6-ol)]dicobalt (81d) 
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 A solution of compound 80d (0.0664 g, 0.114 mmol) in anhydrous CH2Cl2 (15 
mL) was treated with BF3-OEt2 (14.0 µL, 0.114 mmol, 1.0 equiv) as described in 
Procedure C. The crude compound was purified by flash chromatography (2:1 petroleum 
ether/Et2O) to afford pure compound 81d (0.0132 g, 54 % yield) as black/ dark green 
solid. IR (KBr) max 3561, 2921, 2086, 2036, 2000, 1720 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3)  7.87 (d, J= 8.0, 1H), 7.38 (d, J= 8.0, 1H), 7.34 (td, J= 1.0, 7.0, 1H), 7.27 (td, J= 
1.0, 7.0, 1H), 5.91 (s, 1H), 5.71 (d, J= 1.5, 1H), 5.22 (apparent dd, J= 1.5, 2.0, 1H), 3.84 
(s, 3H), 3.15 (d of 0.5 ABq, J= 5.5, 14.0, 1H), 2.90 (0.5 ABq, J= 14.0, 1H), 1.70 (d, J= 
10.0, 1H); 
13
C NMR (75 MHz, CDCl3)  199.9, 142.1, 138.3, 137.7, 128.4, 123.7, 123.3, 
121.0, 119.8, 110.1, 109.6, 92.1, 83.0, 63.5, 40.3, 29.6; HRMS m/e for C21H13Co2NO7 
[M
+
] calcd 508.9356, found 508.9352. 
Hexacarbonyl [μ-(8,9-dehydro-7-methylene-6,7-dihydro-5H-benzo[7]annulen-5-
one)]dicobalt (72) 
 
 
 
To a solution of alcohol 71 (0.248 g, 0.544 mmol) in anhydrous CH2Cl2, 
manganese oxide (MnO2) powder (0.2364 g, 2.720 mmol, 5 equiv.) was added in one 
portion at -5 C. Following stirring for 1 h at this temperature, the solution was filtered to 
remove the excess solid. The filtrate was concentrated under reduced pressure and was 
subjected to flash chromatography (5:1 petroleum ether/ Et2O) to give the sequential 
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elution of ketone 72 (0.0691 g, 28 % yield, 43 % based on recovered 71) and starting 
material 71 (0.0868 g, 35 % recovery). IR (KBr) max 2926, 2095, 2057, 2026, 1682, 
1596 cm
-1
;
 1
H NMR (500 MHz, CDCl3)  7.75 (d, J= 7.5, 1H), 7.68 (dd, J= 1.5, 7.7, 1H), 
7.56 (td, J= 1.5, 7.7, 1H), 7.41 (td, J= 1.0, 7.7, 1H), 5.77 (s, 1H), 5.75 (s, 1H), 3.76 (s, 
2H); 
13
C NMR (125 MHz, CD2Cl2)  198.8, 198.3, 139.1, 138.6, 136.8, 133.4, 132.6, 
128.9, 128.4, 122.3, 87.8, 87.4, 51.9; HRMS m/e for C18H8Co2O7[M
+
] calcd 453.8934, 
found 453.8914. 
Hexacarbonyl [μ-(8,9-dehydro-7-methyl-5H-benzo[7]annulen-5-one)]dicobalt (73) 
 
 
To a stirred ice cold solution of 72 (80.9 mg, 0.20 mmol) in anhydrous CH2Cl2 (10 
mL) was added H2SO4 (3 drops in 2 mL of anhydrous CH2Cl2) in a dropwise fashion over 
a period of 20 min. Following stirring for 2 h at 0 C, water was added, and the mixture 
was subjected to a conventional extractive workup using dichloromethane. The isolated 
crude extract was subjected to flash chromatography (5:1 petroleum ether/Et2O) to afford 
pure 73 (70.8 mg, 88 % yield). IR (KBr) max 2918, 2095, 2057, 2031, 1730, 1605, 1582 
cm
-1
; 
1
H NMR (300 MHz, CDCl3)  8.25 (dd, J= 1.2, 8.1, 1H), 7.87 (dd, J= 1.2, 7.6, 
1H), 7.66 (td, J= 1.2, 7.5, 1H), 7.53 (td, J= 1.2, 7.5, 1H), 6.67 (d, J= 1.2, 1H), 2.43 (d, J= 
1.2, 3H); 
13
C NMR (75 MHz, CD2Cl2)  198.5, 189.3, 149.5, 137.8, 136.7, 133.6, 133.5, 
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132.4, 131.4, 129.1, 85.4, 83.7, 23.6; HRMS m/e for C18H8Co2O7 [M
+
] calcd 453.8934, 
found 453.8941. 
Hexacarbonyl [μ-(8,9-dehydro-7-methyl-7H-benzo[7]annulen-7-ol)]dicobalt (74) 
 
 
Compound 73 (52 mg, 0.11 mmol) was dissolved in anhydrous CH2Cl2 (7 mL) 
and the solution was cooled to -78 C. DIBAL-H (0.46 mL of a 1.0 M solution in THF, 
0.46 mmol, 4 equiv.) was added dropwise and the solution was stirred for 1 h at the same 
temperature. Then, a saturated aqueous solution of NH4Cl was added and the reaction 
mixture was subjected to a conventional extractive workup using dichloromethane. 
Removal of the volatiles under reduced pressure afforded a crude mixture which was 
subjected to flash chromatography (5:1 petroleum ether/Et2O) to afford alcohol 
compounds 74 and 75 (inseparable by chromatography) and the elimination product 83 
(14.0 mg, 29 % yield). The isolated mixture containing (74) and (75) was mixed with 
silica in hexanes. After stirring for 1 h, the silica was filtered off and the collected filtrate 
was concentrated under reduced pressure to afford alcohol (75) exclusively (35.5 mg, 68 
% yield from ketone 73). Compound 75: IR (KBr) max 3448, 2924, 2853, 2092, 2055, 
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2024, 1723 cm
-1
; 
1
H NMR (500 MHz, CDCl3)  7.67 (m, 1H), 7.34 (m, 2H), 7.18 (m, 
1H), 6.38 (d, J= 12.5, 1H), 6.13 (d, J= 12.5 Hz, 1H), 2.23 (s, 1H), 1.54 (s, 3 H); 
13
C 
NMR (75 MHz, CD2Cl2)  199.3, 139.6, 135.9, 135.4, 133.0, 131.2, 128.8, 128.2, 125.4, 
90.8, 88.0, 71.6, 22.7; HRMS m/e for C18H10Co2O7 [M
+
 - 2CO] calcd 399.9192, found 
399.9196. Resonances from (83) could be detected at: 
1
H NMR (300 MHz, CDCl3)  
7.68 (m, 1H), 7.28 (m, 2H), 7.13 (m, 1H), 6.37 (d, J= 7.5, 1H), 6.32 (d, J= 7.5, 1H), 5.69 
(s, 1H), 5.61 (s, 1H).  
 
General Procedure D: To a solution of (75) in anhydrous dichloromethane at       
0 C, an excess amount of the nucleophile (5-8 equiv.) was added. Then, BF3-OEt2 (3 
equiv.) was added dropwise while maintaining the temperature at 0 C. The solution was 
stirred for 30 min (TLC monitoring). The reaction was quenched with a saturated aqueous 
sodium bicarbonate solution, and was followed with a conventional aqueous workup 
using dichloromethane. The crude mixture was purified by flash chromatography (100:1 
petroleum ether/Et2O) to afford the final product. 
Hexacarbonyl [μ-(8,9-dehydro-5-allyl-7-methyl-5H-benzo[7]annulene)]dicobalt (84a 
and 84b) 
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 A solution of alcohol compound 75 (11.41 mg, 0.0250 mmol) in CH2Cl2 (7 mL) 
was subjected to Procedure D using allyltrimethylsilane (22.81 mg, 0.201 mmol, 8 
equiv.) to afford a (6:1) mixture of 84a and 84b  (9.943 mg, 83 % total yield 84a + 84b). 
IR (KBr) max 2924, 2854, 2088, 2048, 2015, 1445, 1102 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) (major product, 84a) 7.68 (d, J= 6.5, 1H), 7.30-7.35 (m, 2H), 7.20 (d, J= 7.5, 
1H), 5.73-5.79 (m, 2H), 5.06-5.13 (m, 2H), 3.13 (m, 1H), 2.66 (m, 2H), 2.14 (s, 3H); 
resonances from the minor product (84b) could be detected at 6.37 (d, J= 12.0, 1H), 5.86 
(d, J= 12.0, 1H), 3.65 (br s, 2H); 
13
C NMR (75 MHz, CDCl3) (major product, 84a) 
199.7, 139.3, 137.4, 136.5, 135.4, 132.9, 131.4, 128.5, 127.0, 126.2, 117.0, 92.8, 89.4, 
38.2, 29.7, 23.0; resonances from the minor product (84b) could be detected at 49.5, 
118.7, 129.8, 133.9, 140.3; HRMS m/e for C21H14Co2O6 [M
+
] calcd 479.9454, found 
479.9440. 
Hexacarbonyl [μ-(8,9-dehydro-7-methyl-5-(2-methylallyl)-5H-benzo[7]annulene)] 
dicobalt (85a and 85b) 
 
 A solution of alcohol compound 75 (25.6 mg, 0.056 mmol) in CH2Cl2 (10 mL) 
was subjected to Procedure D using methallyltrimethylsilane (36.1 mg, 0.280 mmol, 5 
equiv.) to afford a (6:1) mixture of 85a and 85b (18.25 mg, 66 % total yield 85a + 85b). 
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IR (KBr) max 2956, 2922, 2852, 2094, 2055, 2011, 1601, 1463 cm
-1
; 
1
H NMR (500 
MHz, CDCl3) (major product, 85a)  7.69 (d, J= 7.5, 1H), 7.29-7.35 (m, 2H), 7.21 (d, J= 
7.5, 1H), 5.71 (d, J= 4.5, 1H), 4.86 (s, 1H), 4.77 (s, 1H), 3.23 (apparent t, J= 4.5, 1H), 
2.60-2.66 (m, 2H), 2.13 (s, 3H), 1.68 (s, 3H); resonances from the minor product (85b) 
could be detected at 6.37 (d, J= 12.0, 1H), 5.94 (d, J= 12.0, 1H); 
13
C NMR (75 MHz, 
CDCl3) (major product, 85a) 199.2, 143.1, 139.5, 135.3, 133.1, 131.2, 128.6, 127.1, 
126.0, 113.3, 94.5, 89.0, 42.3, 40.9, 23.1, 22.3; HRMS m/e for C22H16Co2O6 [M
+
 - 2CO] 
calcd 437.9713, found 437.9720. 
Hexacarbonyl[μ-(8,9-dehydro-2-(7-methyl-5H-benzo[7]annulen-5-yl)-1 
phenylethanone)]dicobalt (86a and 86b) 
 
 A solution of alcohol compound 75 (30.10 mg, 0.066 mmol) in CH2Cl2 (10 mL) 
was subjected to Procedure D using trimethyl((1-phenylvinyl)oxy)silane (76.86 mg, 
0.396 mmol, 6 equiv.) to afford a 4:1 mixture of 86a and 86b (estimated yield based on 
1
H NMR spectrum is 55 % total yield 86a + 86b). IR (KBr) max 2923, 2853, 2088, 2050, 
2017, 1688, 1449 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (major product, 86a)  8.00 (d, J= 
7.5, 2H), 7.15-7.70 (m, 7H), 5.84 (d, J= 5.5, 1H), 4.03 (m, 1H), 3.53 (m, 1H), 3.46 (d, J= 
5.0, 1H), 2.12 (s, 3H); resonances from the minor product (86b) could be detected at 6.69 
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(s, 1H), 6.35 (d, J= 12.0, 1H), 6.29 (d, J= 12.0, 1H), 3.43 (d, J= 5.0, 1H); 
13
C NMR (75 
MHz, CDCl3) (major product, 86a) δ 199.9, 197.9, 140.7, 138.8, 137.4, 137.1, 135.3, 
131.7, 130.8, 129.8, 129.2, 128.9, 128.3, 127.7, 127.2, 89.0, 83.3, 44.5, 29.6, 23.3; 
HRMS m/e for C26H16Co2O7 [M
+
 - 6CO] calcd 389.9865, found 389.9844. 
Hexacarbonyl [μ-(8,9-dehydro-1-methyl-3-(7-methyl-5H-benzo[7]annulen-5-yl)-1H-
pyrrole)]dicobalt (87) 
 
 
 A solution of alcohol compound 75 (10.20 mg, 0.0224 mmol) in CH2Cl2 (5 mL) 
was subjected to Procedure D using N-methylpyrrole (9.085 mg, 0.112 mmol, 5 equiv.) 
to afford product 78 (9.358 mg, 81 % yield). IR (KBr) max 3434, 2918, 2090, 2051, 
2021, 1641 cm
-1
; 
1
H NMR (300 MHz, CD2Cl2)  7.71 (dd, J= 1.5, 7.5, 1H), 7.28 (m, 
1H), 7.21 (td, J= 1.8, 7.5, 1H), 6.64 (apparent t, J= 2.1, 1H), 6.34 (m, 1H), 6.30 (m, 1H), 
6.25 (m, 1H), 6.19 (td, obscured, 1H), 4.38 (d, J= 2.1, 1H), 3.20 (s, 3 H), 2.21 (t, J= 2.8, 
3H); 
13
C NMR (75 MHz, CD2Cl2)  199.5, 139.7, 137.1, 136.3, 132.8, 132.7, 130.2, 
128.7, 127.2, 126.5, 122.0, 108.1, 106.9, 92.8, 89.4, 41.8, 33.5, 22.8; HRMS m/e for 
C23H15Co2NO6 [M
+
 - 2CO] calcd 462.9665, found 462.9662. 
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Hexacarbonyl [μ-(8,9-dehydro-7-methoxy-7-methyl-7H-benzo[7]annulene)]dicobalt 
(88a and 88b) 
 
 A solution of alcohol compound 75 (17.4 mg, 0.0381 mmol) in 10 mL of (1:1) 
CH2Cl2/MeOH solvent was subjected to Procedure D to afford a 3:1 mixture of 88a and 
88b (9.7 mg, 54 % total yield 88a + 88b). IR (KBr) max 3395, 2924, 2091, 2053, 2020, 
1576, 1081 cm
-1
; 
1
H NMR (500 MHz, CD2Cl2) (major product, 88a) δ 7.69 (m, 1H), 7.34 
(m, 2H), 7.22 (m, 1H), 6.47 (d, J= 12.5, 1H), 6.05 (d, J= 12.5, 1H), 3.42 (s, 3H), 1.49 (s, 
3H); resonances from the minor product (88b) could be detected at 7.74-7.79 (m, 2H), 
6.61 (d, J= 12.5, 1H), 6.12 (dd, J= 1.0, 5.5, 1H), 4.53 (d, J= 6.0, 1H), 3.21 (s, 3H), 1.50 
(s, 3H); 
13
C NMR (75 MHz, CD2Cl2) (major product, 88a) δ 199.7, 138.2, 136.0, 132.2, 
131.6, 129.6, 128.7, 128.1, 127.7, 88.0, 78.2, 50.9, 28.2; resonances from the minor 
product (88b) could be detected at 133.3, 128.3, 81.0, 56.3, 29.7; 
13
C NMR (75 MHz, 
CDCl3) δ 199.3, 138.1, 136.0, 132.1, 131.6, 131.5, 129.8, 128.8, 128.0, 91.0, 78.4, 51.1, 
28.5; resonances from the minor product (88b) could be detected at 133.3, 81.2, 53.4, 
29.7; HRMS m/e for C19H12Co2O7 [M
+
 - CO] calcd 441.9298, found 441.9299. 
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PART II 
 
CHAPTER 1: INTRODUCTION 
 
1.1 Colchicine and Allocolchicinoids 
 
1.1.1   (–)-Colchicine 
 
 (aR,7S)-Colchicine [(–)-colchicine] (100), (Figure 1.6), the principal alkaloid of 
the poisonous plant meadow saffron (Colchicum autumnale), is one of the oldest known 
natural products. It was first isolated in its pure state by Pelletier and Caventou
1
 in the 
19
th
 century, but it was not until 1959 when Eschenmoser and co-workers
2
 reported the 
first successful total synthesis of colchicine. For thousands of years, colchicine has been 
considered a well-known ancient remedy for treating acute gout, Mediterranean fever, 
and liver cirrhosis.
3
 In 2009, colchicine became officially approved by FDA and was 
patented as brand-name "Colcrys".
4 
 
 
Figure 1.6  Structure of ()-(aR, 7S) colchicine and its numbering system. 
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 Colchicine has gained increased interest due to its antitumor activity; it was shown 
to be effective in inhibiting the proliferation of cancer cells in mice and inducing tumor 
regression.
5-7
 Like other tubulin-binding natural products such as taxol and epothilones, 
colchicine exhibits great pharmaceutical potential and has experienced a renaissance in 
interest in the last few years.
8
  The mechanism of action of this alkaloid involves binding 
to the intracellular protein tubulin (which is the main constitutive protein of 
microtubules), hence disrupting the microtubule-dependent functions in the cell. Due to 
the essential role of the mitotic spindle in cell division, the microtubule dynamic is still 
regarded as one of the most relevant drug targets for the treatment of cancer.
5
 Tubulin 
consists of α and β protein subunits which combine to form a heterodimer. These 
heterodimers polymerize in a helical fashion to form long tubes known as microtubules.
9
 
Microtubules are known to be responsible for a multitude of cellular functions including: 
formation of the cytoskeleton to maintain the cellular shape, transport systems for moving 
material around inside the cell, and most importantly, the formation of the mitotic spindle 
during cell division. Colchicine (100) disrupts these activities by binding to the tubulin 
heterodimer and preventing polymerization to form microtubules. This leads to the 
termination of the cell cycle in the G2/M phase, ultimately resulting in apoptotic cell 
death.
8 
 Despite colchicine's intriguing anti-proliferative properties, and following many 
years of clinical research, its high cytotoxicity in chemotherapy has precluded further 
development of the drug as a potential antitumor agent. It was found that its therapeutic 
effects are only observed at toxic or nearly toxic doses, hence rendering it clinically 
unusable for cancer treatment.
10
 Nevertheless, owing to its unique tricyclic-based 
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structure, colchicine has became a useful structural reference for the search of other 
tubulin-targeting antitumor compounds. This prompted researchers to find alternative 
structural analogues that possess similar structural features to the parent alkaloid but also 
provide a lower systemic toxicity.
5
 
 
1.1.2 Allocolchicinoids 
 
 Among several classes of structurally related compounds, allocolchicinoids; or 
allocolchicines, (the terms will be used interchangeably hereafter), have been identified 
as promising candidates for further development (Figure 1.7). These are compounds with 
an altered C-ring, where the tropolone ring has been replaced by an aryl moiety.
11
  
 
 
Figure 1.7  Numbering system of allocolchicinoids. 
 
 
 There is a myriad of naturally occurring allocolchicinoids (Figure 1.8) such as     
(–)-allocolchicine (101, isolated from Colchicum cornigerum and Colchicum 
autumnale),
12
 (–)-colchibiphenyline (105) and (–)-androbiphenyline (106) (both from 
Colchicum ritchii),
13
 and (–)-jerusalemine (107, derived from Colchicum decaisnei).14 In 
addition, there are also semi-synthetic congeners such as N-acetylcholchinol (NAC, 
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102)
15
 and its water-soluble form known as ZD6126 (104), and synthetic ones such as N-
acetylcolchinol-O-methylether (103, NCME or NSC 51046).
16 
 Like colchicine, allocolchicinoids such as allocolchicine (101) and N-
acetylcolchinol ZD6126 (104) have also shown anticancer activity owing to their ability 
to arrest cellular mitosis by inhibiting tubulin polymerization.
17
 Most importantly, they 
possess the added feature of owning reduced toxicity compared to colchicine, the parent 
alkaloid. This has led to an increasing interest in the development of synthetic protocols 
to provide allocolchicine and its derivatives for biological evaluation. 
 
 
 
 
Figure 1.8  Common allocolchicinoids. 
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1.2 Literature Overview and Previous Syntheses  
 
 
1.2.1 Preparation of Allocolchicine Derivatives from Natural Colchicine 
 
 
 For a long time, allocolchicinoids have been typically obtained by synthetic 
transformation of colchicine (100), which itself is isolated on a commercial scale for 
treating acute gout. This resulted in limiting the range of structural variation of novel 
derivatives which possess reduced toxicity. Several approaches have been reported for the 
partial synthesis of allocolchicine or derivatives. For example, N-acetylcolchicinol (102) 
has been obtained by treatment of colchicine with 30 % hydrogen peroxide.
18
 Thereafter, 
an O-methylation under standard conditions provided N-methyl ether acetylcolchicinol 
(102) with a total yield of 33 %. Alternatively, a different method to derive (102) with a 
total yield of 40 % over two steps, featured photooxygenation of colchicine followed by 
triphenylphosphine-assisted rearrangement to give (102).
19 
 
 
Scheme 1.20  Obtaining allocolchicine by derivatization of colchicine.  
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 Another example in this field is the work of Davis and co-workers
17a
 who reported 
the synthesis of compound ZD6126 (104) by deriving it from natural colchicine (100), 
using a series of three transformations as shown in (Scheme 1.21).  
 
 
 
Scheme 1.21  Obtaining compound ZD6126 (104) by derivatization of colchicine.  
 
 
 
 
1.2.2 Total Syntheses of N-Acetylcolchinol 
 
 
 N-Acetylcolchinol, (NAC, 102) is an allocolchicine derivative whose popularity is 
mainly attributed to its phosphate pro-drug, (ZD6126, 104). Sponsored by the 
AstraZeneca company, the results of Phase I clinical trials showed that ZD6126 has 
promising properties as a novel vascular targeting agent for the therapy of solid tumors.
20
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In fact, it induced tumor cells necrosis in in-vivo mouse models of a number of human 
cancer cell lines (such as lung, breasts, and ovarian tumor). Unfortunately, a few years 
later, further studies were ceased in Phase II clinical trials due to cardiotoxicity and 
critical side effects observed in humans when the required dose of the drug was 
administered. In view of this pharmaceutical potential, much attention has been dedicated 
to developing effective ways of obtaining NAC (102) itself. 
 
Sawyer and Macdonald's Method 
 
 In 1988, Sawyer and Macdonald
21
 performed the first total synthesis of racemic 
NAC (102). Using thallium (III) to mediate an intramolecular non-phenolic coupling 
reaction of the protected 1,3-diarylpropyl acetamide (108), the seven membered B-ring 
was constructed and the biaryl linkage was created simultaneously. 
 
 
 
Scheme 1.22  The first asymmetric synthesis of N-acetylcolchinol, (NAC), by Sawyer     
            and Macdonald.
21
   
 
 
94 
 
 Stemming from Sawyer and Macdonald's synthetic strategy, Kocienski and co-
workers
22
 developed an asymmetric version of the synthesis of NAC (102). The key 
distinction was the use of phenyliodonium bis(trifluoroacetate) as an oxidant in the final 
step. 
 
 
 
Scheme 1.23  Kocienski's asymmetric synthesis of NAC.
22 
 
 
 
Using Biaryl Reductive Coupling  
 
 
 In 2007, Leonard et al.
23
 reported an alternative synthetic approach to (S)-N-
acetylcolchinol. The authors devised a modified Ziegler-Ullmann process as the key step 
in the total synthesis of allocolchicine (102) by allowing the formation of the biaryl 
product, which in turn was readily cyclized under basic conditions. With the tricyclic core 
system in hand, the asymmetric hydrogentation of the enamide (109) was achieved using 
ruthenium catalyst, namely FerroTANE-based catalyst. The retrosynthetic analysis is 
given in (Scheme 1.24). 
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Scheme 1.24  Retrosynthesis of NAC by Leonard et al.
23 
 
 
 
 
1.2.3 Methods for Allocolchicine Synthesis 
 
 
Wulff's Method 
 
 
 The first total synthesis of (–)-(7S)-allocolchicine (101) was performed in 2003 by 
Wulff's group
24
 at the University of Michigan, by employing Diels-Alder reaction for 
constructing the C-ring around the A-B-framework (Scheme 1.25). The key step was 
employing the bicyclic diene (110) to undergo a regioselective Diels-Alder reaction in the 
presence of methyl propiolate as dienophile. The diene was first protected with TBDMS 
group which the authors propose as a necessary step not only for alcohol protection, but 
also as a major player in regiocontrol during the DA cycloaddition reaction. To complete 
the synthesis of dibenzoheptanone compound, a sequence of deprotection and oxidation 
steps were conducted, which gave (111), which in turn was asymmetrically reduced with 
(+)-TarB-NO2/LiBH4. Inversion of stereochemistry at C7 with concomitant introduction 
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of the requisite nitrogen functionality was achieved by Mitsunobu reaction with   
Zn(N3)2-2Py as azide source, generating the desired natural (–)-allocolchicine (101). 
 
 
 
 
 
Scheme 1.25  Wulff's total synthesis of ()-allocolchicine (101).24 
 
 
 
Fagnou and Leblanc's Method 
 
 
 In 2005, Fagnou and Leblanc
25
 reported an enantioselective formal synthesis of  
(–)-allocolchicine (101). Their novel approach involved employing a palladium-catalyzed 
intramolecular direct arylation of aryl chloride (112) to forge the key A-C biaryl carbon-
carbon bond needed to the construct seven-membered ring (i.e. B ring) of allocolchicine's 
tricyclic core (113). Deprotection of the OMOM group followed by employing Wulff's 
method to introduce the acetamide group at C7 completed the formal total synthesis of the 
natural product (101). 
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Scheme 1.26  Formal synthesis of allocolchicine (101) by Fagnou and Leblanc.
25 
 
 
 
 
 Unlike Wulff
24
 who established the chiral center in the allocolchicine after 
constructing the tricyclic core, Fagnou's strategy was to introduce the molecule's chirality 
in the early stages of the synthesis before forming the tricyclic framework. This method 
presented itself as a new and unique strategy in the asymmetric allocolchicinoid synthetic 
work.  
 
 
1.2.4 Syntheses of NCME or NSC 51046 
 
 Several total syntheses of allocolchicine have been reported in literature, however, 
there are considerably fewer methods for synthesis of NCME (103). In fact, this 
allocolchicinoid possesses tubulin inhibition activity that is greater than that of colchicine 
itself,
26
 yet researchers have only recently started to show some synthetic interest. 
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DeShong Synthesis 
 
 In 2006, DeShong's group
27
 from the University of Maryland published a novel 
and versatile approach to the allocolchicine carbocyclic skeleton. First, the A-C biaryl 
ring system was accessed using a palladium catalyzed siloxane coupling method; this was 
followed by ring expansion reaction of substituted MOM-protected phenanthrol (114) as 
the key step for the construction of tricyclic skeleton of N-acetylcolchinol-O-methyl 
ether. The authors implemented this strategy to accomplish the first total synthesis of 
racemic NCME (103). 
 
 
 
 
 
Scheme 1.27  Retrosynthesis of NCME (rac-103) by DeShong and Seganish.
27 
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Green's Synthesis of NCME and iso-NSC 51046 via Nicholas Reaction Chemistry 
 
 
 Central to the Green group's research interests is the synthesis of 6,7,6-containing 
compounds, primarily by utilizing Nicholas reaction chemistry for the construction of the 
seven-membered ring core. From previous research performed by Green's group, it was 
evident that intramolecular Nicholas reactions constitute a reliable approach towards the 
synthesis of dibenzocycloheptanone, ultimately leading to achieving an enantioselective 
synthesis of N-acetyl-O-methylcolchinol (NSC 51046 or NCME, 103).  
 In the synthesis of Djurdjevic and Green
28
 (Scheme 1.28), the biaryl propargyl 
acetate hexacarbonyldicobalt complex (115a) underwent a Lewis acid intramolecular 
Nicholas reaction to afford dibenzocycloheptadienyneCo2(CO)6 complex (116a). This 
latter compound was in turn readily reductively decomplexed by hydrosilylation-acidic 
desilylation method, followed by hydroboration and oxidation reactions to afford the C-7 
ketone (117). Compound (117a) was subsequently subjected to a sequence of 
transformations that were analogous to those previously employed by Wulff
24
 in his 
asymmetric total synthesis of (103).  
100 
 
 
 
 
Scheme 1.28 Green's synthesis of allocolchicine NCME via Nicholas reaction  
                     chemistry.
28 
 
 In addition, this approach was further extended to prepare a novel allocolchicine 
analogue (118), namely (S)-3,8,9,10-tetramethoxy (A-ring) regioisomer of NSC 51046 
(103). Compound (118) will be referred to as iso-NSC 51046 hereafter, and will be 
presented in more detail in CHAPTER 2 (vide infra). 
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1.3 Modified Allocolchicinoids  
 Besides the synthesis of conventional allocolchicine derivatives, novel targets that 
include allocolchicinoids analogues with modified B-, C-, and B,C-ring
29
 systems have 
also been synthesized and tested for biological activity. Some relevant selected examples 
will be discussed in the following section.    
 Boyer and Hanna have developed a synthetic strategy which was based on a 
conceptually similar approach to Wulff’s work24 in synthesizing allocolchicine 
derivatives. Using [4+2]cycloaddition, structural analogues of allocolchicine were 
obtained with an altered position of the ester group in the C-ring, namely at the C-10 and 
C-11 positions
30
 (Figure 1.9; 119a/b and 120, respectively). In their most recent work, 
Boyer's group
31
 were involved in the synthesis of allocolchicinoids derivatives with B-
and C-ring variations via sequential enyne-metathesis/Diels-Alder reactions. These 
compounds were evaluated for their tubulin assembly inhibition effects. Some of the 
noteworthy results of these evaluations revealed that allocolchicine (119a) with methyl 
ester at C-10 had a comparable biological activity in comparison to natural colchicine 
alkaloid. However, complete activity loss was observed for allocolchicine (120) with a 
methyl ester at C-11 of the C-ring.
30,31
 
 
Figure 1.9  Examples of C-ring modified allocolchicines. 
102 
 
 Seitz and co-workers
32
 have synthesized two series of novel B-ring modified 
allocolchicinoid congeners that mimic the structure of (S)-N-acetylcolchinol-O-methyl 
ether (103, NCME). The first series of NCME variants (121) included a nitrogen 
containing eight membered B-ring, whereas in the second series (122), the seven-
membered B-ring of NCME was modified by annulation with a heterocyclic ring system. 
These novel heterocyclic-fused seven membered B-ring allocolchicinoids were found to 
be highly potent antimicrotubule agents.  
 
 
Figure 1.10  Examples of B-ring modified allocolchicines. 
 
 
 
 
 Recently, Fedorov and co-workers
33-35
 reported the synthesis and biological 
assessment of a group of heterocyclic allocolchicine variants in which the C-ring of the 
parent allocolchicine is fused to an indole, furan-, or pyrrolo-derived core. Selected 
examples are shown in (Figure 1.11). 
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Figure 1.11  Heterocyclic allocolchicinoids.  
 
 
 
 The indole-derived allocolchicine analogues
33a
 (123a) and (123b) are considered 
the first examples of heteroarene-based allocolchicines. Biological evaluation studies 
revealed that these individual derivatives exhibited pronounced anti-proliferative activity, 
and were also capable of inducing apoptosis in different lymphoma cells. Although their 
unspecific cytotoxicity was found to be low, they were effective in very small nanomolar 
concentration (and even in sub-nanomolar levels).
33
  
 In their most recent work, Fedorov et al.
34
 also reported the synthesis of pyrrolo- 
allocolchicinoids of type (124), which are in fact constitutional isomers of (123a) and 
(123b). They, too, possessed anti-proliferative and pro-apoptotic activities which were 
very comparable to that of the indole-based analogues (123a/b). The authors also 
extended their studies where they reported a semi-synthetic route to furan-based 
allocolchicinoids. After preparing a set of furan-based allocolchicinoids of type (125), in 
vitro studies showed that the most potent compound is when R = CH2-OH, where it was 
found to be a more effective tubulin inhibitor than colchicine.
35 
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1.4   Arene-Enone Conjugate Addition Reactions 
 
 
 In addition to allocolchicines derivatives, the 6,7-ring framework is a commonly 
encountered motif in many other natural products. Amongst the remarkable number of 
approaches available in literature, conjugate addition chemistry lends itself as a valuable 
and versatile means to access 6,7-bicyclic systems. Several methodologies have been 
developed in which activated arenes were used as Michael donors in conjugate addition 
reactions. Of note, the work of Majetich
36
 provides excellent and relevant examples that 
fit very well in this topic.  
 The Majetich group has elaborately employed Lewis acid mediated 
cycloalkylation reactions in the synthesis of natural products based on 6,7-ring systems. 
Their debut work
36a
 in this area was reported in 1993, where they prepared the [6-7-6] 
tricyclic compounds via Lewis acid catalyzed intramolecular alkylation of electron-rich 
arenes with conjugated dienones (Scheme 1.29). Two series of arene-dienones were 
employed (2-arene-dienones and 4-arene-dienones), and they were both shown to be 
effective in providing the corresponding 6,7,6-fused tricycles. 
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Scheme 1.29  Construction of 6,7,6-tricylic compounds via Lewis acid mediated     
                        cycloalkylation by Majetich et al.
36a
   
 
 These results prompted Majetich to apply the aforementioned approach in 
synthesizing a significant number of natural products, such as (±)-barbatusol, (±)-
pisiferin, (±)-deoxofaveline, (±)-xochitlolone, and (±)-faveline.
36b
 Despite the versatility 
of Majetich's Friedel-Crafts alkylation method, the published cases to date required either 
stoichiometric or super-stoichiometric amounts of Lewis acid; in addition, the 6,7,6-
systems of the allocolchicines derivatives have not been among the reported synthetic 
targets. 
 Another relevant example in literature was provided by the Chen group.
37
 In their 
recent work, Chen et al. reported the synthesis of dibenzocycloheptenones, the core 
structure of allocolchicine, via a stoichiometric IClmediated electrophilic 
iodocyclization.  
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1.5   Origin of Current Project and Proposed Research 
 
 
 The search for novel allocolchicinoids with improved antitumor properties 
remains an ongoing quest for synthetic chemists. With the exception of our group's 
previous work
28
 (Djurdjevic and Green's synthesis), allocolchicinoid analogues with a 
modified A-ring are non-existent in literature. As stated earlier, Green's approach using 
Nicholas reaction chemistry was successfully implemented in preparing two 
allocolchicinoids derivatives (NSC 51046 and iso-NSC 51046), whose biological 
properties were underexplored for the most part.  
 Dr. Siyaram Pandey, a prominent biochemist in our Department of Chemistry and 
Biochemistry, became interested in studying the biological properties (namely the 
anticancerous activity) of these two closely related allocolchicine derivatives. In a recent 
publication, Pandey
38
 and his group have reported the detailed findings of their study of 
these compounds. NSC 51046 was found to be non-selective as it induced apoptosis in 
both BxPC-3 and PANC-1 pancreatic cancer cells and in normal human fibroblasts. 
Interestingly, it was found that iso-NSC 51046 was able to induce pro-death autophagy in 
these pancreatic cancer cells and E6-1 leukemia cells but not in normal human fibroblasts. 
 Unlike colchicine and NSC 51046, iso-NSC 51046 did not appear to affect tubulin 
polymerization, indicating that it has a different molecular target. It also caused increased 
reactive oxygen species (ROS) production in mitochondria isolated from pancreatic 
cancer cells. Furthermore, in vivo studies revealed that it was well tolerated in mice.
38
 
These findings suggested that a small change in the structure of the parent allocolchicine 
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derivative can presumably change the mechanism of action and improve selectivity. This 
may also lead to better selective treatments in cancer therapy.
 
 Despite the significance of the aforementioned Nicholas reaction synthetic 
approach, there were two main drawbacks in using this method, particularly if the 
synthesis was carried on a larger scale. The first issue is attributed to the use of excess 
(greater than stoichiometric) amounts of dicobalt octacarbonyl reagent, which may pose 
an environmental concern if the synthesis was scaled-up. The other shortcoming was the 
length of the synthesis. The overall total synthesis was carried out in 11 steps and 
afforded the allocolchicine in an overall yield of 14 %. Specifically, there were a total of 
8 steps required to arrive at the dibenzocycloheptanone, followed by an additional 3 steps 
to furnish the end product.  
 Conjugate addition reactions (both intermolecular and intramolecular) are 
amongst the most efficient tools for C-C formation in organic synthesis. However, in 
most cases strong Brønsted or Lewis acid reagents are required in stoichiometric or 
excess amounts, and many of them require the use of rare (hence cost ineffective) metals. 
Herein we report the construction of tricyclic framework of various allocolchicinoids via 
intramolecular Michael-type Friedel-Crafts alkylation to form the seven-membered ring. 
This process requires an appropriate Lewis acid that's capable of catalytic turnover. 
 On the basis of our group's continuing interest in constructing 6-7-6 tricyclic core 
systems, and given the biological significance of allocolchicine analogues that were 
alluded to earlier, we envisioned that a short, atom-economical, catalytic, and overall 
more efficient synthesis of the relevant dibenzocycloheptanone (en route to iso-NSC 
51046 synthesis and other A-ring modified allocolchicines) would be worth investigating. 
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CHAPTER 2: RESULTS AND DISCUSSION 
 
 In continuation of our group's interest in the synthesis of seven-membered ring 
containing compounds, herein we report a short and efficient synthesis of allocolchicine 
derivatives under mild conditions. From a synthetic perspective, the dibenzo-
cycloheptanone represents a key intermediate en route to numerous allocolchicine 
analogues. Having stated that, the key step in this synthetic approach can be viewed as the 
construction of the seven membered B-ring using an appropriate catalyst. The 
methodology will also be expanded to other related substrates with variable substituents.  
 
2.1 General Synthetic Strategy  
 Multiple strategies to access the tricyclic fused ring system of allocolchicinoids 
analogues have been developed to date. To access the desired dibenzocycloheptanone, the 
synthetic strategy depicted in (Scheme 2.9) was investigated. The synthetic plan first 
features a facile preparation of the biarylcarboxaldehyde by means of Suzuki-Miyaura 
coupling chemistry. Conversion of the biarylcarboxaldehyde into the corresponding 
alkenones or alkynones could be accomplished by nucleophilic addition of the proper 
Grignard reagent followed by alcohol oxidation to the corresponding ketone. At this 
point, closure of the cycloheptane (or cycloheptene) would be assessed by screening 
several Lewis acids, primarily to seek a Lewis acid reagent that can effectively catalyze 
the ring closure process using a minimum catalytic loading. Once obtained, the 
cycloheptanone can be readily converted to the corresponding allocolchicine, such as 
allocolchicine iso-NSC 51046 (118) shown in (Scheme 2.9) as a general example, by 
implementing a series of previously reported protocols. 
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Scheme 2.9  Proposed retrosynthetic approach to dibenzoheptanone and ultimately to    
          allocolchicine iso-NSC 51046 (118). 
 
 
 From a synthetic point of view, two plausible routes can provide access to the 
intended dibenzocycloheptanone (117b) as depicted in (Scheme 2.10). The synthetic 
scheme following (Route A) involves obtaining the biaryl compound (128) which may be 
further derivatized to get the alkynone cyclization precursor (130). Catalyzed by the 
proper Lewis or Brønsted acid, it was envisioned that the ring closure step could 
potentially take place to yield the dibenzocycloheptenone B-ring (131). This step would 
be followed by subsequent reduction of the C=C bond which in turn forms the intended 
dibenzocycloheptanone species (117b). Alternatively, (Route B) was also proposed as 
another means of reaching the cycloheptanone. Through the steps indicated in (Scheme 
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2.10), the biaryl compound could be converted to the corresponding enone substrate 
(133). The next step would involve subjecting the acyclic enone to the proper catalytic 
condition (Lewis or Brønsted acid) to directly furnish the intended cycloheptanone 
(117b). If completed successfully, this would constitute the tricyclic core of a group of 
the allocolchicinoids (which will be discussed later in this section). 
 
 
Scheme 2.10  Two proposed routes to construct the tricyclic core of allocolchicinoids via     
            intramolecular conjugate addition reaction. 
 
 Our initial proposal was to obtain the desired tricyclic framework via ring closure 
of corresponding alkynone (128). To access the cyclization precursor, the first synthetic 
task involved obtaining a biaryl carboxaldehyde by utilizing the Suzuki-Miyaura coupling 
reaction. This specific step was duplicated from the previous allocolchicine synthesis 
reported by our group (Djurdjevic and Green).
28
 Using the Fürstner
39
 conditions, the 
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Suzuki cross-coupling reaction of 5-methoxy-2-bromobenzaldehyde (126) and 3,4,5-
trimethoxyphenylboronic acid (127) furnished the desired biaryl product (128) in 88 % 
yield (Scheme 2.11).  
 
                      
 
Scheme 2.11  Suzuki-Miyuara cross-coupling reaction. 
 
 
 To proceed further with the preparation of the precursor required for (Route A) 
synthetic pathway, the biarylcarboxaldehyde substrate (128) was then subjected to 
reaction with ethynylmagnesium bromide to afford the corresponding propargylic alcohol 
(129) in 97 % yield. The latter compound was converted to the corresponding ketone 
using MnO2 oxidation to attain the intended acyclic alkynone (130) in 57 % yield 
(Scheme 2.12).  
 
 
 
Scheme 2.12  Preparation of alkynone cyclization precursor (Route A). 
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 With substrate (130) in hand, a number of protocols were investigated to carry out 
the key conjugate addition reaction towards the construction of the seven membered ring. 
To achieve this, a Lewis acid is necessary to catalyze the cyclization, namely the 7-endo- 
dig process. The first attempt to induce the cyclization reaction was using "carbophilic" or 
"-electrophilic" Lewis acid.                                       
 The use of gold (I) and (III) salts has dramatically increased in organic syntheses 
due to their unique Lewis acidic nature.
40
 Specifically, gold (III) compounds have been 
used as potential Lewis acids by virtue of their ability to activate bonds under 
extremely mild conditions. In light of the versatility and fascinating reactivity of gold 
catalysis in modern organic transformations, we chose AuCl3 as the first catalyst. The 
soft, carbophilic Au(III) Lewis acid didn't prove to be effective in promoting cyclization 
of the alkynone. Upon adding 10 mol % loading of AuCl3, an immediate degradation of 
the starting material was evident. A similar observation was noted when using GaCl3, 
which is known to be as both a powerful and Lewis acid,41 under similar reaction 
conditions (Table 2.5). 
Table 2.5  Attempts to induce the cyclization using alkynone as substrate. 
 
 
Lewis acid Catalyst loading Conditions Observations 
AuCl3 10 mol % CH2Cl2, rt immediate decomposition 
GaCl3 10 mol % CH2Cl2, rt immediate decomposition 
113 
 
 Faced with the inability to prepare the desired cycloheptanone via (Route A), our 
attention was turned to the alternative approach (Route B), starting with the same starting 
materials (126 and 127), and following an analogous strategy to assemble of the biaryl 
unit via the Suzuki cross-coupling reaction. The corresponding allylic alcohol (132) was 
generated as a result of the nucleophilic attack of a vinyl Grignard reagent on the 
relatively electron deficient carbon of the aldehyde (128). Subsequently, the allylic 
alcohol was subjected to oxidation to give the enone (133) which is the intended 
precursor for the cyclization reaction (Scheme 2.13).  
 
 
Scheme 2.13  Preparation of alkenone cyclization precursor (Route B). 
 
 
2.2 Lewis Acid Alkylation of Electron-Rich Arenes  
 
 
 In the given enone (133), the electron-rich trioxygenated A-ring (nucleophilic 
species) and the , β-unsaturated ketone (Michael acceptor, i.e. electrophile) are the two 
components of the conjugate addition process. To achieve the B-ring closure, the 
cyclization can proceed only if activated by an appropriate Lewis acid as suggested in the 
proposed mechanism (Scheme 2.14). In view of the availability of a wide array of Lewis 
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acidic metal reagents, it was deemed logical to assess two types of Lewis acids: 
carbophilic (or π-selective) and oxophilic.  
 
Scheme 2.14  Proposed cyclization mechanism. 
 
 
 Attempts at cyclization reactions of (133) by the use of π-selective Lewis acids 
met with limited success (Table 2.6). The use of 10 mol % loading of gold (III) chloride 
(AuCl3) enabled the complete consumption of the starting material, however it led to a 
poor yield (31 %) and extensive baseline material. On the other hand, treating the same 
substrate with the carbophilic gold (I) Lewis acid (AuCl(SMe)2) in the presence of AgBF4 
gave similar results. It's worth noting that in the absence of Au(I), the reaction progress 
appeared to be unaffected, which suggested that the Ag(I) was in fact the active catalytic 
species in the cyclization reaction. Other metal salts were also explored, and they showed 
somewhat limited effectiveness in promoting the conjugate addition reaction. Both FeCl3 
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and InCl3 gave only a small amount of (117b). Furthermore, Sc(OTf)3, an oxophilic 
Lewis acid, led to the complete decomposition of the substrate once added to the reaction 
mixture. Likewise, PtCl4 also resulted in unproductive decomposition when 30 mol % 
loading was introduced to the substrate. Conversely, using SnCl4 gave relatively 
respectable yields (based on the percent conversion) but it lacked the catalytic turnover 
which rendered the reagent less useful in our studies. 
 
Table 2.6  Screening Lewis acids as catalysts for conjugate addition reaction. 
 
Lewis acid Catalytic loading Conditions Yield (%) 
AuCl3 10 mol % acetonitrile [0.003 M], rt, 3h 31 
AuCl(SMe)2 + 
AgBF4 
5 mol % CH2Cl2 [0.005 M], rt, 24h  23 
AgBF4 5 mol % CH2Cl2 [0.005 M], rt, 24h 25 
FeCl3 45 mol % CH2Cl2 [0.005 M], rt, 24h 15 
InCl3 10 mol % CH2Cl2 [0.005 M], rt, 24h 11 
SnCl4 50 mol % CH2Cl2 [0.005 M], rt, 3h 51 
GaCl3 10 mol % CH2Cl2 [0.002 M], rt, 3h 52 
Sc(OTf)3 10 mol % CH2Cl2 [0.005 M], rt (a) 
PtCl4 30 mol % CH2Cl2 [0.005 M], rt (a) 
a 
Immediate decomposition of starting material.  
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 Given the limited success achieving a truly catalytic cyclization reaction, a test 
reaction was run using the most conventional and commonly used Lewis acid in the 
Green lab, BF3-OEt2. There has been wide success in previous projects in our group with 
employing boron trifluoride to mediate the formation of 7-membered rings (albeit being 
used in stoichiometric amounts). In view of these facts, the first cyclization reaction was 
conducted using 1.5 equiv. of BF3-OEt2 to a dichloromethane solution of enone. To our 
surprise, the reaction furnished the intended cyclized product in good yield (75 %). This 
outcome encouraged additional experiments with lower loadings of the Lewis acid to 
bring the cyclization reaction to the catalytic domain.  
 
 
Table 2.7  Optimization of cyclization reaction catalyzed by BF3-OEt2. 
 
Lewis acid Catalyst loading Conditions Yield/ conversion 
 
1.5 equiv CH
2
Cl
2 
[0.005 M], 24h, 0C-rt 75 % 
50 mol % CH
2
Cl
2 
[0.005 M], 24h, 0C-rt 65 % 
 25 mol % CH
2
Cl
2 
[0.005 M], 12h, 0C-rt  78 % 
BF3-OEt2 10 mol % CH
2
Cl
2
 [0.005 M], 3h, 0C-rt 71 % 
 10 mol % CH2Cl2 [0.002 M], 3h, 0C-rt 83 % 
 5 mol % CH2Cl2 [0.002 M], 4h, 0C-rt 75 % 
 
3 mol % CH
2
Cl
2
 [0.002 M], 24h, 0C-rt 90 % conversion
(a)
; 
65 % yield
 
a
 Incomplete conversion. 
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 Indeed, the results were comparably successful even when using sub-
stoichiometric amount of Lewis acid, where good yields were maintained at 25 mol % 
and only slightly compromised at 10 mol % loadings (Table 2.7). To further validate our 
original proposal in developing an atom-economic and "genuinely" catalytic synthesis, 
the catalyst loading was reduced further. Upon exposure to 5 mol % of BF3-OEt2 catalyst, 
complete conversion from (133) to (117b) was realized with an isolated yield of 75 %. 
Lower amounts of the catalyst resulted in incomplete conversion and thus it was 
determined that the lower limit of the BF3-OEt2 was 5 mol %. In addition, the 
concentration of the reaction mixture was noted to play a significant role. In fact, the 
optimal yield was obtained when running the reaction under high dilution conditions 
(0.0002 M) in the presence of the Lewis acid. It's also worth noting that the reaction 
outcome may be slightly jeopardized if the reaction time was longer than 4 hours, 
possibly due to gradual product decomposition that could be taking place.  
 
 
2.2.1   Reaction Scope 
 
 Having established the optimized conditions of the cycloalkylation reaction, the 
next stage was to explore the reaction's scope and to investigate substituent effects on the 
ring closure step in particular. Using Suzuki coupling reaction, a series of biaryl 
compounds were readily prepared (135a-g) in yields ranging from 74 to 94 %. The results 
are summarized in (Table 2.8). 
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Table 2.8  Suzuki-Miyaura cross-coupling reaction. 
 
 
Entry R
1 
R
2 
R
3 
Product/ Yield 
1 H H H 135a/ 86 % 
 2 H CO2Me H 135b/ 81 % 
3 H F H 135c/ 94 % 
4 H OBn H 135d/ 91 % 
5 H H OMe 135e/ 79 % 
6 H -OCH2O- 135f/ 86 % 
7 OMe OMe H      135g/ (45 %)
a 
               a
 Yield in parentheses is based on recovered starting material (134g). 
 
 
 In accordance with the reaction sequence provided earlier in (Scheme 2.13), the 
addition of vinylmagnesium bromide to the corresponding aldehydes (135a-g) readily 
afforded the allylic alcohol compounds (136a-g). The reaction conditions were analogous 
in all substrates and a summary of the formed compounds is given in (Table 2.9). 
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Table 2.9  Synthesis of allylic alcohol compounds (136a-g)  
 
 
 
 
 
 The resultant allylic alcohols were subsequently oxidized to the corresponding 
ketones. Some substrates were oxidized with manganese (IV) oxide (MnO2) as a mild 
oxidant (entries 2, 4, and 7; Table 2.10). In other cases, oxidation with MnO2 was less 
successful, with low yields being obtained; hence we resorted to other choices of 
oxidants, namely tetrapropylammonium perruthenate (TPAP) in combination with N-
methylmorpholine N-oxide (NMO), to give the corresponding enones in respectable 
yields (entries 1, 3, 5, and 6; Table 2.10). 
Entry R
1 
R
2 
R
3 
Product/ Yield 
1 H H H 136a/ 82 % 
2 H CO2Me H 136b/ 82 % 
3 H F H 136c/ 90 % 
4 H OBn H 136d/ 80 % 
5 H H OMe 136e/ 80 % 
6 H -OCH2O- 136f/ 72 % 
7 OMe OMe H 136g/ 96 %
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Table 2.10  Oxidation reaction to form acyclic enones. 
 
Entry R
1 
R
2 
R
3 
[O] Product/ Yield 
1 H H H TPAP (cat.), NMO 137a/ 80 % 
2 H CO2Me H MnO2 137b/ 90 % 
3 H F H TPAP (cat.), NMO 137c/ 66 % 
4 H OBn H MnO2 137d/ 70 (81 %)
 a
 
5 H H OMe TPAP (cat.), NMO 137e/ 70% 
6 H -OCH2O- TPAP (cat.), NMO 137f/ 68 % 
7
 
OMe
 
OMe H MnO2 137g/ 95 % 
 a
 Yields in parentheses are based on recovered starting material (136d). 
 
  
After preparing a series of various enones (137a-g), these substrates were submitted to the 
previously optimized conditions: BF3-OEt2 (5 mol %) and 0.002 M concentration or 
closely related conditions. The results are summarized in (Table 2.11). 
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Table 2.11  Cyclization of enones using BF3-OEt2. 
 
 
 
Entry R
1 
R
2 
R
3 
Conditions Product/Yield 
1 H H H CH2
Cl
2 
[0.002 M], 12h, 0C-rt 138a/ 81 % 
2
(a) 
H CO2Me H CH2
Cl
2 
[0.002 M], 48h, 0C-rt 138b/ 68 % 
3 H F H CH2
Cl
2 
[0.001 M], 48h, 0C-rt 138c/ 68 % 
4 H OBn H CH2
Cl
2 
[0.002 M], 48h, 0C-rt 138d/ 81 % 
5 H H OMe CH2
Cl
2 
[0.001 M], 12h, 0C-rt 138e/ 70 % 
6 H -OCH2O- CH2
Cl
2 
[0.002 M], 72h, 0C-rt 138f/ 63 % 
7 OMe OMe H CH
2
Cl
2
 (b) 
a
 Reaction complete using 10 mol% of BF3-OEt2 
b
 No reaction. Immediate decomposition of the reaction mixture 
 
 
 The presence of either electron donating or electron withdrawing substituents on 
the C-ring was well tolerated. Benzyloxy-substituted (137d) afforded (138d, 81 % yield, 
48 h, Table 2.11, entry 4). The methylenedioxy-substituted (137f) successfully converted 
into (138f, 63 %, 72 h, Table 2.11, entry 6). Among the most interesting cases was the 
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ester-substituted substrate. The acyclic alkenone (137b) was successfully cyclized to the 
corresponding benzosuberone (138b). Even though an incomplete consumption of (137b) 
at the 5 mol % loading of BF3-OEt2 was observed, complete conversion to the intended 
product was realized by doubling the amount of BF3-OEt2 to 10 mol % (138b, 68 %, 48 h, 
Table 2.11, entry 2). The significance of this particular substrate is mainly owing to the 
fact that (138b) can be regarded as the precursor of the A-ring isomer of the natural 
occurring alkaloid ()-allocolchicine (101). Furthermore, by using 5 mol % of BF3-OEt2, 
the fluorinated product (138c) was obtained in 47 % yield in 48 h at 0.002 M, but the 
yields were improved when the concentration was dropped to 0.001 M (138c, 68%, 48 h, 
Table 2.11, entry 3). Placing a methoxy substituent in C-5 position of the C-ring did not 
adversely affect the yields of cyclization either. The cyclization product was readily 
obtained in 70 % yield when subjected to 5 mol % of BF3-OEt2 (138e, Table 2.11, entry 
5). Also, among the targeted examples was a substrate devoid of C-ring substitution 
(137a, Table 2.11, entry 1). Optimal yields of the cyclized compound (138a) were 
realized in 81 % yield using 5 mol % BF3-OEt2, and complete conversion required 
relatively long reaction time (12 h). Regarding the last entry (137g, entry 7, Table 2.11), 
it can be observed that the presence of a methoxy substituent in R
1 
position led to the 
deactivation of the 7-endo-trig cyclization process. Despite attempting this reaction 
multiple times, it was evident that the starting material underwent complete degradation 
instantly once the Lewis acid was added. This was also reinforced by the appearance of 
deep dark purple color which is usually indicative of decomposition.  
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2.3      Heterocyclic Analogues 
 
 
 Given the recent prominence of heterocyclic-based allocolchicinoids as potential 
antitumor agents
32-35
 (by mimicking the colchicine mode of action), we wanted to prove 
the viability of our methodology in accessing heterocyclic analogues of cycloheptanones. 
Following our established approach, the preparation of thiophene-based cycloheptanone 
was initiated by assembling the 3,4,5-trimethoxyphenylboronic acid (127) and 2-bromo-
3-thiophenecarboxaldehyde (134h) to yield the heterocyclic biaryl system (135h) in 40 % 
yield. In accordance with the vinyl Grignard addition protocols applied earlier with other 
substrates, the allylic alcohol compound (136h) was obtained in 85 % yield, which was  
subsequently oxidized with MnO2 to give the thiophene-based enone in 71 % yield 
(Scheme 2.15). 
 
 
 
Scheme 2.15  Preparation of C-ring thiophene-based cycloheptanone (138h). 
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 Lewis acid mediated cyclization of (137h) was first attempted using BF3-OEt2. 
The thiophene-based enone was fully converted to the cyclic compound (138g) in the 
presence of a full equivalent of the Lewis acid (61 % yield). However, BF3-OEt2 proved 
to be not effective in catalytic loadings (incomplete conversion) as shown in (Table 
2.12). Fortunately, GaCl3 provided a decent catalytic turnover in the 7-endo-trig 
cyclization process. After adding 0.25 equivalent of Ga(III), the reaction proceeded 
smoothly and the product was obtained in 70 % yield. 
 
Table 2.12  Screening Lewis acids for cyclization of (137h) to (138g). 
 
Lewis acid Catalytic loading Conditions Yield (%) 
BF3-OEt2 20 mol % CH2Cl2, 12h incomplete conversion 
BF3-OEt2 40 mol % CH2Cl2, 12h incomplete conversion 
BF3-OEt2 1 equiv. CH2Cl2, 4h 61 
GaCl3 25 mol % CH2Cl2, 24h 70 
 
 
2.4 Completion of Enantioselective Synthesis of Allocolchicines  
 
 After successfully arriving at the intended cycloheptanone, there remained 3 steps 
to complete the synthesis of allocolchicine compound iso-NSC 5146 (118). As shown 
previously (Scheme 1.28), these synthetic steps had already been successfully established 
in the previous work of Green.
28 
Hence, the preparation of (117b) constitutes a formal 
synthesis of (118). In view of the success of using Wulff's
24
 approach in our group's 
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previous synthesis of allocolchicinoids, it was logical to adopt a similar approach in this 
current work. The asymmetric reduction of the ketone was achieved using Singaram
44
 and 
co-workers' method where the substrate was exposed to reducing agent LiBH4 in the 
presence of 2-(3-nitrophenyl)-1,3,2-dioxaborolane-4R,5R-dicarboxylic acid [(+)-TarB-
NO2, 139] as a chiral Lewis acid (Scheme 2.16). The reduction of (117b) under these 
conditions proceeded with an excellent yield (97%) and high enantioselectivity (99 % ee), 
as determined by means of HPLC with a chiral stationary phase. To incorporate the 
correct stereochemistry of the molecule, the chirality at C-7 of (140) was inverted (R- to 
S-) using a Mitsunobu reaction; the nucleophilic displacement of the hydroxy group by an 
azide (Zn(N3)2-2Py as azide source) was crucial to introduce the nitrogen function needed 
in the molecule. The reaction proceeded smoothly giving (141) in 77 % yield. 
Subsequently, the reduction of (141) to the corresponding amine was achieved via 
hydrogenolysis using Lindlar's catalyst. This step was followed promptly by acetylation 
of the amine to afford the acetamide functionality at C-7 of the intended allocolchicine. 
The enantiomeric purity of (118) was measured to be 98% ee. After a single 
recrystallization, the purified compound was obtained, and it showed identical physical 
properties to the previously synthesized allocolchicine (mp, spectroscopic data).
28 
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Scheme 2.16  Completion of enantioselective formal synthesis of iso-NSC 51046 (118). 
 
 
 
 
 Two other dibenzocycloheptanones, unsubstituted (138a) and ester-substituted C-
ring (138b) substrates, were chosen for further derivatization, where they were subjected 
to analogous conditions to arrive at the corresponding allocolchicine (Scheme 2.17). 
Singaram's method
44
 worked smoothly and the benzylic chiral alcohols were obtained in 
98% (142a) and 80% (142b) yield and 99% ee for both (142a) and (142b). The 
subsequent step (Mitsunobu reaction) proved to be effective in giving the azide 
containing compounds in 72% (143a) and 77% (143b) yield. Subjecting the formed 
azides to hydrogenolysis using Lindlar's catalyst followed by acetylation gave the 
corresponding allocolchicines (71% yield of (144) and 57% yield of (145)) in high 
enantiomeric excess (98% ee for (144) and 99% ee for (145)). Since these allocolchicine 
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derivatives have not been reported in literature previously, this work constitutes total 
syntheses of two novel allocolchicines analogues of the iso-NSC 51046 series. 
 
 
 
Scheme 2.17  Completion of enantioselective total synthesis of allocolchicinoids (144)      
            and (145).  
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2.5       Targeting Dibenzocycloheptanone Precursor en route to NSC       
            51046 Synthesis 
 
 Encouraged by the results obtained in synthesis of iso-NSC 51046, it was 
envisioned that providing access to compounds with "allocolchicine-like" trimethoxy 
arrangement is very desirable mainly since they provide greater resemblance to the 
naturally occurring family of allocolchicines. Targeting the precursors needed for 
synthesis of the natural alkaloid ()-allocolchicine is recognized as logical, since it serves 
to provide a more generalized substrate scope and complements the applicability of our 
Nicholas chemistry-based methodology.  
 Following an analogous sequence of transformations in preparing the previously 
reported cyclization precursors, the corresponding enone substrate (146a) was 
synthesized via Suzuki cross-coupling reaction, followed by reaction with 
vinylmagnesium bromide to afford the allylic alcohol which was subsequently subjected 
to oxidation to obtain the enone of interest (Scheme 2.18). 
 
Scheme 2.18  Preparation of acyclic enone (146a) as cyclization reaction precursor. 
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 To carry out the ring closing step, a set of Lewis acid mediated conjugate addition 
protocols were surveyed to achieve an efficient synthesis of dibenzocycloheptanone 
(117a) bearing a 2,3,4-trimethoxy substituted A-ring. The complete list of results is 
summarized in (Table 2.13).  
 
Table 2.13  Screening Lewis acids as catalysts for conjugate addition reaction of (146a). 
 
 
 
Lewis Acid Catalyst Loading Solvent Yield/conversion 
BF3-OEt2 1.0 equiv CH2Cl2 74 % 
BF3-OEt2 20 mol % CH2Cl2 (a) 
BF3-OEt2 50 mol % CH2Cl2 50 % conv. 
InCl3 30 mol % CH2Cl2, 24h, rt 45 % conversion 
FeCl3 25 mol % CH2Cl2, 24h, rt 29 % conversion 
AuCl3 30 mol % CH2Cl2 50 % conversion 
GaCl3 50 mol % CH2Cl2, rt 72% 
GaCl3 25 mol % CH2Cl2, ∆ 62 % 
GaCl3 10 mol % CH2Cl2, ∆ 50 % conversion 
          a 
No conversion was obtained; only starting material was recovered. 
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 While BF3-OEt2 proved to be superior to other Lewis acids in the synthesis of iso-
NSC 51046 and other substrates with analogous A-ring substitution pattern, it wasn't 
shown to be effective at catalytic loadings for the current system. The first attempt to 
induce the cyclization reaction was by using BF3-OEt2. Starting with 1.0 equiv. of Lewis 
acid, the conversion was complete in 48h with 74 % yield of a compound initially 
assigned as (117a). However, the catalytic turnover didn't occur and hence, using sub-
stoichiometric amounts of BF3-OEt2 led to incomplete conversion. InCl3, FeCl3, and 
AuCl3 also showed low potential for catalysis. In the continuing search for suitable 
catalytic Lewis acid metal reagent, gallium trichloride was tested next. We were delighted 
to see that it showed a potential to give catalytic turnover to the process, and gave 
acceptable yields at 25 mol % loading in refluxing methylene chloride (62 %, 48 h, Table 
2.13). 
 Having the end product in hand, a quick comparison of the experimental data 
(spectroscopic information and the melting point) of the newly formed cyclized 
compound with those previously reported in literature revealed that the identity of the 
cyclic compound was assigned incorrectly. In fact, the obtained data were unambiguously 
identical to those of compound (117b). To better understand the reaction outcome, a 
plausible mechanism was proposed that accounts for the formation of the spirocyclic 
compound via an ipso-cyclization. As shown in (Scheme 2.19), once the Lewis acid 
complexes to the oxygen of the enone, two reaction pathways are potentially possible: I) a 
6-endo trig ipso-cyclization and II) an 8-endo-trig cyclization. 
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Scheme 2.19  A plausible mechanism for the Lewis acid induced rearrangement of      
            cycloheptanone. 
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 Due to the presence of three electron-donating methoxy substituents on the A ring, 
electronic effects will presumably play a major role in the reaction outcome. To start with 
the carbon in the ipso position (a), the orthomethoxy group (i.e. ortho relative to ipso- 
carbon) can donate electron density to it through resonance effects. In addition, the high 
electron content in the ipso position is even further amplified due to the presence of 
another EDG in the para-position (methoxy group). This means that the ipso position has 
become "doubly" activated to engage in pathway (I) cyclization to form the spiro 6-
membered ring intermediate species via a 6-endo-trig path. On a similar note, position (b) 
(i.e. carbon in the meta position relative to the 1,1'-diphenyl bond) is also activated by 
two methoxy groups through resonance effects. This leads to a high electron density on 
this position which can potentially undergo an 8-endo-trig cyclization (pathway II). In 
spite the fact that both the ipso and the meta positions on the A ring are equally activated 
(based on electronics), yet the formation of 8-membered ring sizes is known to be 
thermodynamically and kinetically unfavourable process. As a result, the outcome of the 
given reaction will be likely dominated by pathway (I) and the spirocyclic compound is 
thought to be the immediate product formed in the first step of the conjugate addition 
reaction. The ipso attack is followed by a skeletal rearrangement (1,2-aryl group 
migration) which results in ring expansion and, upon loss of a proton, affords the 
observed dibenzocycloheptanone. 
 An additional closely related analogue (bearing an 9,10,11-trimethoxy substituted 
A-ring and an unsubstituted C-ring) was investigated. After preparing the alkenone 
compound, we wanted to assess whether it was a suitable substrate for cyclization 
reaction.  
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 This particular example proved to be the most stubborn case in undergoing the 
cyclization step. Upon subjecting the enone to an array of commercially available Lewis 
acids, we had limited success in achieving the sought after transformation. In most cases, 
the consumption of the starting material was not evident even after long reaction times, 
and one case resulted in immediate decomposition of the substrate. 
 
Table 2.14 Screening Lewis acids as catalysts for conjugate addition reaction of (146b). 
 
 
 
 
Lewis acid Catalyst loading Yield/ conversion 
BF3-OEt2 10 mol % no reaction 
BF3-OEt2 1 equiv. no reaction 
GaCl3 25 mol % side product (147) 
AuCl3  decomposition 
AuClPPh3 + 
AgBF4 
 
10 mol % 
 
no reaction 
AlCl3 1 equiv. 45 % (138a) 
AlCl3 excess 52 % (138a) 
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 In an attempt to accomplish the reaction under the same conditions that were 
found to be optimal in the previous example (i.e. using GaCl3), the intended product 
(138a) was not formed, but instead, an unexpected side-product was isolated. After 
carefully examining the NMR spectroscopic data of the compound, the absence of one 
singlet peak (which represents OCH3 protons) revealed that a demethoxylation process 
has been involved. We speculated that a quinone-like spiroconjugated compound (147) 
was the side product in hand.  
 During further testing of other Lewis acids, the aluminum based Lewis acid, 
AlCl3, showed to be ultimately somewhat successful. By subjecting the enone substrate to 
an excess amount (6 equiv.) of AlCl3 in nitrobenzene, we were delighted to finally see 
complete consumption of the starting material, and the product (138a) was obtained in 52 
% yield. It's worth noting that this Lewis acid did not appear to have catalytic turnover, 
where the lowest loading required to fully drive the reaction to completion was 1 equiv; 
the yield was slightly compromised (45 %) presumably due to the longer reaction time. 
On the other hand, both BF3-OEt2 and AuClPPh3 (with AgBF4) were not able to promote 
the cyclization reaction as seen in (Table 2.14). Also, AuCl3 led to complete degradation 
of starting material. It's worth highlighting that the location of the methoxy groups in the 
cyclic compound was analogous to the case reported earlier, where similar aryl migration 
was expected to have occurred resulting in the formation of the rearranged 
cycloheptanone in lieu of the predicted cyclized species (Scheme 2.19).  
 The formation of spirocyclic compounds in intramolecular arene-enone reactions 
has been encountered in several cases in literature.
37,42
 Perhaps the most relevant example 
was the one reported by Majetich et al.
36b
 during their investigations of the substituents' 
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effect on the outcome of cycloalkylation of dienones with activated arenes (Scheme 
2.20). When the methoxy substituent was located at the 3' position of the arene (148), the 
reaction pathway went through 7-endo trig cyclization to furnish the dibenzocycloheptane 
product (149). However, placing the methoxy group on position 2' (150) dictated a 
different reaction pathway, where an ipso-attack formed a cyclohexane intermediate, 
followed by demethylation to ultimately give the spiro-fused enone (151). The authors 
attributed the different outcomes of the two reactions to the stability of the involved 
cations in each case; that is to say that the six-membered ring formation led to 
carbocation (150a) is more stabilized than the cation formed by cycloheptane formation 
(150b). 
 
 
Scheme 2.20  Examples by Majetich
36b
 demonstrating the substituents' effect in the    
                     formation of spiro-fused enone compound (151). 
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CHAPTER 3: CONCLUSIONS AND FUTURE OUTLOOK 
 
 
 
3.1  Conclusions 
 
 
 We have elaborated a conveniently short, efficient, atom-economical, and more 
environmentally benign synthetic route to iso-(aR,7S)-()-N-acetylcolchinol or iso-NSC 
51046 (an A-ring isomer of allocolchicine NSC 51046), exploiting a Lewis acid catalyzed 
Friedel-Crafts intramolecular cyclalkylation. In the key step, the seven-membered ring 
(B-ring) was efficiently constructed under mild conditions, where BF3-OEt2 was found to 
be a privileged catalyst in this process. A 7-step asymmetric synthesis of iso-NSC 51046 
from commercially available 5-methoxy-2-bromobenzaldehyde and 3,4,5-
trimethoxyphenylboronic acid was accomplished in 20 % overall yield. In comparison, 
this is considered a significant improvement over our group's previous method which 
provided an 11-step synthesis for an overall yield of 14 % of iso-NSC 51046. 
Specifically, there were a total of 8 steps required to arrive at the dibenzocycloheptanone 
followed by an additional 3 steps to furnish the end product. As a result, the current 
methodology makes the present route better suited to larger scale syntheses, and it paves 
the way to a rather broad variety of new allocolchicinoids. The synthetic accessibility and 
significant antitumor activity exhibited by the new colchicinoids described here make 
them promising objects for more detailed biological investigations. We consider the A-
ring modified allocolchicinoids of type iso-NSC 51046 as promising lead in the search for 
novel anticancer agents with improved properties. 
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3.2  Future Outlook 
 Having a group of synthesized dibenzoheptanones in hand (138c-g), it can be 
envisioned that an analogous chemistry can be extended to these substrates to ultimately 
attain a reasonable library of compounds of the iso-NSC 51046 series. They can be 
subsequently submitted for biological evaluations.  
 In 1991, Barry M. Trost
43
 introduced the concept of "atom economy" in an 
attempt to prompt synthetic organic chemists to adopt 'greener chemistry'. Simply stated, 
atom economy is a calculation which measures “how much of the reactants remain in the 
final product”.43 Hence, a chemical transformation is considered to have an ideal atom 
economy if all reactant atoms are found in the end product. By examining our proposed 
Lewis acid catalyzed cyclization (which is the key transformation in the synthesis), it is 
evident that there are no "wasted" atoms in the process, and all the atoms of the acyclic 
enone are seen in the produced dibenzocycloheptanone, which makes this process atom 
economical. To increase the efficiency of our reported protocol in preparing the tricyclic 
core of allocolchicinoids, we foresee that the ring-closing process can be made even 
"greener". One major consideration would be to replace the chlorinated solvent 
(dichloromethane) with greener solvent alternatives that can still solvate the reaction 
substrates and the involved catalyst. The careful choice of alternative solvents should 
mainly avoid ones that contain "basic" or nucleophilic atoms which can potentially pair 
with the Lewis acid. Solvents such as hexanes or cyclohexane seem to be logical choices 
and worth investigating in the future.  
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CHAPTER 4: EXPERIMENTAL  
  
 
 General Methods and Materials: All reagents, unless otherwise noted, were 
purchased from Aldrich. 2,3,4-Trimethoxyphenylboronic acid was purchased from Alfa 
Aesar. All reactions were run under a nitrogen atmosphere using oven-dried glassware 
(110 C, > 1h). All reaction solvents (except 1,2-dimethoxyethane, DME) were directly 
obtained from solvent purification system (Innovative Technologies). Commercial      
BF3-OEt2 was distilled and stored under nitrogen. The term “conventional workup” refers 
to the extraction of the product from the aqueous layer with an organic solvent (such as 
dichloromethane or diethyl ether), drying the combined organic layers with anhydrous 
magnesium sulfate and filtration of the resultant mixture, followed by evaporation of the 
volatiles under reduced pressure to obtain the crude product(s).  
 Instrumentation: Flash chromatography was performed using silica gel 60 (230-
400 mesh). Analytical thin layer chromatography (TLC) was performed on silica gel 60 
F254 sheets from Silicycle. Preparative TLC was carried out over silica gel GF-254 plates 
from Silicycle. High- Resolution Mass Spectrometry (HRMS) results were obtained by 
means of a Direct Insertion Probe-Electron Ionization method (70 eV), on a Waters/ 
Micromass GCT (GC-EI/CI Time of Flight Mass Spectrometer) performed at the 
McMaster Regional Centre for Mass Spectrometry. Proton nuclear magnetic resonance 
(
1
H NMR) data were obtained either on Bruker Avance 300 or 500 MHz spectrometers. 
Chemical shifts are reported in delta ( units, parts per million (ppm), relative to the 
singlet at 7.26 ppm for chloroform-d, unless otherwise indicated. Coupling constants are 
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reported in Hertz (Hz). Carbon-13 nuclear magnetic resonance (
13
C NMR) data were 
obtained on Bruker Avance 75 MHz or 125 MHz spectrometers. Infrared Spectroscopy 
(IR) data were recorded on a Bruker alpha-ATR FT-IR spectrometer. The reported IR 
data (neat) reflects the frequencies of the distinctive functional group stretches only. 
Melting points were measured with a Thomas Hoover, Uni-Melt
©
 capillary point 
apparatus. 
 
3',4',5'-Trimethoxy-[1,1'-biphenyl]-2-carbaldehyde (135a) 
 
 Title compound was prepared according to the procedure reported by Kundu,
45
 
starting with 2-bromobenzaldehyde (2.0 g, 10.81 mmol) and 3,4,5-trimethoxy-
phenylboronic acid (2.52 g, 11.89 mmol) to yield 2.56 g of compound (135a) as a white 
solid (86 % yield), mp 92-93 C (lit. 102-106 C). The spectroscopic data matched the 
ones reported in the literature.
45 
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Methyl 2-formyl-3',4',5'-trimethoxy-[1,1'-biphenyl]-4-carboxylate (135b) 
 
  repared according to the   rstner39 method, where methyl 4-bromo-3-
formylbenzoate (1.40 g, 5.78 mmol) afforded the title compound (135b) as a colorless 
powder (1.54 g, 81 % yield), 137-139 C. IR (neat) max 2942, 2839, 1719, 1689, 1119, 
765.6 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 10.03 (s, 1H), 8.65 (d, J= 2.0, 1H), 8.28 (dd, 
J= 1.5, 8.0, 1H), 7.56 (d, J= 8.0, 1H), 6.57 (s, 2H), 3.98 (s, 3H), 3.92 (s, 3H), 3.89 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 191.5, 166.1, 153.3, 149.7, 138.5, 133.9, 132.4, 130.8, 
129.8, 129.1, 107.3, 61.0, 56.3, 52.5; HRMS m/e for C18H18O6 calcd 330.1103, found 
330.1100. 
4-Fluoro-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-carbaldehyde (135c) 
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(The preparation method of this compound was adapted from a literature protocol).
46
  
 To a 100 mL oven-dried flask, was added 3,4,5-trimethoxyphenylboronic acid 
(1.3 g, 5.07 mmol), 2-bromo-5-fluorobenzaldehyde (1.13 g, 5.58 mmol), Pd(PPh3)4 (0.4 
g, 6 mol %), and Na2CO3 (1.13 g, 2 equiv.). Then, the flask was evacuated and refilled 
with nitrogen gas (x 3). The flask was then placed under nitrogen and 52 mL of degassed 
dioxane/water/ethanol was added via syringe (5:1:1). The reaction mixture was heated at 
reflux for 12 h. After cooling the reaction to room temperature, the dioxane was removed 
under reduced pressure. The resulting residue was then dissolved in dichloromethane and 
washed with water/brine. The organic layer was separated, and dried with anhydrous 
magnesium sulfate. The volatiles were removed under reduced pressure and the residue 
was purified by flash chromatography (3:1 hexanes/ diethyl ether) to afford compound 
(135c) as a white solid (1.53 g, 94 % yield), mp 132-134C. IR (neat) max 2956, 1675, 
1582, 1486, 1237, 1127 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 9.85 (d, J= 3.0, 1H), 7.51 
(dd, J= 2.8, 8.8, 1H), 7.39 (dd, J= 5.5, 8.5, 1H), 7.23 (td, J= 3.0, 8.0, 1H), 6.48 (s, 2H), 
3.82 (s, 3H), 3.80 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 191.0, 162.0 (d, JC,F = 247.5), 
153.1, 142.0 (d, JC,F = 3.0), 138.1, 135.3 (d, JC,F = 6.1), 132.5 (d, JC,F = 7.3), 132.3, 120.6 
(d, JC,F = 21.9), 113.3 (d, JC,F = 22.0), 107.4, 60.8 (d, JC,F = 1.4), 56.1 (d, JC,F = 1.1); 
HRMS m/e for C16H15FO4 calcd 290.0954, found 290.0949. 
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4-(Benzyloxy)-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-carbaldehyde (135d) 
 
 
 
  repared according to the   rstner39 method, where 5-benzyloxy-2-
bromobenzaldehyde (1.05 g, 3.6 mmol) afforded the title compound (135d) as a viscous 
yellow oil (1.24 g, 91 % yield). IR (neat) max 2934, 2839, 1711, 1684, 1583, 1486, 1239, 
1123 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 9.98 (s, 1H), 7.58 (d, J= 3.0, 1H), 7.34-7.48 
(m, 6H), 7.26 (dd, J= 3.0, 8.5, 1H), 6.53 (s, 2H), 5.17 (s, 2H), 3.91 (s, 3H), 3.87 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 192.3, 158.3, 153.1, 139.3, 137.8, 136.3, 134.6, 133.1, 
131.9, 128.7, 128.2, 127.6, 121.9, 110.9, 107.5, 70.3, 61.0, 56.2; HRMS m/e for 
C23H22O5 calcd 378.1467, found 378.1456. 
3',4',5,5'-Tetramethoxy-[1,1'-biphenyl]-2-carbaldehyde (135e) 
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  repared according to the   rstner39 method, where 2-bromo-4-
methoxybenzaldehyde (1.03 g, 4.79 mmol) afforded (135e) as a colorless solid (1.15 g, 79 
% yield), mp 128-130 C. IR (neat) max 2926, 1675, 1602, 1580, 1236, 1120 cm
-1
;        
1
H NMR (500 MHz, CDCl3) δ 9.98 (s, 1H), 7.49 (d, J= 2.5, 1H), 7.38 (d, J= 8.5, 1H), 
7.19 (dd, J= 3.0, 8.5, 1H), 6.53 (s, 2H), 3.91 (s, 6H), 3.88 (s, 6H); 
13
C NMR (125 MHz, 
CDCl3) δ 192.3, 159.2, 153.1, 139.1, 137.8, 134.7, 133.2, 131.8, 121.3, 109.7, 107.6, 
61.0, 56.2, 55.7; HRMS m/e for C17H18O5 calcd 302.1154, found 302.1146. 
6-(3,4,5-Trimethoxyphenyl)benzo[d][1,3]dioxole-5-carbaldehyde (135f) 
 
 
  
  repared according to the   rstner39 method, where 6-
bromobenzo[d][1,3]dioxole-5-carbaldehyde (0.214 g, 0.934 mmol) afforded the title 
compound (135f) as a colorless powder (0.254g, 86 % yield) after column 
chromatography (3:1 hexanes/ diethyl ether); mp: 154-155 C. IR (neat) max 2956, 2916, 
1674, 1580, 1120 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 9.79 (s, 1H), 7.45 (s, 1H), 6.86 (s, 
1H), 6.53 (s, 2H), 6.09 (s, 2H), 3.90 (s, 3H), 3.87 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 
190.7, 153.0, 152.0, 147.8, 143.6, 133.1, 128.9, 110.1, 107.4, 106.2, 102.1, 61.0, 56.2; 
HRMS m/e for C17H16O6 calcd 316.0947, found 316.0942. 
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3,3',4,4',5'-Pentamethoxy-[1,1'-biphenyl]-2-carbaldehyde (135g) 
 
  repared according to the   rstner39 method, where 6-bromo-2,3-
dimethoxybenzaldehyde (1.433 g, 5.847 mmol) afforded (135g) as a yellow solid (0.67 g, 
35 % yield, or 45 % brsm), mp 86-87.5 C (Et2O). IR (neat) max 2934, 2836, 1690, 1584, 
1565, 1484, 1225 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 10.03 (s, 1H), 7.13 (d, J= 8.5, 1H), 
7.11 (d, J= 8.5, 1H), 6.47 (s, 2H), 3.96 (s, 3H), 3.93 (s, 3H), 3.88 (s, 3H), 3.85 (s, 6H);
 
13
C NMR (75 MHz, CDCl3) δ 191.9, 153.0, 152.7, 149.5, 137.6, 137.1, 134.1, 129.4, 
126.1, 116.2, 107.1, 62.4, 61.1, 56.3; HRMS m/e for C18H20O6 calcd 332.1260, found 
332.1245. 
3-(3,4,5-Trimethoxyphenyl)thiophene-2-carbaldehyde (135h) 
 
 
 
 Prepared according to the   rstner39 method, where 3-bromothiophene-2-
carbaldehyde (0.36 g, 1.884 mmol) afforded the title compound (135h) as an off-white 
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powder (0.206 g, 40 % yield) after column chromatography (3:1 hexanes/ diethyl ether); 
mp 127.5129 C. IR (neat) max 2930, 1647, 1583, 1415, 1237, 1123 cm
-1
; 
1
H NMR 
(300 MHz, CDCl3) δ 9.93 (s, 1H), 7.73 (apparent dd, J= 1.0, 5.0, 1H), 7.22 (d, J= 4.8, 
1H), 6.66 (s, 2H), 3.91 (s, 3H), 3.89 (s, 6H); 
13
C NMR (75 MHz, CDCl3) δ 184.4, 153.5, 
151.6, 138.8, 138.6, 134.3, 130.7, 129.6, 107.0, 61.1, 56.4; HRMS m/e for: C14H14O4S 
calcd 278.0613, found 278.0613. 
2',3',4'-Trimethoxy-[1,1'-biphenyl]-2-carbaldehyde (135i) 
 
 
  repared according to the   rstner39 method, starting with 2-bromobenzaldehyde 
(1.59 g, 8.59 mmol) and 2,3,4-trimethoxyphenylboronic acid (2.00 g, 9.43 mmol) to 
afford compound 135i (1.83 g, 78 % yield) as a white solid (mp 95-96 C; lit. mp 98-99 
C). The product showed spectroscopic data identical with the literature.39 
 
 General Procedure E: A solution of the biaryl compound (1 equiv.) in anhydrous 
diethyl ether was cooled down in an ice-bath to 0 C. Then, vinylmagnesium bromide 
solution (2.0 equiv. of 1.0 M in THF solution) was added in dropwise fashion while 
stirring. The reaction mixture was stirred further for 1-2 h (TLC control). Upon the 
complete consumption of the starting material, the reaction was quenched with a saturated 
146 
 
solution of ammonium chloride and extracted with diethyl ether (2 times). The organic 
layer was separated and dried with anhydrous magnesium sulfate. The volatiles were 
removed under reduced pressure and the residue was purified by flash chromatography to 
afford the final product.  
1-(3',4,4',5'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (132) 
 
 
 Title compound was prepared by following General Procedure E. Column 
chromatography (3:1 diethyl ether/hexanes) yielded compound (132) as a yellow viscous 
oil (76% yield). IR (neat) max 3455, 2938, 1708, 1607, 1583, 1488, 1234, 1122, 728     
cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.19 (d, J= 8.4, 1H), 7.10 (d, J= 2.4, 1H), 6.87 (dd, 
J= 2.4, 8.4, 1H), 6.54 (s, 2H), 6.05 (ddd, J= 5.3, 10.3, 17.1, 1H), 5.30 (d, J= 5.1, 1H), 
5.22 (d, J= 17.1, 1H), 5.17 (d, J= 10.3, 1H), 3.88 (s, 6H), 3.84 (s, 3H), 3.83 (s, 3H), 1.99 
(br s, 1H); 
13
C NMR (125 MHz, CDCl3) δ 159.3, 152.7, 141.1, 140.5, 136.9, 136.1, 
133.8, 131.0, 115.0, 113.4, 111.8, 106.8, 71.3, 60.94, 60.93, 56.1, 56.09, 55.4; HRMS 
m/e for C19H22O5 calcd 330.1467, found 330.1463. 
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1-(3',4',5'-Trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136a) 
 
 Title compound was prepared by following General Procedure E. Column 
chromatography (3:1 diethyl ether/hexanes) yielded compound (136a) as a yellow solid 
(82 % yield), mp 80-83C. IR (neat) max 3434, 2937, 1707, 1583, 1408, 1343, 1235, 
1121, 998, 764 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.57 (dd, J= 1.5, 8.0, 1H), 7.40 
(apparent dt, J= 1.5, 7.5, 1H), 7.33 (apparent dt, J= 1.5, 7.5, 1H), 7.57 (dd, J= 1.5, 7.5, 
1H), 6.57 (s, 2H), 6.08 (ddd, J= 5.5, 10.5, 17.5, 1H), 5.32 (br s, 1H), 5.23 (apparent td, J= 
1.5, 17.5, 1H), 5.18 (apparent td, J= 1.5, 10.5, 1H), 3.90 (s, 3H), 3.85 (s, 6H), 1.92 (d, J= 
4.0, 1H); 
13
C NMR (75 MHz, CDCl3) δ 152.9, 141.3, 140.8, 139.9, 137.2, 136.4, 129.9, 
128.1, 127.6, 127.1, 115.0, 106.8, 71.4, 61.1, 56.2; HRMS m/e for C18H20O4 calcd 
300.1362, found 300.1366. 
Methyl 2-(1-hydroxyallyl)-3',4',5'-trimethoxy-[1,1'-biphenyl]-4-carboxylate (136b) 
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 Title compound was prepared by following General Procedure E. Column 
chromatography (3:1 diethyl ether/hexanes) yielded compound (136b) as a yellow 
viscous oil (82 % yield). IR (neat) max 3473, 2947, 1718, 1583,  1232, 1120 cm
-1
;          
1
H NMR (500 MHz, CDCl3) δ 8.25 (d, J= 1.5, 1H), 7.98 (dd, J= 1.5, 8.0, 1H), 7.35 (d, J= 
8.0, 1H), 6.56 (s, 2H), 6.09 (ddd, J= 5.5, 10.5, 17.0, 1H), 5.34 (br m, 1H), 5.20-5.27 (m, 
2H), 3.94 (s, 3H), 3.90 (s, 3H), 3.85 (s, 6H), 1.99 (d, J= 4.0, 1H); 
13
C NMR (125 MHz, 
CDCl3) δ 166.8, 152.9, 145.7, 140.2, 137.5, 135.2, 130.1, 129.7, 128.6, 128.5, 115.6, 
106.4, 71.1, 61.0, 56.2, 52.2; HRMS m/e for C20H22O6 calcd 358.1416, found 358.1431. 
1-(4-Fluoro-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136c) 
 
 Title compound was prepared by following General Procedure E. Column 
chromatography (3:1 diethyl ether/hexanes) yielded compound (136c) as a yellow viscous 
oil (90 % yield). IR (neat) max 3459, 2936, 1709, 1580, 1485, 1403, 1232, 1118, 993   
cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.19-7.24 (m, 2H), 6.99 (ddd, J= 2.8, 8.3, 8.3 (JH,F) 
1H), 6.50 (s, 2H), 6.00 (ddd, J= 5.3, 10.3, 17.4, 1H), 5.26 (d, J= 5.0, 1H), 5.20 (apparent 
td, J= 1.4, 10.3, 1H), 5.15 (apparent td, J= 1.4, 17.4, 1H), 3.87 (s, 3H), 3.82 (s, 6H), 2.21 
(br s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 162.5 (d, JC,F = 245), 153.0, 142.3 (d, JC,F = 
6.7), 140.2, 137.4, 137.1, 135.5, 131.5 (d, JC,F = 8.2), 115.5, 114.5 (d, JC,F = 21.0), 113.8 
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(d, JC,F = 22.5), 106.9, 71.2, 61.0, 56.2; HRMS m/e for C18H19FO4 calcd 318.1267, found 
318.1259. 
1-(4-(Benzyloxy)-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136d) 
 
 Title compound was prepared by following General Procedure E. Column 
chromatography (3:1 diethyl ether/hexanes) yielded compound (136d) as a yellow 
viscous oil (80 % yield). IR (neat) max 3455, 2935, 1606, 1583, 1487, 1233, 1123, 728 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.34-7.45 (m, 5H), 7.21 (d, J= 8.5, 1H), 7.19 (d, J= 
2.5, 1H), 6.94 (dd, J= 2.5, 8.5, 1H), 6.54 (s, 2H), 6.04 (ddd, J= 5.5, 10.2, 17.2, 1H), 5.30 
(br s, 1H), 5.23 (dt, J= 1.5, 17.0, 1H), 5.18 (dt, J= 1.5, 10.4, 1H), 5.11 (s, 2H), 3.89 (s, 
3H), 3.84 (s, 6H), 1.98 (d, J= 3.5, 1H); 
13
C NMR (125 MHz, CDCl3) δ 158.5, 152.8, 
141.1, 140.4, 137.0, 136.9, 136.0, 134.1, 131.0, 128.6, 128.1, 127.6, 115.0, 114.2, 113.0, 
106.8, 71.3, 70.1, 61.0, 56.1; HRMS m/e for C25H26O5 calcd 406.1780, found 406.1764. 
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1-(3',4',5,5'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136e) 
 
 
 Title compound was prepared by following General Procedure E. Column 
chromatography (3:1 diethyl ether/hexanes) yielded compound (136e) as a yellow viscous 
oil (80 % yield). IR (neat) max 3447, 2936, 1707, 1607, 1583, 1488, 1235, 1122, 729   
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.20 (d, J= 8.5, 1H), 7.10 (d, J= 2.8, 1H), 6.88 (dd, 
J= 2.8, 8.5, 1H), 6.54 (s, 2H), 6.06 (ddd, J= 5.5, 10.5, 17.0, 1H), 5.30 (br m, 1H), 5.24 
(dt, J= 1.5, 17.0, 1H), 5.19 (apparent td, J= 1.5, 10.5, 1H), 3.89 (s, 3H), 3.85 (s, 3H), 3.84 
(s, 6H), 1.90 (d, J= 3.5, 1H); 
13
C NMR (75 MHz, CDCl3) δ 159.4, 152.8, 141.2, 140.6, 
137.0, 136.2, 133.9, 131.1, 115.1, 113.6, 111.9, 106.9, 71.5, 61.1, 56.2, 55.5; HRMS m/e 
for C19H22O5 calcd 330.1467, found 330.1458. 
1-(6-(3,4,5-Trimethoxyphenyl)benzo[d][1,3]dioxol-5-yl)prop-2-en-1-ol (136f) 
 
 Title compound was prepared by following General Procedure E. Column 
chromatography (3:1 diethyl ether/hexanes) yielded the product (136f) as an off-white 
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solid (72 % yield), mp 93-95 C. IR (neat) max 3254, 2967, 2938, 1582, 1479, 1227, 
1115, 1010, 921, 849 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.01 (s, 1H), 6.73 (s, 1H), 6.52 
(s, 2H), 6.03 (ddd, J= 5.5, 11.0, 17.0, 1H), 5.98 (s, 2H), 5.16-5.25 (m, 3H), 3.88 (s, 3H), 
3.84 (s, 6H), 1.86 (br s, 1H); 
13
C NMR (125 MHz, CDCl3) δ 152.8, 147.3, 146.8, 140.6, 
137.1, 136.1, 135.1, 133.5, 114.8, 109.7, 107.0, 106.7, 101.3, 71.1, 60.9, 56.1; HRMS 
m/e for C19H20O6 calcd 344.1260, found 344.1243. 
1-(3,3',4,4',5'-Pentamethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136g) 
 
 
 Title compound was prepared by following General Procedure E. Column 
chromatography (3:1 diethyl ether/hexanes) yielded compound (136g) as a viscous pale-
yellow oil (96 % yield). IR (neat) max 3520, 2939, 2836, 1582, 1484, 1454, 1404, 1124 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 6.98 (d, J= 8.0, 1H), 6.90 (d, J= 8.5, 1H), 6.48 (s, 
2H), 6.21-6.27 (m, 1H), 5.13-5.19 (m, 3H), 3.92 (s, 3H), 3.90 (s, 3H), 3.87 (s, 3H), 3.82 
(s, 6H);
 13
C NMR (75 MHz, CDCl3) δ 152.8, 152.1, 147.5, 142.2, 137.2, 136.2, 134.7, 
133.7, 125.5, 114.1, 111.8, 106.8, 72.3, 61.1, 61.0, 56.2, 56.0; HRMS m/e for C20H24O6 
calcd 360.1573, found [M
+
  H2O] 342.1466. 
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1-(3-(3,4,5-Trimethoxyphenyl)thiophen-2-yl)prop-2-en-1-ol (136h) 
 
 Title compound was prepared from compound 135h (0.154 g, 0.555 mmol) by 
following General Procedure E. Column chromatography (3:1 diethyl ether/hexanes) 
yielded compound (136h) as a viscous colorless oil (0.141 g, 85 % yield). IR (neat) max 
3447, 2937,1583, 1502,1453, 1240, 1124 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.31 (d, J= 
5.0, 1H), 7.06 (dd, J= 1.5, 5.0, 1H), 6.69 (s, 2H), 6.19 (ddd, J= 5.5, 10.0, 17.2, 1H), 5.53 
(br s, 1H), 5.40 (dd, J= 1.0, 17.0, 1H), 5.26 (dd, J= 1.0, 10.0, 1H), 3.89 (s, 3H), 3.87 (s, 
6H), 2.16 (br s, 1H); 
13
C NMR (125 MHz, CDCl3) δ 153.1, 140.6, 140.3, 139.8, 137.3, 
131.7, 129.2, 124.7, 115.5, 106.1, 68.9, 61.0, 56.2; HRMS m/e for C16H18O4S calcd 
306.0926, found 306.0911. 
1-(2',3',4,4'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136i) 
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 Title compound was prepared by following General Procedure E. Column 
chromatography (3:1 diethyl ether/hexanes) yielded compound (136i) as a yellow viscous 
oil (70 % yield). IR (neat) max 3459, 2937, 2836, 1710, 1598, 1483, 1460, 1408, 1092, 
1076, 1001, 804 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (two diastereomers on NMR time 
scale, major isomer reported, 23 C) δ 7.13 (d, J= 8.5, 1H), 7.06 (d, J= 2.5, 1H), 6.88 (m, 
2H), 6.75 (d, J= 8.5, 1H), 5.90 (ddd, J= 4.3, 10.6, 17.3, 1H), 5.33 (dt, J= 1.7, 17.2, 1H), 
5.16 (dt, J= 1.7, 10.6, 1H), 5.03 (m, 1H), 3.93 (s, 3H), 3.90 (s, 3H), 3.85 (s, 3H), 3.54 (s, 
3H); 
13
C NMR (125 MHz, CDCl3) δ 159.5, 153.2, 151.0, 143.0, 142.4, 139.1, 131.3, 
129.3, 127.7, 125.5, 114.1, 113.6, 112.1, 108.1, 71.5, 61.1, 56.1, 55.2; HRMS m/e for 
C19H22O5 calcd 330.1467, found 330.1478. 
1-(2',3',4'-Trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-ol (136j) 
 
 Title compound was prepared from compound 135i (1.83 g, 6.72 mmol) by 
following General Procedure E. Column chromatography (3:1 diethyl ether/hexanes) 
yielded compound (136j) as a yellow oil (1.46 g, 73 % yield). IR (neat) max 3350, 2932, 
2840, 1598, 1461,1408,1289, 1092 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (two diastereomers 
on NMR time scale, major isomer reported, 23 C) δ 7.53 (dd, J= 1.0, 8.0, 1H), 7.40 
(apparent td, J= 1.0, 8.0, 1H), 7.33 (apparent td, J= 1.5, 7.5, 1H), 7.21 (dd, J= 1.5, 7.5, 
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1H), 6.89 (d, J= 8.5, 1H), 6.77 (d, J= 8.5, 1H), 5.93 (ddd, J= 4.5, 11.0, 17.4, 1H), 5.32 
(apparent dt, J= 2.0, 17.0, 1H), 5.16 (apparent dt, J= 1.5, 10.5, 1H), 5.06 (m, 1H), 3.94 (s, 
6H), 3.54 (s, 3H); 
13
C NMR (75 MHz, CDCl3) (two diastereomers on NMR time scale, 
major isomer reported, 23 C) δ 153.5, 150.8, 141.7, 139.2, 130.3, 128.3, 128.0, 127.5, 
127.4, 125.4, 114.2, 108.1, 71.4, 61.4, 61.2, 56.2; HRMS m/e for C18H20O4 calcd 
300.1362, found 300.13. 
 
 General Procedure F: After dissolving the vinyl alcohol compound in anhydrous 
dichloromethane, an excess amount of activated manganese (IV) dioxide was added in 
one portion. After stirring the reaction mixture at room temperature for 1-3 h (TLC 
control), it was filtered through Celite which was washed with dichloromethane. The 
filtrate was concentrated under reduced pressure to yield the crude compound which was 
purified using flash chromatography to afford the , β-unsaturated ketone compounds 
(137a-h and 146a-b). 
 
1-(3',4,4',5'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (133) 
 
 To a solution of 132 (0.1435 g, 0.435 mmol) in anhydrous dichloromethane (20 
mL) were added 4 Å molecular sieves, N-methylmorpholine N-oxide (0.153 g, 1.30 
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mmol). After stirring the solution for 5 minutes at room temperature, 
tetrapropylammonium perruthenate (0.010 g, 0.0028 mmol) was added. The reaction was 
stirred for 2 h, then it was filtered through Celite and washed with diethyl ether. After 
removing the volatiles under reduced pressure, the obtained crude sample was purified by 
column chromatography (1:1 diethyl ether/hexanes) to afford the product (133) as a 
yellow solid (0.107 g, 75 % yield), mp 99-100 C. IR (neat) max 2937, 2836, 1711, 1665, 
1583, 1484, 1240, 1121, 1005, 821 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.38 (d, J= 8.5, 
1H), 7.05-7.08 (m, 2H), 6.47 (s, 2H), 6.18 (dd, J= 10.5, 17.5, 1H), 6.00 (dd, J= 1.5, 17.5, 
1H), 5.56 (dd, J= 1.5, 10.5, 1H), 3.86 (s, 6H), 3.82 (s, 6H); 
13
C NMR (125 MHz, CDCl3) 
δ 197.0, 158.9, 153.2, 140.1, 137.5, 135.8, 135.5, 133.4, 130.9, 128.8, 117.2, 113.1, 
106.4, 61.0, 56.1, 55.6; HRMS m/e for C19H20O5 calcd 328.1311, found 328.1307. 
1-(3',4',5'-Trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (137a) 
 
 To a solution of 136a (0.0455 g, 0.151 mmol) in anhydrous dichloromethane (10 
mL) were added 4 Å molecular sieves, N-methylmorpholine N-oxide (0.053 g, 0.455 
mmol). After stirring the solution for 5 minutes at room temperature, 
tetrapropylammonium perruthenate (0.0033 g, 0.0095 mmol) was added. The reaction 
was stirred for 12 h, then it was filtered through Celite and washed with diethyl ether. 
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After removing the volatiles under reduced pressure, the obtained crude sample was 
purified by column chromatography (1:1 diethyl ether/hexanes) to afford the product 
(137a) as a yellow solid (80 % yield), mp 68-70 C. IR (neat) max 2938, 2835, 1658, 
1582, 1455, 1406, 1344, 1239, 1122, 994, 729 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.41-
7.46 (m, 2H), 7.51-7.54 (m, 2H), 6.51 (s, 2H), 6.20 (dd, J= 10.5, 17.5, 1H), 5.98 (dd, J= 
1.5, 17.5, 1H), 5.57 (dd, J= 1.5, 10.5, 1H), 3.87 (s, 3H), 3.82 (s, 6H); 
13
C NMR (125 
MHz, CDCl3) δ 197.3, 153.3, 140.7, 139.2, 137.8, 136.0, 135.8, 130.7, 129.6, 128.8, 
128.7, 127.4, 106.4, 61.0, 56.1; HRMS m/e for C18H18O4 calcd 298.1205, found 
298.1213. 
Methyl 2-acryloyl-3',4',5'-trimethoxy-[1,1'-biphenyl]-4-carboxylate (137b)  
 
 Title compound was prepared by following General Procedure F. Column 
chromatography (2:1 diethyl ether/hexanes) yielded the product (137b) as a yellow 
viscous oil (90 % yield). IR (neat) max 2937, 2839, 1719, 1661, 1598, 1284, 1092 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.18 (s, 1H), 8.17 (d, J= 1.5, 1H), 7.54 (d, J= 8.0, 1H), 
6.52 (s, 2H), 6.23 (dd, J= 10.5, 17.0, 1H), 5.99 (dd, J= 1.0, 17.5, 1H), 5.65 (dd, J= 1.0, 
10.5, 1H), 3.95 (s, 3H), 3.88 (s, 3H), 3.83 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 196.5, 
166.2, 153.4, 144.9, 139.2, 138.4, 135.8, 134.7, 131.5, 130.0, 129.9, 129.6, 129.2, 106.3, 
61.0, 56.2, 52.4; HRMS m/e for C20H20O6 calcd 356.1260, found 356.1251.  
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1-(4-Fluoro-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (137c) 
 
 To a solution of 136c (0.171 g, 0.538 mmol) in anhydrous dichloromethane (10 
mL) were added 4 Å molecular sieves, N-methylmorpholine N-oxide (0.189 g, 1.614 
mmol). After stirring the solution for 5 minutes at room temperature, 
tetrapropylammonium perruthenate (0.028 g, 0.081 mmol) was added. The reaction was 
stirred for 1 h, then it was filtered through Celite and washed with diethyl ether. After 
removing the volatiles under reduced pressure, the obtained crude sample was purified by 
column chromatography (1:1 diethyl ether/hexanes) to afford the product (137c) as a 
yellow solid (0.112 g, 66 % yield), mp 73-74.5 C. IR (neat) max 2941, 2836, 1659,1575, 
1482, 1453, 1304, 1241, 1122, 827 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.37 (m, 1H), 
7.15-7.18 (m, 2H), 6.42 (s, 2H), 6.13 (dd, J= 10.5, 17.4, 1H), 5.94 (dd, J= 1.5, 17.4, 1H), 
5.56 (dd, J= 1.5, 10.2, 1H), 3.81 (s, 3H), 3.77 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 
195.7, 161.8 (d, JC,F = 247), 153.3, 140.6 (d, JC,F = 6.1), 137.9, 136.8, 136.8, 135.5, 134.7, 
131.5 (d, JC,F = 7.7), 129.4, 117.6 (d, JC,F = 21.1), 115.4 (d, JC,F = 22.7), 106.5, 61.0, 56.1; 
HRMS m/e for C18H17FO4 calcd 316.1111, found 316.1107. 
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1-(4-(Benzyloxy)-3',4',5'-trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (137d) 
 
 Title compound was prepared by following General Procedure F. Column 
chromatography (1:1 diethyl ether/hexanes) yielded the product (137d) as a yellow solid 
(70 %, 81 % brsm), mp 97-98.5 C. IR (neat) max 2964, 2935, 1712, 1674, 1585, 1488, 
1228, 1190, 1123, 1001 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.33-7.46 (m, 6H), 7.12-
7.16 (m, 2H), 6.47 (s, 2H), 6.18 (dd, J= 10.5, 17.5, 1H), 6.00 (dd, J= 1.5, 17.5, 1H), 5.57 
(dd, J= 1.5, 10.5, 1H), 5.13 (s, 2H), 3.87 (s, 3H), 3.82 (s, 6H); 
13
C NMR (75 MHz, 
CDCl3) δ 197.0, 158.2, 153.3, 140.2, 137.7, 136.6, 136.0, 135.6, 133.8, 131.1, 129.0, 
128.8, 128.3, 127.7, 118.0, 114.4, 106.5, 70.4, 61.1, 56.2; HRMS m/e for C25H24O5 calcd 
404.1624, found 404.1609. 
1-(3',4',5,5'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (137e) 
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 To a solution of 136e (0.0522 g, 0.158 mmol) in anhydrous dichloromethane (10 
mL) were added 4 Å molecular sieves, N-methylmorpholine N-oxide (0.055 g, 0.474 
mmol). After stirring the solution for 5 minutes at room temperature, 
tetrapropylammonium perruthenate (0.0035 g, 0.001 mmol) was added. The reaction was 
stirred for 30 min, and then it was filtered through Celite and washed with diethyl ether. 
After removing the volatiles under reduced pressure, the obtained crude sample was 
purified by column chromatography (1:1 diethyl ether/hexanes) to afford the product 
(137e) as a yellow solid (0.0365 g, 70 % yield), mp 98-100 C. IR (neat) max 2935, 1681, 
1583, 1488, 1235, 1124, 998 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.38 (d, J= 8.5, 1H), 
7.07 (m, 2H), 6.47 (s, 2H), 6.19 (dd, J= 10.5, 17.5, 1H), 6.01 (dd, J= 1.5, 17.5, 1H), 5.57 
(dd, J= 1.5, 10.5, 1H), 3.87 (s, 3H), 3.87 (s, 3H), 3.83 (s, 6H); 
13
C NMR (125 MHz, 
CDCl3) δ 197.0, 158.9, 153.2, 140.1, 137.5, 135.8, 135.5, 133.4, 130.9, 128.8, 117.2, 
113.1, 106.4, 61.0, 56.1, 55.6; HRMS m/e for C19H20O5 calcd 328.1311, found 328.1318. 
1-(6-(3,4,5-Trimethoxyphenyl)benzo[d][1,3]dioxol-5-yl)prop-2-en-1-one (137f) 
 
 To a solution of 136f (0.0935 g, 0.271 mmol) in anhydrous dichloromethane (20 
mL) were added 4 Å molecular sieves, N-methylmorpholine N-oxide (0.095 g, 0.814 
mmol). After stirring the solution for 5 minutes at room temperature, 
tetrapropylammonium perruthenate (0.0143 g, 0.041 mmol) was added. The reaction was 
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stirred for 1 h at room temperature, and then it was filtered through Celite and washed 
with diethyl ether. After removing the volatiles under reduced pressure, the obtained 
crude sample was purified by column chromatography (2:1 diethyl ether/hexanes) to yield 
the product (137f) as colorless solid (68 %), mp 136-138 C. IR (neat) max 2937, 1662, 
1575, 1479, 1244, 1233, 1117 cm
-1
; 
1
H NMR (500 MHz, CD2Cl2) δ 7.04 (s, 1H), 6.91 (s, 
1H), 6.46 (s, 2H), 6.10 (dd, J= 10.3, 17.3, 1H), 6.07 (s, 2H), 5.97 (dd, J= 1.8, 17.3, 1H), 
5.46 (dd, J= 1.8, 10.3, 1H), 3.79 (s, 6H), 3.78 (s, 3H); 
13
C NMR (125 MHz, CD2Cl2) δ 
194.9, 153.3, 149.7, 147.1, 136.9, 135.8, 135.7, 133.2, 127.1, 109.5, 108.8, 106.7, 102.1, 
60.6, 56.0; HRMS m/e for C19H18O6 calcd 342.1103, found 342.1107. 
1-(3,3',4,4',5'-Pentamethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (137g) 
 
 Title compound was prepared by following General Procedure F. Column 
chromatography (2:1 hexanes/diethyl ether) yielded the product (137g) as a yellow oil (95 
% yield). IR (neat) max 2958, 2932, 2838, 1652, 1582, 1482, 1458, 1402, 1255, 1124   
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.12 (d, J= 8.5, 1H), 7.00 (d, J= 8.5, 1H), 6.46 (s, 
2H), 6.36 (dd, J= 11.0, 17.5, 1H), 5.85 (d, J= 10.5, 1H), 5.83 (d, J= 17.5, 1H), 3.91 (s, 
3H), 3.83 (s, 3H), 3.82 (s, 3H), 3.80 (s, 6H); 
13
C NMR (75 MHz, CDCl3) δ 197.4, 153.1, 
152.1, 146.1, 138.1, 137.3, 135.1, 133.8, 132.9, 131.3, 125.3, 113.2, 106.4, 61.9, 61.0, 
56.2, 56.1; HRMS m/e for C20H22O6 calcd 358.1416, found 358.1414. 
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1-(3-(3,4,5-Trimethoxyphenyl)thiophen-2-yl)prop-2-en-1-one (137h) 
 
 
 Title compound was prepared from compound 136h (0.0840 g, 0.274 mmol) by 
following General Procedure F. Column chromatography (2:1 diethyl ether/hexanes) 
yielded the product (137h) as a yellow oil (0.0587 g, 71 % yield). IR (neat) max 2956, 
2915, 2871, 1643, 1583, 1497, 1127 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.60 (d, J= 5.0, 
1H), 7.13 (d, J= 5.0, 1H), 6.59 (s, 2H), 6.41 (dd, J= 9.5, 17.0, 1H), 6.35 (dd, J= 2.5, 17.0, 
1H), 5.56 (dd, J= 2.5, 9.5, 1H), 3.91 (s, 3H), 3.85 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 
184.6, 153.1, 146.5, 139.7, 138.2, 133.8, 131.7, 131.4, 131.36, 128.2, 106.8, 61.0, 56.2; 
HRMS m/e for C16H16O4S calcd 304.0769, found 304.0756.  
1-(2',3',4,4'-Tetramethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (146a) 
 
 
Title compound was prepared by following General Procedure F. Column 
chromatography (1:1 diethyl ether/hexanes) yielded the product (146a) as a yellow oil (73 
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% yield). IR (neat) max 2937, 2837, 1668, 1599, 1482, 1463, 1414, 1291, 1272, 1087, 
1014 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.30 (d, J= 8.5, 1H), 7.15 (d, J= 2.5, 1H), 7.07 
(dd, J= 3.0, 8.5, 1H), 6.88 (d, J= 8.0, 1H), 6.68 (d, J= 8.5, 1H), 6.29 (dd, J= 10.3, 17.3, 
1H), 6.10 (dd, J= 1.5, 17.5, 1H), 5.56 (dd, J= 1.5, 10.0, 1H), 3.88 (s, 3H), 3.87 (s, 3H), 
3.84 (s, 3H), 3.57 (s, 3H); 
13
C NMR (125 MHz, CDCl3) δ 195.1, 158.6, 153.5, 151.1, 
142.1, 140.2, 135.2, 132.3, 129.3, 128.4, 126.9, 125.0, 117.1, 113.1, 107.2, 61.0, 60.4, 
56.0, 55.5; HRMS m/e for C19H20O5 calcd 328.1311, found 328.1318. 
1-(2',3',4'-Trimethoxy-[1,1'-biphenyl]-2-yl)prop-2-en-1-one (146b) 
 
 Title compound was prepared from compound 136j (1.31 g, 4.36 mmol) by 
following General Procedure F. Column chromatography (1:1 diethyl ether/hexanes) 
yielded the product (146b) as a yellow oil (1.17 g, 90 % yield). IR (neat) max 3057, 2937, 
1668, 1599, 1500, 1464, 1406, 1292, 1268, 1214, 1095 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 7.62 (apparent dd, J= 1.0, 8.0, 1H), 7.52 (td, J= 1.5, 7.5, 1H), 7.42 (td, J= 1.5, 
7.5, 1H), 7.38 (apparent dd, J= 1.0, 8.0, 1H), 6.91 (d, J= 8.5, 1H), 6.70 (d, J= 8.5, 1H), 
6.33 (dd, J= 10.5, 17.0, 1H), 6.09 (dd, J= 1.5, 17.5, 1H), 5.59 (dd, J= 1.5, 10.5, 1H), 3.89 
(s, 3H), 3.85 (s, 3H), 3.58 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 195.4, 153.9, 151.1, 
142.3, 139.4, 137.1, 135.5, 131.2, 130.8, 128.7, 128.5, 127.4, 127.2, 125.1, 107.3, 61.1, 
60.6, 56.1; HRMS m/e for C18H18O4 calcd 298.1205, found 298.12. 
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 General Procedure G: A dilute solution of , β-unsaturated ketone compound 
(133, 146a, and 137a-h) in anhydrous dichloromethane (concentration = 0.002 M) was 
cooled to 0 C. Then, a solution of boron trifluoride diethyl ethereate (cat. loading 5 mol 
%) in dichloromethane, was slowly added to the reaction solution. Stirring was continued 
and the mixture was allowed to gradually warm to room temperature. Upon the complete 
consumption of the starting material (3-24 h), the reaction was quenched with a saturated 
solution of sodium bicarbonate and extracted with dichloromethane (twice). The organic 
layer was separated and dried with anhydrous magnesium sulfate. The volatiles were 
removed under reduced pressure and the residue was purified by flash chromatography to 
afford the tricyclic ketone products (117b and 138a-g). 
3,8,9,10-Tetramethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-one (117b) 
 
  
 (117b) from (133): Compound 133 (0.0408 g, 0.12 mmol) was subjected to the 
reaction conditions given under General Procedure G (4 h). Column chromatography 
(2:1 diethyl ether/hexanes) afforded title compound (117b) as a colorless solid (0.0307 g, 
75 % yield); mp 123-124 C (lit.28 123-125 C). Spectral data are in agreement with those 
reported in literature. 
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 (117b) from (146a): To a solution of 146a (0.0374 g, 0.114 mmol) in anhydrous 
dichloromethane (60 mL) was added GaCl3 (4.0 mg, 2.3 x 10
5
 mmol). The mixture was 
heated to reflux until disappearance of starting material was evident by TLC (48 h). 
Following the addition of water and a conventional extractive workup (dichloromethane), 
preparative TLC (1:1 diethyl ether/hexanes) afforded 117b (0.0232 g, 62 % yield). 
8,9,10-Trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-one (138a) 
 
 (138a) from (137a): Compound 137a (0.0408 g, 0.124 mmol) was subjected to 
the reaction conditions given under General Procedure G (12 h). Column 
chromatography (1:1 diethyl ether/hexanes) yielded the title compound (138a) as a 
viscous yellow oil (81 % yield). IR (neat) max 2958, 2923, 2853, 1679, 1455, 1259, 
1109, 1019, 800 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.56-7.62 (m, 2H), 7.40-7.43 (m, 
2H), 6.73 (s, 1H), 3.93 (s, 3H), 3.89 (s. 3H), 3.88 (s, 3H), 2.92-3.00 (m, 4H); 
13
C NMR 
(125 MHz, CDCl3) δ 206.8, 152.4, 150.3, 142.2, 139.0, 138.8, 134.7, 132.0, 129.1, 128.4, 
127.8, 125.6, 109.4, 61.5, 61.0, 56.2, 47.7, 20.6; HRMS m/e for C18H18O4 calcd 
298.1205, found 298.1200. 
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 (138a) from (146b): To a solution of 146b (0.0280 g, 0.093 mmol) in anhydrous 
toluene (30 mL) was added 0.10 mL (0.093 mmol, 1 equiv.) of AlCl3 (1.0 M in 
nitrobenzene). The mixture was heated to reflux until disappearance of starting material 
was evident by TLC (24 h). Following the addition of water and a conventional extractive 
workup, preparative TLC (1:1 diethyl ether/hexanes) afforded 138a (0.0125 g, 45 % 
yield). 
Methyl 8,9,10-trimethoxy-5-oxo-6,7-dihydro-5H-dibenzo[a,c][7]annulene-3 
carboxylate (138b) 
 
 Compound 137b (0.0794 g, 2.23 mmol) was subjected to the reaction conditions 
given under General Procedure G (the catalytic loading of BF3-OEt2 for this reaction was 
10 mol %; reaction time 48 h). Column chromatography (2:1 diethyl ether/hexanes) 
yielded the title compound (138b) as a colorless solid (68 % yield), mp 109-110.5 C;   
IR (neat) max 2935, 1728, 1676, 1237, 1108 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.26 (d, 
J= 1.5, 1H), 8.21 (dd, J= 1.8, 8.1, 1H),7.50 (d, J= 8.1, 1H) 6.73 (s, 1H), 3.94 (s, 3H), 3.93 
(s, 3H), 3.89 (s, 3H), 3.89 (s, 3H), 2.97 (br m, 4H); 
13
C NMR (125 MHz, CDCl3) δ 205.8, 
166.1, 152.6, 150.4, 143.0, 142.8, 139.1, 133.7, 132.6, 129.8, 129.6, 129.4, 125.9, 109.4, 
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61.5, 61.0, 56.2, 52.4, 47.4, 20.5; HRMS m/e for C20H20O6 calcd 356.1260, found 
356.1260. 
3-Fluoro-8,9,10-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-one (138c) 
 
 Compound 137c (0.0413 g, 0.131 mmol) was subjected to the reaction conditions 
given under General Procedure G (48 h) with the exception of a doubling of solvent 
volume. Column chromatography (1:1 diethyl ether/hexanes) afforded the title compound 
(138c) as a viscous yellow oil (68 % yield). IR (neat) max 2936, 2838, 1680, 1480, 1452, 
1410, 1342, 1251, 1196, 1105, 796 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.42 (dd, J= 5.4, 
8.4, 1H), 7.24-7.34 (m, 2H), 6.68 (s, 1H), 3.92 (s, 3H), 3.89 (s, 3H), 3.88 (3, 3H), 2.91- 
3.00 (m, 4H); 
13
C NMR (125 MHz, CDCl3) δ 205.2, 162.0 (d, JC,F = 248), 152.5, 150.3, 
142.2, 140.5 (d, JC,F = 6.4), 135.0 (d, JC,F = 3.5), 133.7, 131.2 (d, JC,F = 7.0), 125.5, 119.0 
(d, JC,F = 21.0), 115.1 (d, JC,F = 22.7), 109.3, 61.4, 60.9, 56.2, 47.3, 20.5; HRMS m/e for 
C18H17FO4 calcd 316.1111, found 316.1102. 
 
 
 
167 
 
3-(Benzyloxy)-8,9,10-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-one 
(138d)  
 
 Compound 137d (0.0702 g, 0.174 mmol) was subjected to the reaction conditions 
given under General Procedure G (reaction time: 48 h). Column chromatography (1:1 
diethyl ether/hexanes) yielded the title compound (138d) as a yellow solid (81 % yield); 
mp 109-111C. IR (neat) max 2928, 1851, 1675, 1600, 1453, 1411, 1108, 1008, 699 cm
-1
;
              
1
H NMR (500 MHz, CDCl3) δ 7.46 (m, 2H), 7.41 (t, J= 7.3, 2H), 7.35-7.37 (m, 2H), 7.24 
(d, J= 3.0, 1H), 7.19 (dd, J= 3.0, 8.5, 1H), 6.69 (s, 1H), 5.13 (s, 2H), 3.92 (s, 3H), 3.89 (s, 
3H), 3.88 (s, 3H), 2.92-3.00 (m, 4H); 
13
C NMR (125 MHz, CDCl3) δ 206.3, 158.3, 152.3, 
150.3, 141.8, 139.9, 136.5, 134.5, 131.8, 130.7, 128.7, 128.2, 127.6, 125.4, 119.6, 113.3, 
109.2, 70.2, 61.5, 61.0, 56.2, 47.5, 29.7, 20.6; HRMS m/e for C25H24O5 calcd 404.1624, 
found 404.1621. 
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2,8,9,10-Tetramethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-one (138e) 
 
 Compound 137e (0.0600 g, 0.183 mmol) was subjected to the reaction conditions 
given under General Procedure G (12 h). Column chromatography (2:1 diethyl 
ether/hexanes) yielded the title compound (138e) as a colorless solid (70 % yield), mp 
120-122 C. IR (neat) max 2928, 1727, 1678, 1482, 1457, 1413, 1255, 1103, 1031 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.36 (m, 1H), 7.13 (m, 2H), 6.69 (s, 1H), 3.92 (s, 3H), 
3.89 (s, 3H), 3.87 (s, 6H), 2.94 (m, 4H); 
13
C NMR (125 MHz, CDCl3) δ 206.4, 159.1, 
152.3, 150.3, 141.8, 139.8, 134.5, 131.6, 130.6, 125.4, 119.0, 112.2, 109.2, 61.4, 61.0, 
56.2, 55.5, 47.5, 20.6; HRMS m/e for C19H20O5 calcd 328.1311, found 328.1310. 
2,3,4-Trimethoxy-5H-benzo[3',4']cyclohepta[1',2':4,5]benzo[1,2-d][1,3]dioxol-7(6H)-
one (138f) 
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 Compound 137f (0.0510 g, 0.149 mmol) was subjected to the reaction conditions 
given under General Procedure G (72 h). Column chromatography (2:1 diethyl 
ether/hexanes) yielded the title compound (138f) as a solid (63 % yield), mp 145-147 C. 
IR (neat) max 2922, 2851, 1730, 1655, 1498, 1478, 1457, 1250, 1101, 1021 cm
-1
;          
1
H NMR (500 MHz, CDCl3) δ 7.12 (s, 1H), 6.88 (s, 1H), 6.65 (s, 1H), 6.06 (s, 2H), 3.92 
(s, 3H), 3.88 (s, 3H), 3.87 (s, 3H), 2.97 (m, 2H), 2.87 (m, 2H); 
13
C NMR (125 MHz, 
CDCl3) δ 204.9, 152.3, 150.9, 150.1, 147.3, 142.0, 134.9, 134.4, 133.1, 125.7, 109.4, 
109.1, 108.6, 101.9, 61.4, 60.9, 56.2, 47.3, 20.6; HRMS m/e for C19H18O6 calcd 
342.1103, found 342.1105. 
7,8,9-Trimethoxy-5,6-dihydro-4H-benzo[3,4]cyclohepta[1,2-b]thiophen-4-one (138g) 
 
 
 To a solution of 137h (12.6 mg, 0.0414 mmol) in anhydrous dichloromethane (30 
mL) was added GaCl3 (1.8 mg, 0.010 mmol, 0.25 equiv.). The mixture was stirred for 48 
h at room temperature. Following the addition of water and a conventional extractive 
workup (dichloromethane), preparative TLC (1:1 diethyl ether/hexanes) afforded 138g 
(8.80 mg, 70 % yield) as a pale yellow oil. IR (neat) max 2931, 1646, 1493, 1452, 1119 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.66 (d, J= 5.5, 1H), 7.33 (d, J= 5.0, 1H), 6.93 (s, 
1H), 3.94 (s, 3H), 3.91 (s, 3H), 3.87 (s, 3H), 3.06 (br s, 2H), 2.83 (m, 2H); 
13
C NMR (125 
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MHz, CDCl3) δ 195.4, 151.9, 150.8, 143.6, 142.8, 139.4, 132.7, 129.7, 129.68, 127.1, 
108.7, 61.5, 61.0, 56.2, 43.1, 20.0; HRMS m/e for C16H16O4S calcd 304.0769, found 
304.0763. 
2,3-Dimethoxy-2'H-spiro[cyclohexa[2,5]diene-1,1'-naphthalene]-4,4'(3'H)-dione 
(147) 
 
 To a solution of 146b (0.0150 g, 0.050 mmol) in anhydrous dichloromethane (15 
mL) was added GaCl3 (2.2 mg, 0.0126 mmol). The mixture was stirred for 12 h at room 
temperature. Following the addition of water and a conventional extractive workup 
(dichloromethane), preparative TLC (1:1 diethyl ether/hexanes) afforded the spiro-
conjugated compound (147) as a colorless solid (9.63 mg, 67 % yield), mp 135-137 C. 
IR (neat) max 3453, 2931, 1685, 1654, 1597, 1491 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
8.12 (dd, J= 1.0, 8.0, 1H), 7.51 (td, J= 1.5, 7.5, 1H), 7.42 (td, J= 1.5, 7.5, 1H), 7.07 (dd, 
J= 0.5, 7.8, 1H), 6.79 (d, J= 10.0, 1H), 6.27 (d, J= 10.0, 1H), 3.94 (s, 3H), 3.81 (s, 3H), 
2.95 (m, 1H), 2.83 (m, 1H), 2.70 (m, 1H), 2.24 (m, 1H);
 13
C NMR (125 MHz, CDCl3) δ 
196.1, 184.1, 164.6, 147.0, 141.5, 138.8, 134.1, 132.6, 128.4, 128.1, 127.3, 126.9, 61.2, 
60.9, 48.5, 34.3, 32.5; HRMS m/e for C17H16O4 calcd 284.1049, found 284.1051.  
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(R)-8,9,10-Trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-ol (142a) 
 
 A suspension of 3-nitrophenylboronic acid (1.002 g, 6.0 mmol), L-tartaric acid 
(0.900 g, 6.0 mmol), and CaH2 (0.500 g, 11.9 mmol) in anhydrous THF (15 mL) was 
heated to reflux for 1.5 h. After cooling and allowing the solids to settle completely, the 
supernatant solution (ca. 8 mL) was added to ketone 138a (0.1207 g, 0.405 mmol) and 
the solution was allowed to stir for 1 h at room temperature. Then, lithium borohydride 
(0.2 mL of a 2.0 M solution in THF, 0.405 mmol) was added dropwise over a period of 
30 min, and stirring was continued for another one hour at room temperature. The 
reaction was then quenched with NaOH (ca. 5 mL of a 10 % aqueous solution) and the 
reaction was subjected to a conventional extractive workup using water and diethyl ether. 
Column chromatography (2:1 Et2O/hexanes) afforded 142a (0.1199 g, 99 %) as a yellow 
viscous oil (99 % ee, Chiralcel OD-H, 10 % i-PrOH/hexanes; flow rate: 0.5 mL/min, 
retention time: 20.0 min). [α]22D +80.1 (c 0.625, CH2Cl2). IR (neat) max 3427, 2933, 
1404, 1340, 1099, 1041, 1011, 764, 733 cm
-1
; 
1
H NMR (500 MHz, DMSO-d6) δ 7.63 (d, 
J= 7.5, 1H), 7.37 (m, 3H), 6.79 (s, 1H), 5.21 (d, J= 4.5, 1H), 4.31 (m, 1H), 3.83 (s, 3H), 
3.79 (s, 6H), 2.87 (m, 1H), 2.41 (m, 1H), 1.81 (m, 2H); 
13
C NMR (125 MHz, DMSO-d6) 
δ 151.9, 150.7, 143.0, 141.6, 137.7, 135.7, 127.9, 127.7, 127.1, 124.9, 123.9, 108.7, 68.9, 
61.9, 60.9, 56.3, 41.9, 21.9; HRMS m/e for C18H20O4 calcd 300.1360, found 300.1360. 
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(R)-Methyl 5-hydroxy-8,9,10-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene-3-
carboxylate (142b) 
 
 Singaram
44
 protocol: A suspension of 3-nitrophenylboronic acid (1.002 g, 6.0 
mmol), L-tartaric acid (0.900 g, 6.0 mmol), and CaH2 (0.500 g, 11.9 mmol) in anhydrous 
THF (15 mL) was heated to reflux for 1.5 h. After cooling and allowing the solids to 
settle completely, the supernatant solution (ca. 4 mL) was added to ketone 138b (0.024 g, 
0.067 mmol) and the solution was allowed to stir for 1 h at room temperature. Then, 
lithium borohydride (0.03 mL of a 2.0 M solution in THF, 0.067 mmol) was added 
dropwise over a period of 30 min, and stirring was continued for another one hour at 
room temperature. The reaction was then quenched with NaOH (ca. 4 mL of a 10 % 
aqueous solution) and the reaction was subjected to a conventional extractive workup 
using water and diethyl ether. Column chromatography (2:1 Et2O/hexanes) afforded 142b 
(0.019 g, 80 %) as a colorless solid (99 % ee, Chiralcel OD-H, 10 % i-PrOH/hexanes; 
flow rate: 0.5 mL/min, retention time: 25.5 min), mp 131-133.5 C; [α]22D +128 (c 
0.110, CH2Cl2). IR (neat) max 3479, 2934, 1713, 1341, 1290, 1101 cm
-1
; 
1
H NMR 
(DMSO-d6) δ 8.26 (s, 1H), 7.94 (dd, J= 1.5, 8.0, 1H), 7.52 (d, J= 8.0, 1H), 6.85 (s, 1H), 
5.40 (d, J= 5.0, 1H), 4.30-4.34 (m, 1H), 3.89 (s, 3H), 3.84 (s, 3H), 3.80 (s, 3H), 3.79 (s, 
3H), 2.88 (dd, J= 6.0, 13.0, 1H), 2.38-2.48 (m, 1H), 1.82-1.88 (m, 1H), 1.72-1.79 (m, 
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1H); 
13
C NMR (75 MHz, DMSO-d6) δ 166.9, 152.1, 150.8, 143.7, 142.6, 142.3, 134.6, 
128.8, 128.5, 128.2, 125.2, 108.9, 68.8, 62.0, 61.0, 56.5, 52.7, 41.8, 21.8; HRMS m/e for 
C20H22O6 calcd 340.1311 [MH2O]
+
, found 340.1299. 
(S)-7-Azido-2,3,4-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene (143a) 
 
 To a suspension of alcohol 142a (0.0436 g, 0.145 mmol), Zn(N3)2-(pyridine)2 
(0.0685 g, 0.217 mmol), and triphenylphosphine (0.1521 g, 0.580 mmol) in toluene (12 
mL) was added diisopropyl azodicarboxylate (116µL, 0.580 mmol) in a dropwise fashion. 
After stirring for 4 h, the mixture was filtered through a plug of silica gel, and 
concentrated under reduced pressure. Column chromatography (5:1 hexanes/Et2O) 
afforded compound (143a) as a yellow oil (0.034g, 72 % yield). [α]22D 87 (c 0.55, 
CH2Cl2). IR (neat) max 2934, 2097, 1717, 1245,1342, 1110, 766, 747 cm
-1
; 
1
H NMR 
(500 MHz, DMSO-d6) δ 7.54 (s, 1H), 7.30 (m, 3H), 6.74 (s, 1H), 4.47 (br s, 1H), 3.95 (s, 
3H), 3.91 (s, 3H), 3.01 (s, 1H), 2.55 (m, 1H); 
13
C NMR (75 MHz, CDCl3) δ 152.1, 150.9, 
142.0, 138.9, 137.2, 135.5, 128.4, 127.9, 124.5, 108.2, 61.7, 61.1, 56.3, 39.1, 21.6; 
HRMS m/e for C18H19N3O3 calcd 325.1426, found 325.1414. 
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(S)-Methyl 5-azido-8,9,10-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene-3-
carboxylate (143b) 
 
 To a suspension of alcohol 142b (0.0844 g, 0.235 mmol), Zn(N3)2-(pyridine)2 
(0.111 g, 0.353 mmol), and triphenylphosphine (0.247 g, 0.942 mmol) in toluene (18 mL) 
was added diisopropyl azodicarboxylate (188µL, 0.942 mmol) in a dropwise fashion. 
After stirring for 4 h, the mixture was filtered through a plug of silica gel, and 
concentrated under reduced pressure. Column chromatography (5:1 hexanes/Et2O) 
afforded compound (143b) as a yellow oil (0.0676 g, 77 % yield). [α]22D 102 (c 0.490, 
CH2Cl2). IR (neat) max 3325, 2980, 2938, 2103, 1721, 1481, 1455, 1435, 1241, 1225, 
1108 cm
-1
; 
1
H NMR (500 MHz, DMSO-d6) δ 8.07 (s, 1H), 8.01 (d, J= 8.0, 1H), 7.61 (d, 
J= 8.0, 1H), 6.91 (s,1H), 4.70 (br s, 1H), 3.89 (s, 3H), 3.86 (s, 3H), 3.81 (s, 6H), 2.80 (br, 
1H), 2.54 (m, 1H), 2.02 (m, 1H), 1.21 (m, 1H); 
13
C NMR (125 MHz, DMSO-d6) δ 166.4, 
152.3, 150.9, 142.5, 137.7, 134.1, 129.6, 129.2, 129.1, 124.3, 109.0, 61.9, 60.9, 56.4, 
52.7, 38.6, 21.6; HRMS m/e for C20H21N3O5 calcd 383.1481, found 383.1481. 
 
 
175 
 
(S)-N-(8,9,10-Trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)acetamide 
(144) 
 
 Title compound was prepared from azide 143a (0.0333 g, 0.10 mmol) according 
to the reductive amination/acylation protocol of Wulff and co-workers.
24
 Column 
chromatography (19:1 CH2Cl2/ MeOH) yielded 144 (0.0248 g, 71% yield) in 98% ee 
(Chiralcel OD-H, 10 % i-PrOH/ hexanes; flow rate: 0.5 mL/min, retention time: 22.4 
min). A single recrystallization afforded (144), in > 99% ee, as colorless crystals, mp 218-
220.6 C; [α]22D 35.0 (c 0.355, CHCl3). IR (neat) max 3279, 2933,1635, 1546, 1108, 
1054, 770, 749; 
1
H NMR (500 MHz, DMSO-d6) δ 8.43 (d, J= 8.0, 1H), 7.34-7.37 (m, 
4H), 6.84 (s, 1H), 4.52 (m, 1H), 3.86 (s, 3H), 3.80 (s, 3H), 3.79 (s, 3H), 2.92 (m, 1H), 
2.18 (m, 1H),1.97 (m, 1H), 1.88 (s, 3H), 1.77 (m, 1H); 
13
C NMR (75 MHz, DMSO-d6) δ 
169.0, 152.2, 150.8, 141.7, 140.3, 138.9, 135.9, 128.5, 128.0, 127.5, 124.4, 123.9, 108.9, 
62.0, 61.0, 56.4, 48.9, 23.2, 22.3; HRMS m/e for C20H23NO4 calcd 341.1627, found 
341.1616. 
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(S)-Methyl 5-acetamido-8,9,10-trimethoxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene-
3-carboxylate (145) 
 
 Title compound was prepared from azide 143b (0.0674 g, 0.175 mmol) according 
to the reductive amination/acylation protocol of Wulff and co-workers.
24
 Column 
chromatography (19:1 CH2Cl2/ MeOH) yielded 145 (0.033 g, 57% yield) in 99 % ee 
(Chiralcel OD-H, 10 % i-PrOH/hexanes; flow rate: 0.5 mL/min, retention time: 29.5 
min). A single recrystallization afforded (145), in > 99% ee, as colorless crystals, mp 205-
207.5 C; [α]22D 136.7 (c 0.1550, CHCl3). IR (neat) max 3266, 2928, 1720, 1643, 1298, 
1103, 1012 cm
-1
; 
1
H NMR (500 MHz, DMSO-d6) δ 8.61 (d, J= 8.5, 1H), 7.95 (m, 2H), 
7.55 (d, J= 7.5, 1H), 6.93 (s, 1H), 4.52 (m, 1H), 3.86 (s, 3H), 3.80 (s, 3H), 3.79 (s, 3H), 
2.92 (m, 1H), 2.18 (m, 1H), 1.97 (m, 1H), 1.88 (s, 3H), 1.77 (m, 1H); 
13
C NMR (75 
MHz, DMSO-d6) δ 169.1, 166.8, 152.3, 150.9, 143.8, 142.4, 141.1, 134.7, 129.1, 129.0, 
128.4, 124.8, 124.6, 109.0, 62.1, 61.0, 56.4, 52.8, 48.9, 26.0, 23.2, 22.2; HRMS m/e for 
C22H25NO6 calcd 399.1682, found 399.1675. 
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